here - 27th Annual Meeting of the Society for Virology
Transcription
here - 27th Annual Meeting of the Society for Virology
PROGRAMME 26th Annual Meeting of the Society for Virology Gesellschaft für Virologie e. V. (GfV) und DVV Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V. (DVV) Viruses in Motion © Presseamt Münster • Angelika Klauser 6–9 April 2016 Münster • Germany University of Münster www.virology-meeting.de Take a step towards better patient outcomes We know that an accurate, timely diagnosis is a vital step in determining the pathways and outcomes of infectious disease patients. That’s why we’ve developed validated assays that use state of the art techniques to provide sensitive and specific diagnostic information. With leading portfolios in microbiology and virology, including PCR and IGRA technologies, QIAGEN has solutions to help you improve the clinical management of patients. Let’s take a step forward together. Join us at the GfV at Booth #15 and at our Lunchsymposium on Friday April 8, 12:30 – 13:30 h Lecture Hall 2 Trademarks: QIAGEN®, Sample to Insight®, (QIAGEN Group). PROM-9253 © 2016 QIAGEN, all rights reserved. Sample to Insight Table of Contents Welcome Notes Conference Chair........................................................................................................ 4 President of the Society for Virology (GfV)................................................................. 5 President of the Robert-Koch-Institute (RKI).............................................................. 6 President of the Friedrich-Loeffler-Institute (FLI)........................................................ 8 Organisation and Imprint............................................................................................................ 10 Societies and Meetings.............................................................................................................. 11 Virology at the WWU Münster.................................................................................................... 12 Cluster of Excellence “Cells in Motion” (CiM)............................................................................. 13 Münster Graduate School of Evolution (MGSE)........................................................................ 14 Keynote Speakers, Awards, Poster Prize Committee and Chair Persons................................. 15 Programme Overviews............................................................................................................... 16 Scientific Programme Wednesday, 6 April 2016............................................................................................. 20 Thursday, 7 April 2016................................................................................................. 28 Friday, 8 April 2016...................................................................................................... 36 Saturday, 9 April 2016................................................................................................. 46 Poster Sessions Poster Session 1......................................................................................................... 51 Poster Session 2......................................................................................................... 66 Poster Session 3......................................................................................................... 83 Sponsors.................................................................................................................................... 102 Media Cooperations and Scientific Sponsors............................................................................ 103 Industrial Exhibition.................................................................................................................... 104 Exhibitors (in alphabetical order)................................................................................................ 105 Floor Plan................................................................................................................................... 106 Site Map..................................................................................................................................... 107 General Information................................................................................................................... 108 Social Programme...................................................................................................................... 114 Index of Presenting Authors and Chair Persons........................................................................ 116 Upcoming Conferences and Meetings....................................................................................... 134 p3 Welcome Note • Conference Chair Dear colleagues, It is a great pleasure to invite you to the 26th Annual Meeting of the Society for Virology held from 6–9 April 2016 in Münster, Germany. The meeting will be hosted by the Westphalian-Wilhelms-University and will take place in the main lecture hall building at the Schlossplatz, directly opposite of the Münster castle and in close proximity to the historical city center of Münster. The University of Münster is one of the four largest universities in Germany with 43,000 students to date. The high number of students, university teachers and scientists that dominate the city not only creates a stimulating atmosphere of creativity and scientific curiosity, it also guarantees for the existence of a wide variety of pubs, bistros and restaurants that are waiting for you for vivid and stimulating after-meeting discussions. The scientific programme will stand under the main theme “Viruses in Motion”. This theme will be reflected in plenary sessions such as “Visualising Viruses” that will be organised together with the Münster Cluster of Excellence “Cells in Motion” and will focus on high-resolution imaging of the dynamics of virus replication. Another plenary session “Evolution of Viruses – Viruses in Evolution” organised together with the Münster Graduate School of Evolution will focus on the evolutionary motion of viral pathogens including their role in evolution of higher organisms. Other sessions will highlight emerging pathogens as well as the interaction of viruses with the host and immune system. Of course, every other topic in virology will also be covered in workshops and poster sessions. Since a major aim of the meeting is to provide a platform for young scientists to present their results and ideas, we particularly welcome next generation´s researchers joining us and would like to encourage all senior virologists to promote their mentees´ attendance. Many years ago, the city of Münster hosted a milestone event in history, when, after five years of meetings and negotiations, the Westphalian peace treaty was signed in 1648, which finally ended the Thirty Years’ War. Thus, Münster can claim a long-standing history to organise successful conferences. In that sense I am convinced that we will also have a very successful and stimulating 26th Annual Meeting of the Society for Virology in our beautiful city. The organising committee and I are looking forward to welcome you all here in Münster! Prof. Dr. Stephan Ludwig Conference Chair p4 Welcome Note • President of the Society for Virology (GfV) Dear colleagues, I warmly welcome you to our annual scientific meeting of the Society for Virology (GfV). As you may remember, during the last conference in Bochum we celebrated the 25th birthday of our society, which has become highly established among the scientific societies in Germany and is by now the greatest virological society in Europe with currently 1,300 members. Thus, our GfV is more than vivid. The society covers the field of virology from basic research to medical virology, a field of great scientific, epidemiological, medical and social impact. By nature, virology is also a cross-sectional discipline and can therefore contribute fruitfully to many interdisciplinary research initiatives. Still, the most obvious evidence of the vitality of our Society is our annual meeting and again, this year we have an exciting program of high quality. Many researchers will present their contributions, from young graduate students to internationally renowned scientists. I am convinced that we will have a very successful, challenging and scientifically stimulating meeting. At this point, I also want to welcome our international guests and deeply feel the need to give my special thanks to Prof. Stephan Ludwig, all the organizers and the many helpers for the work and responsibilities they have taken on to prepare and to perform this year’s highlight in virology. Prof. Dr. Thomas Mertens President of the GfV p5 Welcome Note • President of the Robert-Koch-Institute (RKI) Dear colleagues, Infectious Diseases caused by viruses are as fascinating and challenging as ever. Be it the unexpected current Zika virus epidemic in the Americas or the expected yearly Influenza epidemic – prediction and timely risk assessment and communication remain challenging and thus will stay an exciting area of research. Threats to global health through emerging diseases foster long term cooperation and good networking with partners from hot spots of emerging infectious diseases, be it in Germany or on a global scale. Thus, interdisciplinary collaborations are key for understanding factors for the emergence of diseases, ranging from molecular biology, immunology to anthropology and ecology – an approach known as the “One Health” concept. We are therefore excited to watch the outcome of the recent grant funding line “Zoonoses research”, jointly launched by the German ministries for Research and Education, Health, Food and Agriculture as well as Defense. As Public Health Institute the Robert Koch Institute takes its responsibility by sound epidemiological risk assessment, hypothesis driven wet lab research and evidencebased prepardness. As a result, over the years, the Society for Virology and the Robert Koch Institute have developed strong and close ties, being authoritative partners, both in research and counselling, and more than 40 present and former virologists of the Robert Koch Institute are members of the Society for Virology. Since the Annual Meeting of the Society for Virology is an excellent platform to present latest findings of various aspects in virological research special attention will be given to young scientists to present their results and ideas. Actually, a number of young scientists from the Robert Koch Institute will attend this outstanding conference presenting their data and taking part in discussions. Some of them as rookies are highly excited and ready to unleash their talents. As I have learned from the organizing committee the main theme of this year´s 26th Annual Meeting of the Society for Virology will be “Viruses in Motion” including dynamics of viral replication, virus evolution, emerging pathogens and virus-host interaction. These topics are of special interest for the virologists at the Robert Koch Institute since they are mainly engaged in pathogen-specific characteristics including changes and genetic heterogeneity, influencing spread and virulence of the pathogens and their ability to gain control over the host immune system. It is this research innovation that will provide physicians, epidemiologists, the vaccine sector and the general public not only with information on the circulation of i.e. respiratory viruses and the properties of epidemic strains, but also to help with an assessment of the pathobiology of novel virus strains. Results of this work will hopefully enable the derivation of novel principles for the control of these notorious pathogens. Needless to say that science will only flourish by trustful cooperation - the Robert Koch Institute has been and will stay a trustworty partner. Let me finally thank the organizing committee of the 26th Annual Meeting of the Society for Virology for their great commitment in organizing and running this conference. I wish all attendees best success, interesting talks and discussions, and taking back home a number of fruitful new ideas. Prof. Dr. Lothar H. Wieler President of the RKI p6 Direct-zol™ RNA Purification Visit Our Booth and Get Your Free Sample TRIzol IN RNA Tel: +49 (0)761-6006871 0 OUT www.zymoresearch.de [email protected] Welcome Note • President of the Friedrich-Loeffler-Institute (FLI) Dear Colleagues, Viruses are the most abundant life form on earth. ‘Life’? No virologist would doubt this! Viruses emerge, multiply, evolve, recombine, reassort. Viruses are indeed ‘in motion’! They can devastate their hosts or live innocuously in perfect adaptation. They provide continuous surprises with the detection of new virus species, families, even orders; with unexpected changes in virus virulence or epidemiology; and with the knowledge that we are aware of only a tiny fraction of the viruses on this planet, primarily those which affect us directly or indirectly. Thus, virology is and remains a vast field for research from basic understanding of molecular details of virus-host interaction to the development of antiviral strategies including therapeutic and prophylactic interventions. Virus research has been the core competence of the Friedrich-Loeffler-Institut since it has been founded by the co-discoverer of foot-and-mouth disease virus and co-founder of the scientific discipline of virology, Friedrich Loeffler, on October 10, 1910. Although its portfolio has expanded significantly since then, eight of eleven departments of the FLI focus on infectious diseases with a special emphasis on virology. With its history in research on infections of food-producing animals, the institute is well placed to participate in interdisciplinary interactions, in particular concerning the ‘One Health’ concept which is centered on the cooperation between human and veterinary medicine but extends to include biological, environmental and social sciences. Earlier this year the German ministries for Education and Research; Health; Food and Agriculture; and Defense joined in a new agreement on funding a national research network for zoonotic infectious diseases. This allows the continuation of the successful German Research Platform for Zoonoses coordinating research on pathogens shuttling between animals and humans. The FLI is pleased to be able to contribute by supporting and hosting the ‘veterinary office’ of this network. As a new member of the German Center for Infection Research (DZIF) the FLI will also increase participation in respective cooperative research activities within this consortium. Avian flu, SARS, Swine Flu, MERS, Ebolavirus Disease, Zikavirus infection…infectious diseases caused by viruses frequently hit the headlines all over the world. They symbolize that globalization not only concerns global travel and commerce but also global health. This concept has been adopted last year at the G7 summit returning infectious diseases to the top level of priorities, a position they seem to have lost in the 1970’s and 80’s after the spectacular successes of the 1950’s and 60’s. The book on infectious diseases is definitely not closed! However, we should not forget that viruses are more than nanoparticular elements with the capacity to do harm. They are essential components of the ecosystem, drivers of evolution, tools to analyze and understand basic biological principles. In this context I very much welcome the inclusion of plant viruses in this program and look forward to hearing about novel developments in these somewhat less ‘visible’ but highly exciting areas of virus research. p8 Welcome Note • President of the Friedrich-Loeffler-Institute (FLI) The annual meeting of the Society for Virology is a ‘must’ for virologists in our region covering a wide range of topics from basic science to application but always focusing on the scientific aspects of the different approaches. It is also a ‘family reunion’ to meet fellow virologists for discussion and future planning. ‘Networking’ is the catchword of the day. And there are many nets to be woven in our common interest to understand these ‘most tiny living beings’ (quoted from Friedrich Loeffler). The organization of such a conference is a major challenge and experience, and I want to particularly thank the local organizers for their willingness to accept this burden for the benefit of all virologists. I am certain we will enjoy an interesting and pleasant conference. Prof. Dr. Dr. h.c. Thomas C. Mettenleiter President of the FLI p9 Organisation and Imprint Venue University of Münster (WWU) Central Auditorium Building – Schlossplatz 2 • lectures Vom-Stein-Haus – Schlossplatz 34 • posters/industrial exhibition/catering/registration 48149 Münster (DE) Organiser Gesellschaft für Virologie e. V. (GfV, Society for Virology) www.g-f-v.org Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V. (DVV, German Association for the Control of Virus Diseases) www.dvv-ev.de Conference Chair Prof. Dr. Stephan Ludwig Institute of Molecular Virology • Center for Molecular Biology of Inflammation (ZMBE) University of Münster (WWU) 48149 Münster (DE) Local Organising Committee Dr. Friederike Jansen (Münster/DE) Sebastian Sprengel (Münster/DE) Conference Organisation Conventus Congressmanagement & Marketing GmbH Marlen Schiller Carl-Pulfrich-Straße 1 • 07745 Jena (DE) Tel. +49 3641 31 16-358 • Fax +49 3641 31 16-243 [email protected] • www.conventus.de Design/Layout Layout Print Circulation Editorial deadline p 10 www.krea.tif-design.de www.siblog.de 1.000 23 March 2016 Societies and Meetings Executive Committee of the Society for Virology (GfV, Gesellschaft für Virologie) President Thomas Mertens (Ulm/DE) Secretary Sigrun Smola (Homburg a. d. S./DE) Treasurer Detlev H. Krüger (Berlin/DE) Vice Presidents Hartmut Hengel (Freiburg/DE) Franz X. Heinz (Vienna/AT) Former Presidents Nikolaus Müller-Lantzsch (Homburg a. d. S./DE) Hans-Dieter Klenk (Marburg/DE) Otto Haller (Freiburg/DE) Bernhard Fleckenstein (Erlangen/DE) Advisory Board Ralph Bartenschlager (Heidelberg/DE) Stephan Becker (Marburg/DE) Ulf Dittmer (Essen/DE) Helmut Fickenscher (Kiel/DE) Frank Kirchhoff (Ulm/DE) Klaus Osterrieder (Berlin/DE) Thomas Pietschmann (Hanover/DE) Sibylle Schneider-Schaulies (Würzburg/DE) Thomas Schulz (Hanover/DE) Beate Sodeik (Hanover/DE) For more information and for membership application, please visit our website www.g-f-v.org. German Association for the Control of Virus Diseases (DVV, Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V.) President Barbara Gärtner (Homburg/DE) Meetings of the Society for Virology GfV Board Meeting Wednesday, 6 April 2016, 19.30–21.45 (Vorstands- und Beiratssitzung) Festsaal (ballroom), Schlossplatz 5 GfV General Assembly (Mitgliederversammlung) Thursday, 7 April 2016, 18.45–19.45 Lecture Hall 1 p 11 Virology at the WWU Münster imv Up to 2005 the discipline of virology in teaching, research and patient care at the medical faculty of the University of Münster was organized in a subdivision of the Institute of Medical Microbiology and didn´t exist as an own institutional entity. This changed with the establishment of the Institute of Molecular Virology (IMV) in 2005. The IMV is one of five institutes at the Centre of Molecular Biology of Inflammation (ZMBE) in Münster, a unique research center in Germany that addresses the complex processes of inflammation from various angles. Research at the Institute of Molecular Virology (headed by Prof. Dr. Stephan Ludwig) focuses on intracellular signal transduction pathways and their impact on viral infection and inflammation. The virology research is mainly focussed on influenza viruses, which still represent a serious health problem in humans and animals worldwide. One aim of the work is – via gathering knowledge about the cellular processes that control virus replication – to learn more about viral reproduction strategies and to eventually find new approaches for antiviral intervention by targeting cellular components. The institute just recently reached an important milestone in that approach by contributing to the successful completion of the first phase 2b clinical trial with a cell-directed signalling inhibitor against severe influenza in collaboration with scientists from Giessen and Tübingen, driven forward by a partner company. One of the missions at the ZMBE is to support young researchers on their way to establish their independent scientific profile. One subgroup at the IMV, headed by PD Dr. Christina Ehrhardt, focuses on bacterial co-infection in severe influenza. The IMV-associated Emmy Noether Research Group of Dr. Mario Schelhaas, who received the Loeffler Frosch Award of the GfV in 2013 and just recently was awarded a prestigious ERC consolidator grant, is interested in cell biology of virus infections centered around virus entry processes. The most recent addition to the institute is Dr. Eike Hrincius who started to establish his own junior research group in January 2016. Regarding national networking the IMV also hosts the coordination office of the FluresearchNet, a first nationwide interdisciplinary research network on zoonotic influenza and one of the three decentralized offices of the German Research Platform of Zoonoses. As part of these activities the IMV (co)-organizes the biannual International Influenza Meeting in Münster (next meeting Sep 25–27, 2016) and the yearly National Symposium on Zoonosis Research in Berlin (next symposium Oct, 13–14, 2016) to both of which you are cordially invited. As a future outlook, the IMV will also take over responsibility of clinical virology, welcoming Prof. Dr. Joachim Kühn and his group as new members of the institute starting in Sept 2016. The IMV will further join forces with the Institute of Medical Microbiology and the Institute of Hygiene when moving to a new building, the Center of Infection Medicine expected in 2019. p 12 Cluster of Excellence „Cells in Motion“ (CiM) Imaging to Understand Cellular Behaviour in Organisms Our body is made up of approximately one hundred trillion cells that are the elementary building blocks of all tissues and organs required for life. “Cells in motion” keep body functions in a balance and determine whether we are healthy or not, which is why the researchers of the Cells-in-Motion Cluster of Excellence (CiM) study these cellular processes. Around 80 research groups of the University of Münster and the Max Planck Institute of Molecular Biomedicine aim to decipher crucial aspects of cellular behaviour in organisms by analysing systems of increasing complexity – from individual cells, to cells in barriers, to cells in complex systems. To understand the dynamic interactions of cells in organisms, it is essential to see the cells of interest. The use and development of novel imaging strategies is therefore central to CiM’s concept. Biomedical imaging links different scientific disciplines in CiM – from medicine and biology, to chemistry and pharmacy, to physics, mathematics and computer science. The connection between biomedical research and imaging guarantees continual progress both in basic research and in the translation of information on cell behaviour to clinical applications. Researchers in CiM also explore the motion and spread of pathogens in cells and organisms with the aim to visualize molecular steps in pathogen replication in cells and organisms. This includes studies on different viruses performed by CiM members at the Institute of Molecular Virology and the associated research unit Cell Biology of Virus Infections. CiM has been funded since 2012 by the German Research Foundation (DFG) in the context of the Excellence Initiative of the German federation and the federal states. Visualization of influenza A virus ribonucleoprotein (RNP) complexes by super resolution light microscopy. Influenza virus RNPs (green) in close proximity to mitochondria (red) have been visualized by stochastic optical reconstruction microscopy (STORM). The original STORM picture is shown left, a modelled reconstruction of RNP at right (Liedmann et al. (2014) Nat Commun. 5:5645). p 13 Münster Graduate School of Evolution (MGSE) Evolution is broadly defined as a gradual development that may lead to a more advanced or complex form. Modern evolutionary thinking can help to understand and address urgent problems of humankind, such as climate change, bioinvasions, or (infectious) disease epidemiology. The MGSE is an interdisciplinary graduate school that is devoted to the interdisciplinary study of evolution on multiple scales and levels. Researchers from the faculties of Biology, Medicine, Philosophy, Geosciences, and Mathematics contribute to the MGSE, thus forming an interdisciplinary network of excellent scientists working on diverse topics in evolution. The main research areas of the MGSE include earth system evolution, the history of life, the evolutionary ecology of rapid adaptations, molecular and genome evolution, evolution of pathogens, and the philosophy of evolutionary sciences. One of the major academic aims of MGSE is to connect natural and life sciences with the humanities in a mutually beneficial way. The MGSE offers a structured, multidisciplinary doctoral programme that is tailored to individual career tracks. While the work in each doctoral project is performed at the highest possible scientific level within its discipline, interdisciplinarity is achieved through a specific mentoring system. MGSE doctoral students benefit from one another because similar general principles act across disciplines, thus allowing for common theoretical approaches and experimental testing at different levels. A unique structural component of the MGSE is the Evolution Think Tank (ETT) that is instrumental in achieving the graduate school’s academic aims. It consists of a Junior Research Group Leader and internationally outstanding scientists from different disciplines (ETT-Fellows) who visit the MGSE for 1–6 months. In close cooperation with the doctoral students, the ETT seeks to develop new ideas end establish mechanisms for the transfer and application of evolutionary knowledge. Graduating within the interdisciplinary framework of the MGSE at the WWU Münster provides doctoral students with the necessary skills for acquiring and applying knowledge in a multi-disciplinary world. p 14 Keynote Speakers, Awards, Poster Prize Committee and Chair Persons Keynote Speakers R. Andino (San Francisco, CA/US) R. Belshaw (Plymouth, Devon/GB) H. Feldmann (Hamilton, MT/US) Y. Kawaoka (Madison, WI/US) H.-G. Kräusslich (Heidelberg/DE) C. Münz (Zurich/CH) M. Schwemmle (Freiburg/DE) N. F. Steinmetz (Cleveland, OH/US) B. Sun (Shanghai/CN) B. tenOever (New York, NY/US) M. Way (London/GB) Z. Yuan (Shanghai/CN) Awards Loeffler-Frosch-Award A. Bergthaler (Vienna/AT) Loeffler-Frosch-Medal A. Helenius (Zurich/CH) Poster Prize Committee I. Drexler (Düsseldorf/DE) J. Kühn (Münster/DE) S. Pleschka (Giessen/DE) Chair Persons S. Becker (Marburg/DE) M. Beer (Greifswald, Isle of Riems/DE) B. Biesinger (Erlangen/DE) S. Boulant (Heidelberg/DE) M. Brinkmann (Braunschweig/DE) M. Budt (Berlin/DE) L. Cicin-Sain (Braunschweig/DE) S. Ciesek (Essen/DE) C. Claus (Leipzig/DE) U. Dittmer (Essen/DE) I. Drexler (Düsseldorf/DE) J. F. Drexler (Bonn/DE) A. Ehrhardt (Witten/DE) C. Ehrhardt (Münster/DE) O. Fackler (Heidelberg/DE) G. Gabriel (Hamburg/DE) B. Gärtner (Homburg/Saar/DE) K. Gibbert (Essen/DE) T. Gramberg (Erlangen/DE) A. Grundhoff (Hamburg/DE) T. Grunwald (Leipzig/DE) R. Kaiser (Cologne/DE) A. Karlas (Berlin/DE) A. Kieser (Munich/DE) B. Klempa (Berlin/DE) B. Klupp (Greifswald, Isle of Riems/DE) G. Kochs (Freiburg/DE) R. König (Langen/DE) F. Kreppel (Ulm/DE) J. Kühn (Münster/DE) C. Leib-Mösch (Neuherberg/DE) D. Lindemann (Dresden/DE) P.-Y. Lozach (Heidelberg/DE) D. B. Müller (Heidelberg/DE) M. Müller (Heidelberg/DE) M. A. Müller (Bonn/DE) M. Pawlita (Heidelberg/DE) A. Pichlmair (Martinsried/DE) T. Pietschmann (Hanover/DE) O. Planz (Tübingen/DE) S. Pleschka (Giessen/DE) S. Pöhlmann (Göttingen/DE) D. Sauter (Ulm/DE) T. Schaller (Heidelberg/DE) M. Schelhaas (Münster/DE) J. Schmidt-Chanasit (Hamburg/DE) B. Sodeik (Hanover/DE) P. Stäheli (Freiburg/DE) E. Steinmann (Hanover/DE) M. Tenbusch (Bochum/DE) M. Trilling (Essen/DE) C. Uetrecht (Hamburg/DE) T. W. Vahlenkamp (Leipzig/DE) J. Verheyen (Essen/DE) F. Weber (Giessen/DE) B. Weißbrich (Würzburg/DE) p 15 Programme Overview • Wednesday, 6 April 2016 Track I – The Virus Track II – The Host Track III – The Clinical View 11.30–12.15 Opening Industrial Exhibition by the Conference Chair and Round Tour 12.15–13.00 Opening Ceremony Lecture Hall 1 p. 20 13.00–14.30 Plenary Lecture 1 Visualizing Viruses Lecture Hall 1 p. 20 14.30–15.30 Coffee Break within the Industrial Exhibition Workshop 1 Virus Receptors and Entry Lecture Hall 1 p. 21 Coffee Break within the Industrial Exhibition Workshop 4 Viral Replication I p 16 Workshop 2 Innate Immunity I Vom-Stein-Haus 15.30–17.00 17.00–17.45 Lecture Hall 2 p. 21 Lecture Hall 1 p. 23 Workshop 5 Innate Immunity II 19.15–21.30 19.30–21.30 Workshop 3 Diagnostic Tools Lecture Hall 3 p. 22 Vom-Stein-Haus 17.45–19.15 Get-Together within the Industrial Exhibition Poster Session 1 Virus Receptors and Entry Innate Immunity I & II Diagnostic Tools Viral Replication I & II Vom-Stein-Haus Lecture Hall 3 p. 24 Workshop 6 Virus Imaging Lecture Hall 2 p. 25 p. 113 Vom-Stein-Haus (SR07, SR10, SR11) p. 51 Programme Overview • Thursday, 7 April 2016 Track I – The Virus Track II – The Host Track III – The Clinical View Workshop 7 Viral Replication 2 08.30–10.00 Workshop 8 Adaptive Immunity 1 Workshop 9 Emerging Viruses Lecture Hall 3 p. 28 Coffee Break within the Industrial Exhibition 10.45–12.15 Plenary Lecture 2 Emerging Viruses 10.00–10.45 Lecture Hall 2 p. 29 Lecture Hall 1 p. 30 Vom-Stein-Haus Lecture Hall 1 p. 31 Lunch Break within the Industrial Exhibition 12.30–13.30 Lunch Symposium Hologic Deutschland GmbH Lecture Hall 2 p. 31 14.00–15.30 Workshop 10 Trafficking Workshop 11 Adaptive Immunity 2 Lecture Hall 2 p. 31 Coffee Break within the Industrial Exhibition Poster Session 2 Adaptive Immunity I & II Emerging Viruses Trafficking Virus Vectors and Gene Therapy Structure and Assembly 17.30–18.45 Laudationes and Presentations Loeffler Frosch Award and Medal 18.45–19.45 GfV General Assembly 15.30–17.30 Vom-Stein-Haus Workshop 12 Virus Vectors and Gene Therapy Lecture Hall 1 p. 32 15.30–17.30 Tumor Viruses Antiviral Therapy and Resistance Evolution of Viruses – Viruses in Evolution Signal Transduction Lecture Hall 3 p. 33 Vom-Stein-Haus Vom-Stein-Haus (Halls, SR06) p. 66 Lecture Hall 1 p. 34 p. 34 p 17 Programme Overview • Friday, 8 April 2016 Track I – The Virus Track II – The Host Workshop 13 Structure and Assembly Workshop 14 Tumor viruses Lecture Hall 1 p. 36 Coffee Break within the Industrial Exhibition 10:45–12:15 Plenary Lecture 3 Viral Interaction with the Host and the Immune System Lecture Hall 1 p. 39 Lunch Break within the Industrial Exhibition Track III – The Clinical View 08.30–10.00 10.00–10.45 Workshop 15 Antiviral Therapy and Resistence Lecture Hall 2 p. 37 Lecture Hall 3 p. 38 Vom-Stein-Haus 12.30–13.30 Lunch Symposium Qiagen GmbH Lecture Hall 2 p. 39 Workshop 16 Evolution of Viruses – Viruses in Evolution 13.45–15.15 Workshop 17 Signal Transduction Lecture Hall 3 p. 40 Coffee Break within the Industrial Exhibition Workshop 19 Viral Pathogenisis and Persistence Lecture Hall 2 p. 43 Poster Session 3 Vaccines Viral Pathogenesis and Persistence Epidemiology and Public Health Zoonoses Viral Pathogenesis and Persistence Epidemiology and Public Health Social Evening 15.15–16.00 Workshop 18 Vaccines Lecture Hall 1 p. 41 Workshop 20 Host Cell Factors and Modulation I 20.00–01.00 Lecture Hall 2 p. 42 Vom-Stein-Haus 16.00–17.30 17.30–19.30 Vom-Stein-Haus Lecture Hall 1 p. 44 Workshop 21 Epidemiology and Public Health Lecture Hall 3 p. 45 Vom-Stein-Haus (SR116, SR118) p. 83 p. 113 p 18 Programme Overview • Saturday, 9 April 2016 Track I – The Virus Track II – The Host Track III – The Clinical View Workshop 22 Zoonoses 08.30–10.00 Workshop 23 Host Cell Factors and Modulation II Workshop 24 Clinical Virology Lecture Hall 1 p. 46 Coffee Break within the Industrial Exhibition 10.45–12.15 Plenary Lecture 4 Evolution of Viruses – Viruses in Evolution 12.15–12.45 Poster Prizes and Farewell 10.00–10.45 Lecture Hall 2 p. 47 Lecture Hall 3 p. 48 Vom-Stein-Haus Lecture Hall 1 p. 49 Lecture Hall 1 p. 49 Please note! All lectures will take place in the Central Auditorium Building – Schlossplatz 2. The poster sessions, industrial exhibition, catering as well as the registration is located in the Vom-Stein-Haus – Schlossplatz 34. Please refer to pages 108/109 for a detailed floor plan and follow the signposting on site. p 19 Scientific Programme • Wednesday, 6 April 2016 11.30 Opening Industrial Exhibtion by the Conference Chair and Round Tour 12.15–13.00 Room Opening Ceremony Lecture Hall 1 Welcome Note by the President of the Society for Virology (GfV) T. Mertens (Ulm/DE) Welcome Note by the Conference Chair S. Ludwig (Münster/DE) Welcome Note by the Chinese Delegation G. F. Gao (Beijing/CN) Musical Interlude Prof. Peter von Wienhardt and Chamber Ensemble Hollywood Suite “SciFi” Musical Interlude Prof. Peter von Wienhardt and Chamber Ensemble Hollywood Suite “Fanfare and the wild, wild west” 13.00–14.30 Plenary Lecture 1 – Visualising Viruses (organised in cooperation with the Cluster of Excellence “Cells in Motion”) Room Lecture Hall 1 Chairs M. Schelhaas (Münster/DE), T. Pietschmann (Hanover/DE) 13.00 Dynamics and structural changes upon HIV-1 maturation H.-G. Kräusslich (Heidelberg/DE) 13.30 Plant virus-based nanotechnologies enabling molecular imaging and therapies N. F. Steinmetz (Cleveland, OH/US) 14.00 How vaccinia virus (ab)uses the host cytoskeleton to promote its spread M. Way (London/GB) 14.30–15.30 Coffee Break within the Industrial Exhibition RoomVom-Stein-Haus p 20 Scientific Programme • Wednesday, 6 April 2016 15.30–17.00 Room Chairs 15.30 V1 Workshop 1 – Virus Receptors and Entry Lecture Hall 1 D. Lindemann (Dresden/DE), P.-Y. Lozach (Heidelberg/DE) 15.45 V2 16.00 V3 16.15 V4 Identification of mammalian cell lines that allow the propagation of recombinant H18N11 bat influenza A virus G. Zimmer, S. Locher (Mittelhäusern/CH), E. Moreira, M. Juozapaitis (Freiburg/DE) T. Aydilllo, A. García-Sastre (New York, NY/US), M. Schwemmle (Freiburg/DE) Molecular mechanism of Ebola virus entry into host cells Ha. Wang, Y. Shi, J. Song, J. Qi, G. Lu, J. Yan, G. F. Gao (Beijing/CN) Differential use of C-type lectins for phleboviruses endocytosis P. Leger (Heidelberg/DE), M. Tetard (Heidelberg/DE; Paris/FR), B. Youness N. Cordes (Heidelberg/DE), R. Rouxel (Jouy-en-Josas/FR), M. Flamand (Paris/FR) P.-Y. Lozach (Heidelberg/DE) Nanoscale approaches to characterise the dynamic and biophysical determinants of receptor-mediated virus internalisation M. Fratini, T. Wiegand, A. Cavalcanti-Adam, S. Boulant (Heidelberg/DE) 16.30 The importins of nuclear targeting of herpes simplex virus in fibroblasts and neurons V5 K. Döhner, D. Bialy, F. Anderson, A. Buch, T. Koithan, A. Hinz, A. Binz K. Rudolph (Hanover/DE), S. Hügel (Lübeck/DE), F. Rother (Berlin/DE) E. Hartmann (Lübeck/DE), R. Bauerfeind (Hanover/DE), M. Bader (Berlin/DE) B. Sodeik (Hanover/DE) 16.45 The minor capsid protein of human papillomaviruses tethers the viral genome to V6 mitotic chromosomes for nuclear entry I. Aydin, M. Schelhaas (Münster/DE) 15.30–17.00 Workshop 2 – Innate Immunity I Room Lecture Hall 2 Chairs A. Pichlmair (Martinsried/DE), K. Gibbert (Essen/DE) 15.30 DDX19A senses viral RNA and mediates NLRP3-dependent inflammasome V7activation J. Li, L. Hu, Y. Liua, L. Huang, X. Cai, C. Weng (Harbin/CN) p 21 Scientific Programme • Wednesday, 6 April 2016 15.45 V8 cGAS-mediated innate immunity spreads through HIV-1 Env-induced membrane fusion sites between infected and uninfected cells A. Ducroux, S. Xu, A. Ponnurangam (Hanover/DE), T. Zillinger (Bonn/DE) A. Malassa, E. Ewald (Hanover/DE), V. Hornung (Munich/DE) W. Barchet (Bonn/DE), C. Goffinet (Hanover/DE) 16.00 V9 16.15 V10 16.30 V11 16.45 V12 15.30–17.00 Room Chairs 15.30 V13 15.45 V14 Inhibition of type I interferon induction by sandfly fever Sicilian virus virulence factor NSs J. D. Wuerth (Marburg/DE), M. Habjan, A. Pichlmair (Martinsried/DE) G. Superti-Furga (Vienna/AT), F. Weber (Marburg, Giessen/DE) p 22 Evidence for a positive role of PML in interferon signaling that is antagonised by the IE1 protein of human Cytomegalovirus M. Scherer, V. Otto, R. Müller, N. Reuter, J. Stump, S. Klingl, Y. Muller, H. Sticht T. Stamminger (Erlangen/DE) Cellular polarity is a master regulator of the antiviral innate immune response in intestinal epithelial cells M. Stanifer, A. Rippert, C. Kischnick, S. Bender, R. Bartenschlager S. Boulant (Heidelberg/DE) Bat Mx proteins – Evolution and antiviral specificity J. Fuchs, M. Schilling (Freiburg/DE), C. Patzina (Zurich/CH), M. Hölzer (Jena/DE) M. Müller (Bonn/DE), T. Hoenen (Greifswald, Isle of Riems/DE; Hamilton, MT/US) G. Zimmer (Mittelhäusern/CH), F. Weber (Marburg/DE), M. Marz (Jena/DE) G. Kochs (Freiburg/DE) Workshop 3 – Diagnostic Tools Lecture Hall 3 M. Pawlita (Heidelberg/DE), B. Weißbrich (Würzburg/DE) Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus V. Krähling, D. Becker, C. Rohde, M. Eickmann, Y. Eroğlu, A. Herwig (Marburg/DE) R. Kerber (Hamburg/DE), K. Kowalski, J. Vergara-Alert, Step. Becker (Marburg/DE) Generation of a Gaussia luciferase-expressing endotheliotropic cytomegalovirus for screening approaches and mutant analyses J. J. Falk, K. Laib Sampaio, C. Stegmann, D. Lieber (Ulm/DE), B. Kropff M. Mach (Erlangen/DE), C. Sinzger (Ulm/DE) Scientific Programme • Wednesday, 6 April 2016 16.00 V15 A conserved epitope mapped with a monoclonal antibody against the VP3 protein of Goose Parvovirus by using peptide screening and phage display approaches C. Li, H. Liu, J. Li, D. Liu, R. Meng, Q. Zhang, W. Shaozhou, X. Bai, T. Zhang M. Liu, Y. Zhang (Harbin/CN) 16.15 Monitoring and characterisation of swine influenza virus (swIAV) in Europe V16 since 2015 – newly developed hemagglutinin- and neuraminidase-specific multiplex RT-qPCR D. Henritzi (Greifswald, Isle of Riems/DE), S. Wacheck (Dessau-Tornau/DE) M. Beer, T. Harder (Greifswald, Isle of Riems/DE) 16.30 Screening for potential interaction partners of Bovine Herpesvirus-1 V17 glycoprotein E and implications for diagnostics S. Koethe, P. König, G. M. Keil, M. Beer (Greifswald, Isle of Riems/DE) 16.45 A `Dual Assay Algorithm´ to identify recently acquired HIV-1 infections V18 A. Hauser, A. Hofmann, K. Meixenberger, S. Somogyi, B. Bartmeyer, V. Bremer C. Kuecherer, N. Bannert (Berlin/DE) 17.00–17.45 Coffee Break within the Industrial Exhibition RoomVom-Stein-Haus 17.45–19.15 Workshop 4 – Viral Replication I Room Lecture Hall 1 Chairs T. Schaller (Heidelberg/DE), D. Sauter (Ulm/DE) 17.45 Development and application of a novel Ebola virus replicon model that stably V19 replicates a viral mini-genome W. Tao, T. Gan, M. Guo, J. Zhong (Shanghai/CN) 18.00 Analysis of competing HIV-1 splice donor sites uncovers a tight cluster of V20 splicing regulatory elements within exon 2/2b A.-L. Brillen, L. Walotka (Düsseldorf/DE), M. Widera (Essen/DE), S. Theiss H. Schaal (Düsseldorf/DE) 18.15 MicroRNA-99 family modulates hepatitis B virus replication by V21 PI3K/Akt/mTOR/ULK1 signaling-induced autophagy Y. Lin, W. Deng, J. Pang, T. Kemper, A. Squire, M. Günzer, M. Lu (Essen/DE) p 23 Scientific Programme • Wednesday, 6 April 2016 18.30 V22 Quantitative lipid droplet proteome analysis identifies Annexin A3 as a cofactor for HCV particle production K. Rösch, M. Kwiatkowski, S. Hofmann, A. Schöbel, C. Grüttner, M. Wurlitzer H. Schlüter, E. Herker (Hamburg/DE) 18.45 V23 19.00 V24 17.45–19.15 Room Chairs 17.45 V26 18.00 V27 18.15 V28 18.30 V29 Host range restriction of insect-specific flaviviruses occurs at several levels of the viral life cycle B. Kümmerer, M. Korries (Bonn/DE), W. Grasse (Berlin/DE), S. Junglen (Bonn/DE) p 24 Novel 3D insights into the Hepatitis A Virus (HAV)-induced replication factories I. Romero Brey, K. Esser-Nobis, N. Schieber, Y. Schwab, R. Bartenschlager V. Lohmann (Heidelberg/DE), R. Gosert (Basel/CH) Workshop 5 – Innate Immunity II Lecture Hall 3 M. Budt (Berlin/DE), F. Weber (Giessen/DE) Murine cytomegalovirus encoded m152 perturbs STING trafficking and degradation to antagonise the type I IFN response downstream of cGAS sensing B. Chan, M. Stempel (Braunschweig/DE), S. Jonjic (Rijeka/HR) M. Brinkmann (Braunschweig/DE) A ROS and PGAM5-dependent cell death pathway involved in antiviral mmunity C. Holze, D. Haas, C. Benda (Planegg/DE), P. Stäheli (Freiburg/DE) A. Pichlmair (Planegg/DE) DAPK1 – a novel regulator of the antiviral RIG-I signaling pathway identified by Kinome-Wide siRNA screening J. Willemsen, J. Wolanski, O. Wicht, C. Hüber (Heidelberg/DE) B. Knapp (Greifswald/DE), D. Haas (Martinsried, Munich/DE) L. Kaderali (Greifswald/DE), P. Matula, K. Rohr, H. Erfle (Heidelberg/DE) J. Marcotrigiano (Piscataway, NJ/US), A. Pichlmair (Martinsried, Munich/DE) R. Bartenschlager, M. Binder (Heidelberg/DE) Modulation of retrovirus-specific CD8+ T cell responses by IFNα subtypes J. Dickow, K. Gibbert, U. Dittmer (Essen/DE) Scientific Programme • Wednesday, 6 April 2016 18.45 V145 19.00 V30 17.45–19.15 Room Chairs 17.45 V31 The viral FGARAT homolog ORF75 of rhesus monkey rhadinovirus effects proteasomal degradation of the ND10 components SP100 and PML A. Hahn, A. Großkopf (Göttingen/DE), D. Jungnickl, B. Scholz A. Ensser (Erlangen/DE) 18.00 V32 18.15 V33 18.30 V34 Location and role of Newcastle disease virus proteins during exocytic transport H. Bartikowski, S. Finke, T. C. Mettenleiter A. Römer-Oberdörfer (Greifswald, Isle of Riems/DE) Cell type-dependent ability of Vpx alleles to modulate SAMHD1 and overcome the restriction to HIV infection H.-M. Baldauf (Munich/DE), L. Stegmann, S.-M. Schwarz (Frankfurt/DE) M. Trotard (Heidelberg/DE), M. Martin (Frankfurt/DE), G. Lenzi (Atlanta, GA/US) X. Pan (Heidelberg/DE), O. Fregoso, E. Lim (Seattle, WA/US), L. Abraham (Heidelberg/DE), E. Erikson (Frankfurt/DE), L. Nguyen (Atlanta, GA/US), I. Ambiel (Frankfurt/DE), B. Kim (Atlanta, GA/US) M. Emerman (Seattle, WA/US), O. T. Fackler (Heidelberg/DE) O. T. Keppler (Munich, Frankfurt/DE) Workshop 6 – Virus Imaging Lecture Hall 2 S. Boulant, B. Müller (Heidelberg/DE) Hepatitis C virus is released via a non-canonical secretory route K. Bayer (Munich/DE), C. Banning (Hamburg/DE), V. Bruss (Munich/DE) G. Vieyres, T. Pietschmann (Hanover/DE), L. Wiltzer-Bach (Tübingen/DE) M. Schindler (Tübingen, Munich, Hamburg/DE) Site-specific labelling of human immunodeficiency virus envelope protein using click chemistry V. Sakin, J. Dunder, I. Nikic, H.-G. Kräusslich, E. A. Lemke B. Müller (Heidelberg/DE) Remodeling nuclear architecture allows efficient transport of herpesvirus capsids by diffusion J. B. Bosse (Hamburg/DE; Princeton, NJ/US), I. B. Hogue, M. Feric S. Y. Thiberge (Princeton, NJ/US), B. Sodeik (Hanover/DE), C. Brangwynne L. W. Enquist (Princeton, NJ/US) p 25 Scientific Programme • Wednesday, 6 April 2016 18.45 V35 Time course of HIV-1 proteolytic maturation revealed by STED nanoscopy J. Hanne (Heidelberg/DE), F. Göttfert (Göttingen/DE), J. Schimer (Prague/CZ) M. Anders-Össwein (Heidelberg/DE), D. Meineke, V. Belov (Göttingen/DE) J. Engelhardt, B. Müller (Heidelberg/DE), S. W. Hell (Göttingen, Heidelberg/DE) H.-G. Kräusslich (Heidelberg/DE) 19.00 V36 Ultrastructural 3D analysis of HCMV induced nuclear membrane infoldings by FIB/SEM – Discovery of an unexpectedly complex membrane morphology C. Villinger, G. Neusser, C. Kranz, P. Walther, T. Mertens (Ulm/DE) 19.15–21.30 Get-Together within the Industrial Exhibition RoomVom-Stein-Haus (please refer to page 115) 19.30–21.30 Room p 26 Poster Session 1 Vom-Stein-Haus (SR 07, SR 10, SR 11) (Virus Receptors and Entry, Innate Immunity I & II, Diagnostic Tools, Viral Replication I & II) Introducing the ARIES® System: A sample to answer real-time PCR system that is crafted to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today's lean laboratory The ARIES® System provides unprecedented flexibility and simplicity through: • Ability to simultaneously run IVDs and LDTs (homebrew) in a single run when using a universal protocol, with only minutes of assay prep time • Minimized training time with an easy to learn, intuitive interface • Reduced turnaround time with simultaneous STAT and batch testing on a single ARIES® System • Reduced physician wait time with electronic reporting of patient results • Simplified workflow with Auto Run for a true walk away experience Visit the Luminex booth to learn more about our CE Marked ARIES® HSV 1&2 Assay, and get the latest news about assays in development, such as Flu A/B & RSV. www.luminexcorp.com For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/ regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence. Validation of the LIS compatibility must be performed by the end user. Some features may not be available at launch. The ARIES System is a class 1 laser product. ©2015-2016 Luminex Corporation. All rights reserved. Luminex and ARIES are trademarks of Luminex Corporation, registered in the U.S. and other countries. AD1441.0116 Scientific Programme • Thursday, 7 April 2016 08.30–10.00 Room Chairs Workshop 7 – Viral Replication II Lecture Hall 3 O. Fackler (Heidelberg/DE), M. Brinkmann (Braunschweig/DE) 08.30 V37 Alpha-helix 2 of the multifunctional regulatory protein pUL69 mediates Pin1-interaction and its phosphorylation is required for efficient multiplication of human cytomegalovirus M. Thomas, R. Mueller, G. Horn, A. Svrlanska, E. Sonntag, S. Schmidt B. Zielke (Erlangen/DE), T. Fossen (Bergen/NO) T. Stamminger (Erlangen/DE) 08.45 V38 Mutual interplay between the HCMV terminase subunits pUL51/pUL56/pUL89 for correct subnuclear localisation and terminase .complex assembly S. Neuber (Hanover/DE), T. Goldner, P. Lischka (Wuppertal/DE) K. Wagner, M. Messerle, E. M. Borst (Hanover/DE) 09.00 V39 The influence of a plant geminivirus Rep protein on cell cycle control mechanisms K. Hipp, P. Rau (Stuttgart/DE), B. Gronenborn (Gif-sur-Yvette/FR) H. Jeske (Stuttgart/DE) 09.15 V40 Usp7, an ubiquitin specific protease interacts with Merkel cell polyomavirus Large T-Antigen and modulates viral DNA replication M. Czech-Sioli, S. Siebels, T. Dobner, A. Grundhoff, N. Fischer (Hamburg/DE) 09.30 V41 09.45 V42 Single-cell analysis of influenza A virus-infected cells S. Y. Kupke, F. S. Heldt, U. Reichl, T. Frensing (Magdeburg/DE) p 28 Mutational analysis suggests that acetylation of the influenza A virus nucleoprotein is required for correct bundling of vRNPs S. Giese (Freiburg/DE), S. Lakdawala (Pittsburgh, PA/US) Y. Zhao (Shanghai/CN), V. Götz, E. Moreira, A. Dudek, H. Bolte (Freiburg/DE) Y. E. Chin, K. Xu (Shanghai/CN), M. Schwemmle (Freiburg/DE) Scientific Programme • Thursday, 7 April 2016 08.30–10.00 Room Chairs Workshop 8 – Adaptive Immunity I Lecture Hall 2 I. Drexler (Düsseldorf/DE), L. Cicin-Sain (Braunschweig/DE) 08.30 V43 RNAi-mediated suppression of HBV restores HBV-specific immunity and enhances the efficacy of therapeutic vaccination A. Kosinska, T. Michler, C. Jaeger, N. Roeder (Munich/DE) D. Grimm (Heidelberg/DE), M. Heikenwalder, M. Roggendorf U. Protzer (Munich/DE) 08.45 V44 Induction of immune responses and HBsAg decline after stop of long-term nucleos(t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B F. Rinker, C. Höner zu Siederdissen (Hanover/DE), C. Bremer (Giessen/DE) B. Maasoumy, B. Bremer, C. Falk, M. Manns, H. Wedemeyer (Hanover/DE) D. Glebe (Giessen/DE), M. Cornberg, A. Kraft (Hanover/DE) 09.00 V45 CXCR3 and CCR5 selectively navigate pDC for local IFN delivery A. Brewitz, S. Eickhoff, K. Komander, M. Ataíde, A. E. Peters (Bonn/DE) M. Colonna (St. Louis, MO/US), C. Kurts, W. Kolanus W. Kastenmüller (Bonn/DE) 09.15 V46 Antigen-driven proliferation of effector memory T cells maintains memory Inflation in MCMV infection L. Borkner, A. Drabig, T. Marandu, M. Schuster (Braunschweig/DE) M. Jarvis (Plymouth/GB), L. Čičin-Šain (Braunschweig/DE) 09.30 V47 Role of naïve T cells in HCMV transmission N. Subramanian, Ze. Wu, T. Mertens (Ulm/DE) 09.45 V48 HCMV-antibody complexes induce immune responses Ze. Wu, R. Qin, C. Sinzger, Li. Wang, P. Walther, T. Mertens G. Frascaroli (Ulm/DE) p 29 Scientific Programme • Thursday, 7 April 2016 08.30–10.00 Room Chairs Workshop 9 – Emerging Viruses Lecture Hall 1 M. Beer (Greifswald, Isle of Riems/DE), J. F. Drexler (Bonn/DE) 08.30 V49 Host cell entry mediated by filoviral glycoproteins into bat and human cells relies on the same host cell factors but entry efficiency is species dependent M. Hoffmann, M. González Hernández, E. Berger, S. Pöhlmann (Göttingen/DE) 08.45 V50 Detection of two highly diverse bunyaviruses in neotropical mosquitoes A. Kopp, F. Zirkel, A. Hübner (Bonn/DE), D. Hobelsberger (Berlin/DE) A. Estrada (Mexico City/MX), I. Jordan (Berlin/DE) T. Gillespie (Atlanta, GA/US), C. Drosten, S. Junglen (Bonn/DE) 09.00 V51 A new pegivirus causes chronic infection in domestic pigs C. Bächlein (Hanover/DE), A. Grundhoff, N. Fischer, M. Alawi (Hamburg/DE) D. Höltig, K.-H. Waldmann, P. Becher (Hanover/DE) 09.15 V52 Differential maturation and glycosylation of the envelope glycoprotein GN on UGBuniemi virions derived from tick vector and mammalian host cells M. Mazelier (Heidelberg/DE), R. Rouxel (Laval/CA), M. Zumstein (Zurich/CH) L. Bell-Sakyi (Pirbright/GB) P.-Y. Lozach (Heidelberg/DE; Laval/CA; Zurich/CH) 09.30 V53 Zika virus emergence in the Americas – A potential threat to Europe? J. Schmidt-Chanasit (Hamburg/DE) 09.45 V54 Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein A. Volz (Munich/DE), A. Kupke (Marburg/DE), F. Song, S. Jany R. Fux (Munich/DE), H. Shams-Eldin, J. Schmidt (Marburg/DE) C. Becker (Giessen/DE), M. Eickmann, Step. Becker (Marburg/DE) G. Sutter (Munich/DE) 10.00–10.45 Coffee Break within the Industrial Exhibition RoomVom-Stein-Haus p 30 Scientific Programme • Thursday, 7 April 2016 10.45–12.15 Room Chairs Plenary Lecture 2 – Emerging Viruses Lecture Hall 1 Step. Becker (Marburg/DE), J. Schmidt-Chanasit (Hamburg/DE) 10.45 Vaccine approaches for emerging viruses H. Feldmann (Hamilton, MT/US) 11.15 Current topics in emerging viruses Y. Kawaoka (Madison, WI/US) 11.45 Mapping the intra-hepatic distribution of hepatitis B virus in chronic hepatitis B virus infection Z. Yuan (Shanghai/CN) 12.15–14.00 Lunch Break within the Industrial Exhibition RoomVom-Stein-Haus 12.30–13.30 Room Lunch Symposium – Hologic Deutschland GmbH Lecture Hall 2 12.30 Optimisation of nucleic acid testing in diagnostic virology T. Iftner (Tübingen/DE) 13.00 Persistent infections with high risk HPV types as necessary risk factor for cervical cancer – implications for screenings – HPV DNA or RNA Test? M. Obermeier (Berlin/DE) 14.00–15.30 Room Chairs Workshop 10 – Trafficking Lecture Hall 2 B. Klupp (Greifswald, Isle of Riems/DE), B. Sodeik (Hanover/DE) 14.00 V55 Nipah virus matrix protein nuclear trafficking is cell-type independent M. Ringel, P. Schepsky, Bo. Lamp, A. Maisner (Marburg/DE) 14.15 V56 The intra-cellular cholesterol transport inhibitor U18666A blocks the release of HCV particles F. Elgner, R. Medvedev, H. Ren, K. Himmelsbach, E. Hildt (Langen/DE) 14.30 V57 Subviral HBV filaments are released like infectious viral particles via MVBs B. Jiang, K. Himmelsbach, H. Ren, K. Boller (Langen/DE) E. Hildt (Giessen, Marburg, Langen/DE) p 31 Scientific Programme • Thursday, 7 April 2016 14.45 V58 Transport of Marburg virus glycoprotein is associated with the recycling endosome in non-polarised cells S. Halwe, Step. Becker, O. Dolnik (Marburg/DE) 15.00 V59 Effect of rapid changes in PI (4,5) P2 availability on HIV-1 Gag recruitment and assembly F. Mücksch, V. Laketa, B. Müller, C. Schultz, H.-G. Kräusslich (Heidelberg/DE) 15.15 V60 Transfer of HTLV-1 p8 to target T-cells depends on VASP, a novel interaction partner of p8 N. Donhauser, E. Socher, S. Millen, H. Sticht, .A. K. Thoma-Kreß (Erlangen/DE) 14.00–15.30 Room Chairs Workshop 11 – Adaptive Immunity II Lecture Hall 1 T. Grunwald (Leipzig/DE), T. Gramberg (Erlangen/DE) 14.00 V61 Intravital imaging of physical interactions between regulatory and effector T cells in a murine retrovirus model L. Otto, A. Hasenberg, G. Zelinskyy, U. Dittmer, M. Gunzer (Essen/DE) 14.15 V62 Hominid cytomegalovirus immunoevasin US11 driven diversification of HLA-A C. Zimmermann (Freiburg/DE), D. Kowalewski (Tübingen/DE) V. T. K. Le-Trilling (Essen/DE), F. Momburg (Heidelberg/DE) S. Stevanović (Tübingen/DE), H. Hengel, A. Halenius (Freiburg/DE) 14.30 V63 IL1β is a potent mucosal adjuvant in adenoviral vector immunisations to enhance heterologous immunity against Influenza A D. Lapuente, A. Maaske, V. Stab (Bochum/DE) D. Hannaman (San Diego, CA/US), C. Ehrhardt (Münster/DE) W. Bayer (Essen/DE), M. Tenbusch (Bochum/DE) 14.45 V64 Non-hematopoietic cells in memory inflation Z. Banki (Innsbruck/AT; Oxford/GB), J. Colston, C. Willberg L. N. Lee (Oxford/GB), J. Holzki (Braunschweig/DE) A. E. Denton (Cambridge/GB), H. Stoiber, D. Holm-von Laer (Innsbruck/AT) L. Cicin-Sain (Braunschweig/DE), D. T. Fearon (Cambridge/GB) B. Ludewig (St. Gallen/CH), P. Klenerman (Oxford/GB) p 32 Scientific Programme • Thursday, 7 April 2016 15.00 V65 The C-terminus of HSV-1 encoded ICP47 is required to “freeze” the TAP (transporter associated with antigen processing) peptide transport cycle A. Halenius, Ju. Busch, C. Gerke, T. Matschulla, H. Hengel (Freiburg/DE) 15.15 V66 PD-L1 expression on retrovirus-infected cells mediates immune escape from CD8 +T cell killing I. Akhmetzyanova, M. Drabczyk (Essen/DE), C. P. Neff (Aurora, CO/US) K. Gibbert, T. Werner (Essen/DE), Jia Liu (Essen/DE; Wuhan/CN) K. S. Lang (Essen/DE), B. E. Palmer (Aurora, CO/US), U. Dittmer G. Zelinskyy (Essen/DE) 14.00–15.30 Room Chairs Workshop 12 – Virus Vectors and Gene Therapy Lecture Hall 3 F. Kreppel (Ulm/DE), A. Ehrhardt (Witten/DE) 14.00 V67 Regulated TRIM5α expression as a tool to prevent HIV infection C. Elsner, T. Klause, J. Bohne (Hanover/DE) 14.15 V68 Adenovirus type 5 transduction of tumor cell lines can be substantially increased by complex formation between virus and the chemically designed dendrimer PPD4 L. Frank, K. Hopfensperger, Yu. Wu, T. Weil, F. Kreppel (Ulm/DE) 14.30 V69 A carbohydrate-based model to determine the in vivo fate of defined adenovirus immune complexes R. F. Kratzer, A. Hoffmeister, S. Espenlaub, F. Kreppel (Ulm/DE) 14.45 V70 Human adenovirus D17 has tropism for endothelium cells and can use both hCAR and CD46 as receptors Jin Liu, P. Boehme (Witten/DE), J. Fu (Dresden/DE), Wen. Zhang M. Solanki (Witten/DE), R. Yumul (Seattle, WA/US), A. Schmidtko (Witten/DE) F. Stewart (Dresden/DE), A. Lieber (Seattle, WA/US), A. Ehrhardt (Witten/DE) 15.00 V71 Efficient oncolysis of non-small-cell lung cancer tissue upon influenza A virus infection in a lung tumor model in mice D. Masemann (Münster/DE), K. Koether (Münster/DE; Cambridge/GB) M. Kuhlencord, G. Varga, J. Roth (Münster/DE), B. Lichty (Hamilton/CA) V. Wixler, S. Ludwig (Münster/DE) p 33 Scientific Programme • Thursday, 7 April 2016 15.15 V72 Augmenting the therapeutic efficacy of oncolytic LCMV-GP pseudotyped vesicular stomatitis virus via modulation of the innate immune system C. Rodrigez Urbiola, C. Dold, P. Erlmann, L.-M. Schreiber, H. Fiegl, C. Marth F. Santer, Z. Culig (Innsbruck/AT), A. Muik (Frankfurt/DE), G. Wollmann D. von Laer, J. Kimpel (Innsbruck/AT) 15.30–17.30 Coffe Break within the Industrial Exhibition 15.30–17.30 Room Poster Session 2 Vom-Stein-Haus (Halls, SR 06) (Adaptive Immunity I & II, Emerging Viruses, Trafficking, Virus Vectors and Gene Therapy, Structure and Assembly, Tumor Viruses, Antiviral Therapy and Resistance, Evolution of Viruses – Viruses in Evolution, Signal Transduction) 17.30–18.45 Room Laudations and Presentations for the Loeffler Frosch Award and Medal Lecture Hall 1 18.45–19.45 Room GfV General Assembly Lecture Hall 1 p 34 NOW I CAN Increase my lab’s productivity Introducing the DxN VERIS Molecular Diagnostics System.* DxN VERIS enhances laboratory productivity through a simplified, flexible LEAN workflow and true single sample random access. It’s the ultimate in ease of use, so you choose how to best optimize your team to do the work you want, when you want — you decide. Solidify your choice for productivity at www.beckmancoulter.com/moleculardiagnostics *Not for sale or distribution in the U.S.; not available in all markets. ©2015 Beckman Coulter, Inc. Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc. Scientific Programme • Friday, 8 April 2016 08.30–10.00 Room Chairs Workshop 13 – Structure and Assembly Lecture Hall 1 E. Steinmann (Hanover/DE), C. Uetrecht (Hamburg/DE) 08.30 V73 The HCMV terminase subunit pUL89 -new insights into structure-function relationships A. Holzenburg, M. W. Sung (College Station, TX/US), S. M. Lapp E. Bogner (Berlin/DE) 08.45 V74 The inner tegument proteins pUL36 and pUL37 of herpes simplex virus are sufficient for intracellular motility but not for targeting capsids to the axons of dorsal root ganglia neurons A. Buch, O. Müller, L. Ivanova, K. Döhner (Hanover/DE) J. Bosse (Hamburg/DE), A. Pohlmann, A. Binz, M. Hegemann (Hanover/DE) M. Koltzenburg (London/GB), B. Rosenhahn, R. Bauerfeind B. Sodeik (Hanover/DE) 09.00 Re-programming viral nucleoprotein self-assembly – Tobamovirus-based V75 nanosticks, boomerangs and star colloids for diagnostics and technical purposes F. J. Eber, F. Geiger, A. Mueller, C. Koch (Stuttgart/DE) S. Shukla (Cleveland, OH/US), C. Azucena (Eggenstein-Leopoldshafen/DE) Zh. Wu, C. Krill III (Ulm/DE), N. F. Steinmetz (Cleveland, OH/US) H. Gliemann (Eggenstein-Leopoldshafen/DE), H. Jeske, S. Eiben C. Wege (Stuttgart/DE) 09.15 V76 Viral budding regulated by a critical residue located at the putative dimeric interface of the canine distemper virus matrix protein F. Bringolf, M. Wys, M. Herren, Z. Andreas, P. Plattet (Bern/CH) 09.30 V77 Ion-channel function and cross-species determinants in viral assembly of nonprimate hepacivirus p7 S. Walter, A. Bollenbach, J. Doerrbecker, S. Pfaender, R. J. P. Brown G. Vieyres (Hanover/DE), C. Scott, R. Foster (Leeds/GB), A. Kumar N. Zitzmann (Oxford/GB), S. Griffin (Leeds/GB), F. Penin (Lyon/FR) T. Pietschmann, E. Steinmann (Hanover/DE) 09.45 V78 Prediction of conserved long-range RNA-RNA interaction in full viral genomes M. Fricke, M. Marz (Jena/DE) p 36 Scientific Programme • Friday, 8 April 2016 08.30–10.00 Room Chairs Workshop 14 – Tumor Viruses Lecture Hall 2 B. Biesinger (Erlangen/DE), A. Kieser (Munich/DE) 08.30 V79 Papillomavirus-associated tumor formation critically depends on c-fos expression induced by viral protein E2 and bromodomain protein Brd4 M. Delcuratolo, J. Fertey, M. Schneider, J. Schuetz, N. Leiprecht, B. Hudjetz S. Brodbeck, S. Corall, M. Dreer, R. M. Schwab, M. Grimm (Tübingen/DE) S.-Y. Wu (Dallas, TX/US), F. Stubenrauch (Tübingen/DE) C.-M. Chiang (Dallas, TX/US), T. Iftner (Tübingen/DE) 08.45 V80 The fibronectin / α3β1 integrin axis serves as molecular basis for HPV8 induced keratinocyte invasion S. Heuser, M. Hufbauer, J. Steiger (Cologne/DE), J. Marshall (London/GB) A. Sterner-Kock, C. Mauch, P. Zigrino, B. Akgül (Cologne/DE) 09.00 V81 A highly conserved interaction of the cellular NCOR/SMRT complex with papillomavirus E8^E2C proteins inhibits viral replication M. Dreer, J. Fertey, S. van de Poel, E. Straub, J. Madlung, B. Macek T. Iftner, F. Stubenrauch (Tübingen/DE) 09.15 V82 A comparative epigenome and transcriptome analysis of KSHV and MHV68 latency T. Günther (Hamburg/DE), H. Adler (Munich/DE), A. Grundhoff (Hamburg/DE) 09.30 V83 Kaposi sarcoma’s herpesvirus (KSHV) latent associated nuclear antigen (LANA) recruits components of the cellular MRN repair complex to modulate an innate immunity signaling pathway and viral latency G. Mariggiò, G. Zhang, S. Koch, J. Rückert, S. Santag, T. Schulz (Hanover/DE) 09.45 V84 The Tax-inducible actin-bundling protein Fascin is required for release and cell-to-cell transmission of human T-cell leGBemia virus type 1 (HTLV-1) C. Gross, V. Wiesmann, T. Wittenberg (Erlangen/DE) J. Gettemans (Ghent/BE), A. K. Thoma-Kreß (Erlangen/DE) p 37 Scientific Programme • Friday, 8 April 2016 08.30–10.00 Room Chairs Workshop 15 – Antiviral Therapy and Resistance Lecture Hall 3 R. Kaiser (Cologne/DE), S. Ciesek (Hanover/DE) 08.30 V85 New strategies for anti-hepatitis C vaccine, neutralising monocloncal antibody and drug development X. Zhang (Wuhan/CN) 08.45 V86 Inhibition of coronavirus 2‘-O-Methyltransferase to reduce replication and pathogenesis via multiple mechanisms S. Wang, C. Zeng, Y. Wang, R. Pan, Y. Chen, D. Guo (Wuhan/CN) 09.00 V87 In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome D. Todt, A. Gisa (Hanover/DE), A. Radonic, A. Nitsche (Berlin/DE) P. Behrendt, P. V. Suneetha (Hanover/DE) S. Pischke (Hanover, Hamburg/DE), B. Bremer, R. J. P. Brown (Hanover/DE) M. P. Manns, M. Cornberg (Hanover, Braunschweig/DE) C. T. Bock (Berlin/DE), H. Wedemeyer (Hanover, Braunschweig/DE) E. Steinmann (Hanover/DE) 09.15 V88 Single domain antibodies against human respiratory syncytial virus I. Rossey, B. Schepens (Ghent/BE), J. McLellan (Hanover/DE) B. Graham (Bethesda, MD/US), X. Saelens (Ghent/BE) 09.30 V89 Macromolecular prodrugs of as antiviral agents A. Zelikin (Aarhus/DK) 09.45 V90 Identification of a human respiratory syncytial virus (hRSV) cell entry inhibitor by using a novel lentiviral pseudotype (hRSVpp) system S. Haid, C. Grethe, D. Bankwitz (Hanover/DE), T. Grunwald (Leipzig/DE) T. Pietschmann (Hanover/DE) 10.00–10.45 Coffee Break within the Industrial Exhibition RoomVom-Stein-Haus p 38 Scientific Programme • Friday, 8 April 2016 10.45–12.15 Room Chairs Plenary Lecture 3 – Viral interaction with the host and the immune system Lecture Hall 1 U. Dittmer (Essen/DE), S. Pöhlmann (Göttingen/DE) 10.45 Cellular tools for virus warfare B. ten Oever (New York, NY/US) 11.15 TRIM30α is a negative regulator in DNA virus infection by targeting STING B. Sun (Shanghai/CN) 11.45 Infection and immune control of a human tumor virus in vivo C. Münz (Zurich/CH) 12.15–13.45 Lunch Break within the Industrial Exhibition RoomVom-Stein-Haus 12.30–13.30 Lunch Symposium – Qiagen GmbH Respiratory diseases: Diagnostics and clinical implications Room Lecture Hall 2 Chair A. Plaschke-Schlütter (Hombrechtikon/CH) 12.30 Respiratory pathogens: diagnostics and epidemiology O. Adams (Düsseldorf/DE) 12.50 Panel diagnostics of respiratory pathogens using multiplex PCR: A field report after 2000 analysed patient samples J. Kühn (Münster/DE) 13.10 Respiratory pathogens: Clinical implications A. Pettke (Münster/DE) p 39 Scientific Programme • Friday, 8 April 2016 13.45–15.15 Room Chairs Workshop 16 – Evolution of Viruses – Viruses in Evolution Lecture Hall 3 S. Pleschka (Giessen/DE), G. Kochs (Freiburg/DE) 13.45 V91 Evolution of species D human adenoviruses (HAdV-D) – Are intestinal infections of adults the recombination factory for the huge diversity of types? A. Heim, E. Hage (Hanover/DE), S. Bergs, U.-G. Liebert (Leipzig/DE) 14.00 V92 Evolution of infectious pancreatic necrosis virus – IPNV K. Ulrich (Stirling/GB), M. Dilcher (Göttingen/DE), .C. Palaiokostas (Edinburgh/GB) S. Wehner (Stirling/GB), E. Thomson (Glasgow/GB), M. Weidmann (Stirling/GB) 14.15 V93 High Resolution Method (HRM) for genotyping Bovine ephemeral fever virus (BEFV) Y. Stram, O. Erster (Bet Dagan/IL), R. Stram, M. Rubistein-Giuni (Berlin/DE) B. S. Sharir, M. Van Straten (Caesarea/IL), E. Kchinich (Bet Dagan/IL) B. Sharir (Caesarea/IL) 14.30 V94 Analysis of bat-borne Makokou virus underlines the risk of emergence of non-conventional hantaviruses P. T. Witkowski (Berlin/DE), J. F. Drexler, R. Kallies (Bonn/DE), M. Lickova S. Bokorova (Bratislava/SK), G. D. Maganga (Franceville/GA) T. Szemes (Bratislava/SK), E. M. Leroy (Franceville/GA) D. H. Kruger (Berlin/DE), C. Drosten (Bonn/DE), B. Klempa (Berlin/DE) 14.45 V95 Minimal requirements for high virulence of non-H5/H7 avian influenza viruses J. Veits, S. Weber, E.-S. M. Abdelwhab T. C. Mettenleiter (Greifswald, Isle of Riems/DE) 15.00 V96 In silico prediction and experimental confirmation of HA residues conferring enhanced human receptor specificity of H5N1 influenza A viruses S. Schmier (Frankfurt, Melsungen/DE), A. Mostafa (Dokki/EG; Giessen/DE) T. Haarmann (Frankfurt, Darmstadt/DE), N. Bannert (Berlin/DE) J. Ziebuhr (Giessen/DE), V. Velkovic, U. Dietrich (Frankfurt/DE) S. Pleschka (Giessen/DE) p 40 Scientific Programme • Friday, 8 April 2016 13.45–15.15 Room Chairs Workshop 17 – Signal Transduction Lecture Hall 1 O. Planz (Tübingen/DE), C. Ehrhardt (Münster/DE) 13.45 V97 Encephalomyocarditis virus 3C protease relieves TANK inhibitory effect on TRAF6-mediated NF-kappaB signaling through cleavage of TANK L. Huang, Q. Liu, L. Zhang, S. Cui, C. Weng (Harbin/CN) 14.00 V98 The nuclear shuttle protein of the Abutilon mosaic virus, a ssDNA plant virus, forms a complex with the stress granule component G3BP B. Krenz, S. Krapp, E. Greiner, U. Sonnewald (Erlangen/DE) 14.15 V99 The Epstein-Barr virus oncogene LMP1 activates MAPKinases through IkappaB kinase 2 (IKK2) and the oncogenic serine/threonine kinase Tpl2 K. Sterz, St. Voigt, A. Kieser (Munich/DE) 14.30 V100 Differential activation of the PI3K–Akt–mTOR pathway by the alphaviruses Semliki Forest virus (SFV) and chikungunya virus (CHIKV) to determine replication complex localisation B. Thaa, R. Biasiotto, K. Eng (Stockholm/SE), M. Neuvonen (Helsinki/FI) B. Götte, L. Rheinemann (Stockholm/SE), M. Mutso, A. Utt (Tartu/EE) F. Varghese, G. Balistreri (Helsinki/FI), A. Merits (Tartu/EE) T. Ahola (Helsinki/FI), G. M. McInerney (Stockholm/SE) 14.45 V101 Functional comparison of the Molluscum Contagiosum virus vFLIP MC159 with the Murine Cytomegalovirus M36/vICA and M45/vIRA proteins J. Hüttmann, E. Krause, T. Schommartz, W. Brune (Hamburg/DE) 15.00 V102 NF-κB and interferon-β regulation by the viral oncoprotein Tio in HeLa cells D. Weidl, J.-C. Albrecht, A. Ensser (Erlangen/DE), A. Kieser (Munich/DE) B. Biesinger (Erlangen/DE) p 41 Scientific Programme • Friday, 8 April 2016 13.45–15.15 Room Chairs Workshop 18 – Vaccines Lecture Hall 2 M. Tenbusch (Bochum/DE), M. Müller (Vienna/AT) 13.45 V103 A multi-antigenic DNA vaccine that induces broad HCV-specific T-cell responses in mice J. Gummow, Yanr. Li (Woodville/AU), W. Yu (Woodville, Adelaide/AU) T. Garrod (Woodville, North Adelaide/AU), D. Wijesundara (Woodville/AU) A. Brennan (Melbourne/AU), R. Mullick (Bangalore/IN) I. Voskoboinik (Melbourne/AU), B. Grubor-Bauk, E. Gowans (Woodville/AU) 14.00 V104 Out-manipulating the manipulator – development of a live attenuated human cytomegalovirus vaccine A. Tomic, P. R. Varanasi, E. M. Borst (Hanover/DE), M. Golemac S. Malic (Rijeka/HR), E. M. Mischak-Weissinger (Hanover/DE), P. Riese C. Guzman (Braunschweig/DE), A. Krmpotic, S. Jonjic (Rijeka/HR) M. Messerle (Hanover/DE) 14.15 V105 Adeno-associated virus (AAV) vector as a vehicle for a universal influenza vaccine D. Demminger, T. Wolff (Berlin/DE) 14.30 V106 Effective tumor-vaccination with oncolytic measles virus S. Hutzler (Langen/DE), S. Erbar, R. A. Jabulowsky (Mainz/DE) J. Hanauer (Langen/DE), Ö. Türeci, R. Mitnacht-Kraus, S. Kreiter M. Diken, C. Britten, U. Sahin (Mainz/DE), M. D. Mühlebach (Langen/DE) 14.45 V107 The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CTL responses M. Storcksdieck, Bochum/DE), T. Niezold (Bochum/DE) D. Hannaman (San Diego, CA/US), H. Streeck (Essen/DE) K. Überla (Bochum, Erlangen/DE), M. Tenbusch (Bochum/DE) 15.00 V108 Viral vector vaccines expressing nucleoprotein and phosphoprotein genes of avian bornaviruses ameliorate homologous challenge infections in cockatiels and common canaries M. Olbert (Freiburg/DE), A. Römer-Oberdörfer (Greifswald, Isle of Riems/DE) C. Herden, S. Malberg (Giessen/DE), G. Sutter (Munich/DE), P. Staeheli D. Rubbenstroth (Freiburg/DE) 15.15–16.00 Coffee Break within the Industrial Exhibition RoomVom-Stein-Haus p 42 Scientific Programme • Friday, 8 April 2016 16.00–17.30 Room Chairs Workshop 19 – Viral pathogenisis and persistence Lecture Hall 2 A. Grundhoff (Hamburg/DE), M. Trilling (Essen/DE) 16.00 V109 Serum HBV RNA is pregenome RNA present in virions and may be associated with persistence of HBV infection and viral rebound J. Wang, X. Huang, T. Shen, X. Chen, F. Lu (Beijing/CN) 16.15 V110 Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor E. Hildt (Giessen, Marburg, Langen/DE), S. Barthel, T. Heinrich S. M. Büchner, R. Medvedev, N. Kettern (Langen/DE) E. Hildt (Giessen, Marburg, Langen/DE) 16.30 V111 HBV strengthens intrahepatic myeloid-derived cells mediated T cell tolerance through TLR1/2 induced Kupffer cell expansion and IL-10 production Jia Liu (Essen/DE; Wuhan/CN), X. Huang, W. Wu, R. Broering M. Roggendorf (Essen/DE), D. Yang (Wuhan/CN), M. Lu (Essen/DE) 16.45 V112 Interaction of the Merkel Cell Polyomavirus LT-Antigen with host cell chromatin J. Theiß, N. Fischer, A. Grundhoff (Hamburg/DE) 17.00 V113 A novel role for a viral interferon regulatory factor during the establishment of KSHV latency S. Koch, M. Damas, E. Hage, J. Rückert (Hanover/DE), A. Gallo W. Brune (Hamburg/DE), T. Schulz (Hanover/DE) 17.15 V114 Nanoparticle exposure of persistently herpesvirus-infected cells reactivates latent virus and restores features of an acute virus infection in vitro and in vivo C. Sattler, F. Moritz, S. Chen, B. Steer, D. Kutschke, M. Irmler, J. Beckers P. Schmitt-Kopplin, T. Stoeger, H. Adler (Munich/DE) p 43 Scientific Programme • Friday, 8 April 2016 16.00–17.30 Room Chairs Workshop 20 – Host cell factors and modulation I Lecture Hall 1 G. Gabriel (Hamburg/DE), R. König (Langen/DE) 16.00 V25 The tumor suppressor PTEN plays a critical role in antiviral innate immunity S. Li, M. Zhu, Y. Cao, R. Pan, D. Guo (Wuhan/CN) 16.15 V116 Importin-α3 restricts pandemic H1N1 influenza A virus infection in the mammalian host N. Mounogou Kouassi, S. Thiele (Hamburg/DE) P. Resa-Infante (Grenoble/FR; Hamburg/DE), S. Bertram G. Gabriel (Hamburg, Lübeck/DE) 16.30 V117 Novel role of the vRNP-associated multifunctional host factor ANP32B for IFN-β induction during influenza A virus infection L. Brunotte (Münster/DE), P. Hubel (Martinsried/DE), H. Bolte (Freiburg/DE) A. Pichlmair (Martinsried/DE), M. Schwemmle (Freiburg/DE) 16.45 V118 Influenza A virus infection triggers IFITM3 clustering in human lung cells S. Kummer, H.-G. Kräusslich (Heidelberg/DE) 17.00 V119 Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A K. Schott (Langen/DE), R. Derua (Leuven/BE), J. Seifried, A. Reuter E. Schnellbächer, H. Schmitz, C. Tondera, N. Esly (Langen/DE) A. Brandariz-Nuñez, F. Diaz-Griffero (New York, NY/DE) V. Janssens (Leuven/BE), R. König (La Jolla, San Diego, CA/US, Langen/DE) 17.15 V120 Viral DDB1-interacting proteins exhibit discordant DDB1 affinities and interactomes C. Landsberg, V. T. K. Le-Trilling (Essen/DE), D. A. Megger B. Sitek (Bochum/DE), M. Trilling (Essen/DE) p 44 Scientific Programme • Friday, 8 April 2016 16.00–17.30 Room Chairs Workshop 21 – Epidemiology and Public Health Lecture Hall 3 B. Klempa (Berlin/DE), B. Gärtner (Homburg/Saar/DE) 16.00 V121 Increase in Chikungunya virus notifications in NRW with exposure in the Americas 2014 A. Maisa, I. Daniels-Haardt, A. Jurke (Münster/DE) 16.15 V122 Serological prevalence of hemorrhagic fever viruses in Equatorial Africa I. Steffen, K. Lu (San Francisco, CA/US), S. Saragosti (Paris/FR) N. Ndembi (Abuja/NG), C. A. Brennan (Abbott Park, IL/US) W. M. Switzer (Atlanta, GA/US), A. W. Rimoin (Los Angeles, CA/US) G. Simmons (San Francisco, CA/US) 16.30 V123 The Respiratory Virus Network – an initiative to collect and provide data on respiratory virus diseases via internet R. Kaiser, M. Neumann-Fraune, E. Knops, M. Timmen-Wego (Cologne/DE) B. Gärtner (Homburg/Saar/DE), O. Adams (Düsseldorf/DE) 16.45 V124 Human infections by non-rodent associated hantaviruses in Africa P. Heinemann, P. T. Witkowski (Berlin/DE), S. Essbauer (Munich/DE) N. Krüger (Berlin/DE), C. G. Akoua-Koffi, F. Schaumburg (Münster/DE) F. H. Leendertz, D. H. Krüger (Berlin/DE) 17.00 V125 Control and response measures under ILI, ARI and SARI surveillance system in Moldova C. Spinu, V. Eder, P. Scoferta, R. Cojocaru, I. Spinu, I. Gostev A. Donos (Chisinau/MD) 17.15 V126 Cytomegalovirus seroprevalence among children and adolescents in Germany: Data from the KiGGS interview and examination survey, 2003–2006 Se. Voigt, A. Schaffrath Rosario, A. Mankertz (Berlin/DE) 17.30–19.30 Room Poster Session 3 Vom-Stein-Haus (SR 116, SR 118) Vaccines, Viral Pathogenesis and Persistence, Host Cell Factors and Modulation I & II, Epidemiology and Public Health, Zoonoses, Clinical Virology 20.00–01.00 Social Evening (please refer to page 115) p 45 Scientific Programme • Saturday, 9 April 2016 08.30–10.00 Room Chairs Workshop 22 – Zoonoses Lecture Hall 1 T. W. Vahlenkamp (Leipzig/DE), M. A. Müller (Bonn/DE) 08.30 V127 Variegated squirrel 1 bornavirus (VSBV-1) – a novel zoonotic pathogen B. Hoffmann (Greifswald, Isle of Riems/DE), D. Tappe (Hamburg/DE) D. Hoffmann, D. Höper (Greifswald, Isle of Riems/DE) C. Herden (Giessen/DE), K. Schlottau, M. Jenckel, T. Homeier-Bachmann J. P. Teifke, C. Fast (Greifswald, Isle of Riems/DE), S. Herzog (Giessen/DE) D. Cadar, J. Schmidt-Chanasit (Hamburg/DE), R. Ulrich M. Beer (Greifswald, Isle of Riems/DE) 08.45 V128 Alimentary tract as entry route for hantavirus infection P. T. Witkowski, C. Jürgensen, A. Petrich, J.-D. Schulzke, D. H. Krüger R. Bücker (Berlin/DE) 09.00 V129 H5N1 highly pathogenic avian influenza A virus outbreak among poultry in Ghana – 2015 I. A. Asante (Hamburg/DE; Accra/GH), S. Bertram (Hamburg, Lübeck/DE) J. Awuni, A. N. O. Commey, W. K. Ampofo (Accra/GH) G. Gabriel (Hamburg, Lübeck/DE) 09.15 V130 Virological characterisation of a newly established pig breed, Aachen Minipigs E. Plotzki (Berlin/DE), G. Heinrichs (Heinsberg/DE), B. Kubícková R. G. Ulrich (Greifswald, Isle of Riems/DE), J. Denner (Berlin/DE) 09.30 V131 Evolution and antiviral specificity of rodent Mx proteins B. Muether (Freiburg/DE), L. Radosa (Berlin/DE), I. Eckerle (Bonn/DE) M. Hölzer, M. Marz (Jena/DE), S. Drewes, M. Lenk R. Ulrich (Greifswald, Isle of Riems/DE), D. Krüger, B. Klempa (Berlin/DE) G. Kochs (Freiburg/DE) 09.45 V132 Co-circulation of sandfly-transmitted phleboviruses and Leishmania infantum in a zoonotic visceral leishmaniais focus located in arid bio-geographical areas Central Tunisia W. Fares, K. Dachraoui, W. Barhoumi, S. Cherni, S. Sakhria, W. Fraihi I. Chelbi (Tunis/TN), J. Clos (Hamburg/DE), Stefanie Becker (Hanover/DE) E. Zhioua (Tunis/TN) p 46 Scientific Programme • Saturday, 9 April 2016 08.30–10.00 Room Chairs Workshop 23 – Host Cell Factores and Modulation II Lecture Hall 2 A. Karlas (Berlin/DE), C. Claus (Leipzig/DE) 08.30 V133 Modulation of cellular metabolism by rubella virus is strain-specific and targets mitochondrial activity and glycolysis C. Claus, A. Lüdtke, K. Jahn (Leipzig/DE), J. Hübschen (Luxembourg/LU) U. G. Liebert (Leipzig/DE) 08.45 V134 PIAS2 and PIAS1, novel interaction partners of Ebola and Marburg virus VP30, negatively regulate transcription and replication of filoviruses M. Klüver, Step. Becker (Marburg/DE) 09.00 V135 Deciphering the interactions between yellow fever virus and the human immune system F. Douam, G. Hrebikova, Q. Ding, A. Ploss (Princeton, NJ/US) 09.15 V136 A host genome-wide loss-of-function screen reveals effective chikungunya antiviral drugs A. Karlas (Berlin/DE), S. Berre, T. Couderc (Paris/FR), M. Varjak (Tartu/EE) P. Braun, M. Meyer (Falkensee/DE), N. Gangneux (Paris/FR) L. Karo-Astover (Tartu/EE), U. Klemm (Berlin/DE), A. Wurzlbauer F. Bracher (Munich/DE), A. Merits (Tartu/EE), T. F. Meyer (Berlin/DE) M. Lecuit (Paris/FR) 09.30 V137 KAP1 is a host restriction factor that promotes human adenovirus (HAdV) E1B-55K SUMO modification C. Bürck (Hamburg/DE), A. Mund (Copenhagen/DE), J. Berscheminski L. Kieweg (Hamburg/DE), S. Müncheberg S. Schreiner (Hamburg, Munich/DE), T. Dobner (Hamburg/DE) 09.45 V138 Severe beta-HPV infection and skin cancer in genetically predisposed individuals with EV3 deficiency S. J. de Jong, A. Crequer (New York, NY/US), L. Lorenzo J.-H. Fabienne (Paris/FR), A. A. Arias (Medellin/CO), P. M. Nataly R. C. Xavier (Bogota/CO), F. Jose Luis (Medellin/CO), V. K. Gunasekharan L. Laimins (Chicago, IL/US), E. Imahorn, B. Burger (Basel/CH) G. Orth (Paris/FR), E. Jouanguy, J.-L. Casanova (New York, NY/US; Paris/FR) p 47 Scientific Programme • Saturday, 9 April 2016 08.30–10.00 Room Chairs Workshop 24 – Clinical Virology Lecture Hall 3 J. Kühn (Münster/DE), J. Verheyen (Essen/DE) 08.30 V139 Identification of a new Enterovirus 71 genogroup C variant emerging in DE, 2015 S. Böttcher, P. Obermeier, K. Neubauer, S. Diedrich (Berlin/DE) and on behalf of the LaNED 08.45 V140 Interim rsults of a phase Ib/IIa study of the entry inhibitor myrcludex B in chronic hepatitis D infected patients P. Bogomolov (Moscow/RU), A. Alexandrov (Bad Homburg/DE) N. Voronkova, M. Macievich, K. Kokina, M. Petrachenkova (Moscow/RU) T. Lehr (Saarbrücken/DE), F. A. Lempp (Heidelberg/DE) H. Wedemeyer (Hanover/DE), M. Haag, M. Schwab (Stuttgart/DE) W. E. Haefeli, A. Blank, S. Urban (Heidelberg/DE) 09.00 V141 CMV particles mediate acute myeloid leGBaemia cell death via soluble factors irrespective of viral gene expression L. Rink, V. T. K. Le-Trilling, M. Trilling (Essen/DE) 09.15 V142 Multiple virus infections in pediatric allogeneic transplant recipients including Adeno-, Cytomegalo-and Epstein-Barr virus reactivations Se. Voigt, J.-S. Kühl, J. Hofmann, W. Ebell (Berlin/DE) 09.30 Nona-valent HPV-vaccination could potentially prevent the majority of V143 (pre)malignant anogenital lesions in HIV-positive men U. Wieland, M. Hellmich, S. Silling (Cologne/DE) N. Brockmeyer (Bochum/DE), H. Pfister (Cologne/DE) A. Kreuter (Oberhausen/DE) 09.45 V144 Treatment of HIV and acute myeloid leGBemia by allogeneic CCR5-d32 blood stem cell transplantation B. Jensen (Düsseldorf/DE), E. Knops (Cologne/DE) N. Luebke (Düsseldorf/DE), G. Dunay (Hamburg/DE) R. Kaiser (Cologne/DE), R. Haas, D. Häussinger, G. Kobbe (Düsseldorf/DE) 10.00–10.45 Coffee Break within the Industrial Exhibition RoomVom-Stein-Haus p 48 Scientific Programme • Saturday, 9 April 2016 10.45–12.15 Room Chairs Plenary Lecture 4 – Evolution of Viruses – Viruses in Evolution (organised in cooperation with the Münster Graduate School of Evolution (MGSE)) Lecture Hall 1 P. Stäheli (Freiburg/DE), C. Leib-Mösch (Neuherberg/DE) 10.45 Mechanisms and consequences of RNA virus micro-evolution R. Andino (San Francisco, CA/US) 11.15 Reverse genetic analysis of the newly discovered bat influenza A-like viruses M. Schwemmle (Freiburg/DE) 11.45 Paleovirology and our 100-million-year co-evolution with endogenous retroviruses R. Belshaw (Plymouth, Devon/GB) 12.15–12.45 Room Poster Prizes & Farewell Lecture Hall 1 p 49 Postersessions • Vom-Stein-Haus – Schlossplatz 34 Posters will be displayed during the whole duration of the conference. The following topics will be included in the respective sessions: Poster Session 1 Date and Time Wednesday, 6 April 2016 • 19.30–21.30 Topics Virus Receptors and Entry Innate Immunity I & II Diagnostic Tools Viral Replication I & II RoomsNumbers SR07, basement P1–P36 SR10, basement P38–P68 SR11, basement P69–P85 SR11, basement P86–P111 Poster Session 2 Date and Time Thursday, 7 April 2016 • 15.30–17.30 Topics Adaptive Immunity I & II Emerging Viruses Trafficking Virus Vectors and Gene Therapy Structure and Assembly Tumor Viruses Antiviral Therapy and Resistance Evolution of Viruses – Viruses in Evolution Signal Transduction RoomsNumbers hall, basement P112–P125 hall, basement P126–P140 SR06, basement P141–P144 SR06, basement P145–P149 SR06, basement P150–P172 SR06, basement P173–P179 SR06, basement P180–P217 hall, ground floor hall, ground floor P218–P225 P226–P230 Poster Session 3 Date and Time Friday, 8 April 2016 • 17.30–19.30 Topics Vaccines Viral Pathogenesis and Persistence Host Cell Factors and Modulation I & II Epidemiology and Public Health Zoonoses Clinical Virology RoomsNumbers SR116, first floor P231–P256 SR116, first floor P257–P289 SR118, first floor P290–P338 SR116, first floor P339–P343 SR116, first floor P344–P347 SR118, first floor P348–P366 p 50 Poster Session 1 • Virus Receptors and Entry P1 Identification and characterisation of a receptor midgut protein for begomovirus in Bemisia tabaci V. S. Rana, S. Popli, G. K. Saurav, R. Rajagopal (Delhi/IN) P2 Susceptibility of human pulmonary cells to Old World Hantaviruses A. Müller, A. Baumann, M. Zeier, E. Krautkrämer (Heidelberg/DE) P3 Identification of key residues in canine distemper virus attachment protein regulating host cell entry M. Herren, F. Bringolf, M. Wyss, P. Plattet (Bern/CH) P4 Species-specific and inter-individual differences in Nipah virus receptor expression influence NiV infection of primary airway epithelial cells from pigs and humans L. Sauerhering, M. Zickler, M. Elvert, T. Matrosovich, M. Matrosovich A. Maisner (Marburg/DE) P5 Hyperfusogenic mutations in PrV glycoprotein gB – in search of the super-fuser M. Vallbracht, C. Schröter (Greifswald, Isle of Riems/DE), J. Kühn (Münster/DE) B. G. Klupp, T. C. Mettenleiter (Greifswald, Isle of Riems/DE) P6 Species-specific domains of CD81 required by hepatitis C virus for cell entry P. Banse, J. Bruening, S. Kahl, T. Pietschmann, G. Gerold (Hanover/DE) P7 Human Norovirus GII.4 capsid protein contains multiple sialic acid and histo-blood group antigen binding sites H. Wegener, A. Mallagaray (Lübeck/DE), J. Lockhauserbäumer, C. Uetrecht (Hamburg/DE) G. Hansman (Heidelberg/DE), T. Peters, S. Taube (Lübeck/DE) P8 Flavivirus binding to cells D. Haslwanter, D. Blaas, J. Blazevin, F. X. Heinz, K. Stiasny (Vienna/AT) p 51 Poster Session 1 • Virus Receptors and Entry P9 Flavivirus E protein stem interactions in virus entry I. Medits, F. X. Heinz, K. Stiasny (Vienna/AT) P11 A conserved eph receptor binding site in the N-terminal domain of the gH/gL glycoprotein complexes of Kaposi’s sarcoma-associated herpesvirus and the related rhesus monkey rhadinovirus A. Großkopf (Göttingen/DE), A. Ensser, R. Desrosiers (Erlangen/DE) A. Hahn (Göttingen/DE) P12 TMPRSS11A and HAI-1 -a novel activator and inhibitor of influenza virus hemagglutinin proteolytic cleavage P. Zmora, A.-S. Moldenhauer, S. Pӧhlmann (Göttingen/DE) P13 Superinfection exclusion during infection with African swine fever virus G. Keil, R. Potugal (Greifswald, Isle of Riems/DE) P14 Functional relevance of the N-terminal domain of pseudorabies virus envelope glycoprotein H and its interactions with glycoprotein L W. Fuchs, S. Rehwaldt, M. Vallbracht, C. Schröter, B. G. Klupp T. C. Mettenleiter (Greifswald, Isle of Riems/DE) P15 Early phlebovirus host cell interactions using Uukuniemi virus as a model A. Hoffmann, P.-Y. Lozach, H. Fleckenstein, N. Brady, V. Lang (Heidelberg/DE) P16 Branched actin polymerisation regulated by WASH is required for vesicle scission during papillomavirus endocytosis L. Kühling, P. Brinkert, C. Bannach, L. Greune, A. Schmidt, M. Schelhaas (Münster/DE) P17 The tetraspanins CD151 and CD9 are novel host factors during initial events of human cytomegalovirus infection D. Hochdorfer (Ulm/DE), L. Florin (Mainz/DE), C. Sinzger, D. Lieber (Ulm/DE) p 52 Poster Session 1 • Virus Receptors and Entry P18 Entry of bat-associated influenza A viruses is restricted to bat cells, depends on endosomal low pH and proteolytic activation of the hemagglutinin-like protein but does not require canonical FLUAV receptors M. Hoffmann (Göttingen/DE), N. Krüger (Hanover/DE), P. Zmora F. Wrensch (Göttingen/DE), G. Herrler (Hanover/DE), S. Pöhlmann (Göttingen/DE) P19 Mapping of amino acid residues controlling fusion activity within the N-terminal part of the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B M. Vallbracht (Greifswald, Isle of Riems/DE), T. Schräder, A. Krüger, A. Hofemeier E. Lorentzen, M.-L. Romberg, W. Hafezi, J. Kuehn (Münster/DE) P20 The contribution of cellular receptors to herpes simplex virus type 1 entry into skin cells K. Thier, P. Petermann, D. Knebel-Mörsdorf (Cologne/DE) P21 Hemagglutinin compensatory mutations provide new insights in virus-receptor interactions B. Sawatsky (Langen/DE), R. Cattaneo (Rochester, NY/US), V. von Messling (Langen/DE) P22 The cytoskeletal adaptor protein obscurin-like 1 interacts with L2 and is required for HPV16 endocytosis E. Wüstenhagen, L. Hampe, F. Boukhallouk, M. A. Schneider, G. A. Spoden L. Florin (Mainz/DE) P23 Comparative study of Lassa virus replication in immortalised cells and in primary cells derived from the human airway epithelium H. Müller, S. K. Fehling, J. Koepke, T. Strecker (Marburg/DE) P24 The fusion and hemagglutinin-neuraminidase protein of a bat-derived paramyxovirus show functional similarities to human mumps virus N. Krüger (Hanover/DE), M. Hoffmann (Göttingen/DE), J. F. Drexler, M. Müller (Bonn/DE) C. Sauder, S. Rubin (Silver Spring, MD/US), C. Örvell (Stockholm/SE) C. Drosten (Bonn/DE), G. Herrler (Hanover/DE) p 53 Poster Session 1 • Virus Receptors and Entry P25 Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library J. Martin, S. Beck, T. Weidner (Langen/DE), J. Herrmann (Saarbrücken/DE), C. Weber B. Schnierle (Langen/DE) P26 NTCP is the key host factor restricting hepatitis B virus infection in macaques and pigs F. Lempp (Heidelberg/DE), P. Roques (Paris/FR), E. Wiedtke (Heidelberg/DE) I. Chemin (Lyon/FR), F. Vondran (Hanover/DE), D. Grimm (Heidelberg/DE) R. Le Grand (Paris/DE), S. Urban (Heidelberg/DE) P27 Cell entry of human papillomavirus type 16 requires an unconventional trafficking route to the trans-Golgi-network via late endosomes P. Samperio Ventayol, M. Schelhaas (Münster/DE) P28 Human coronavirus OC43 entry is caveolin-1-dependent K. Kosowicz, K. Pyrc (Krakow/PL) P29 Conformational changes in the capsid contribute to asynchronous uptake of human papillomavirus type 16 by endocytosis M. Becker, L. Greune, M. A. Schmidt, M. Schelhaas (Münster/DE) P30 Importance of the GXXXA motif in the Ebolavirus GP transmembrane domain for entry and sensitivity towards host-cell encoded antiviral factors M. Gonzalez Hernandez, M. Hoffmann, S. Pöhlmann (Göttingen/DE) P31 Characterisation of the susceptibility of the Chikungunya virus glycoprotein-mediated cell entry process to pharmacological and immunological inhibition and cellular restriction Se. Franz, S. Dapa (Hanover/DE), G. Simons (San Francisco, CA/US) M. Brönstrup (Braunschweig/DE), C. Goffinet (Hanover/DE) p 54 Poster Session 1 • Virus Receptors and Entry P32 The coxsackievirus and adenovirus receptor – impact of glycosylation and the extracellular D2 domain on coxsackievirus B3 infection S. Pinkert, J. Kurreck (Berlin/DE), J. Bergelson (Philadelphia, PA/US), H. Fechner (Berlin/DE) P33 SEVI and semen prolong the half-life of HIV-1 J. Müller, J. Münch (Ulm/DE) P34 The Ephrin A2 receptor tyrosin kinase (EphA2) is downregulated by the KSHV immediate-early transactivator RTA F. Neipel, M. Fischer, A. Holzer (Erlangen/DE) P35 Visualising the entry of a Picornaviridae, Coxsackievirus A16, into host cells occurs via clathrin-mediated endocytosis through quantum dot-based single-particle tracking Y. Xiong, L. Jia, B. Tang, F. Liu, Yingl. Liu, K. Wu, D. Pang (Wuhan/CN) P36 Specific glycans increase the success of viral infections – native MS reveals glycan mediated structural changes during cell attachment H. Yan, J. Lockhauserbäumer (Hamburg/DE), H. Wegener, A. Mallagaray, S. Taube T. Peters (Lübeck/DE), G. Hansman (Heidelberg/DE), C. Uetrecht (Hamburg/DE) Poster Session 1 • Innate Immunity I & II P38 Nucleic-acid binding proteins with antiviral activity across different species M. Habjan (Martinsried/DE), C. Meignin (Strasbourg/FR), R. E. Boulos J. Colinge (Montpellier/FR), J.-L. Imler (Strasbourg/FR), A. Pichlmair (Martinsried/FR) P39 Allelic variations in the human MxA protein affect its antiviral activity L. Graf, F. Sendker (Freiburg/DE), A. Dick (Berlin/DE), E. Barth, M. Marz (Jena/DE) O. Daumke (Berlin/DE), G. Kochs (Freiburg/DE) p 55 Poster Session 1 • Innate Immunity I & II P40 KIR3DL1 in combination with HLA-Bw4-80T is associated with superior functionality of NK cells and spontaneous immune control of HCV infection in people who inject drugs T. Senff, C. Thöns (Düsseldorf/DE), T. Hydes (Southampton/GB), F. Heinemann, A. Heinold M. Heilmann (Essen/DE), M. Uhrberg (Düsseldorf/DE), N. Scherbaum (Essen/DE) S. Khakoo (Southampton/GB), J. Timm (Düsseldorf/DE) P41 The role of Toll-like receptors in detection of MHV68 in vitro and in vivo S. Murthy, K. A. Bussey, B. Chan, E. Reimer, G. Wolf, C. Standfuß-Gabisch M. M. Brinkmann (Braunschweig/DE) P42 Contribution of herpes virus persistence to inflammatory pathology in the aging host Xi. Zheng (Braunschweig/DE) P43 The mammalian response to virus infection is independent of small RNA silencing S. Backes (Mainz/DE), B. ten Oever (New York, NY/US) P44 Primary human hepatocytes exhibit toll-like receptor 2 activation upon infection with cell culture-derived Hepatitis B virus R. Broering, Zhe. Zhang, M. Trippler, C. Real, M. Werner, G. Gerken (Essen/DE) J. Schlaak (Essen, Duisburg/DE), M. Lu (Essen/DE) P45 The MCMV tegument protein M35 evades the type I IFN response via interaction with regulatory proteins associated with RNAPII-mediated transcription of antiviral genes V. G. Magalhaes, B. Chan (Braunschweig/DE), N. A. W. Lemmermann (Mainz/DE) V. Juranic Lisnic, S. Jonjic (Rijeka/HR), M. J. Reddehase (Mainz/DE), O. Becherel M. Larvin (Brisbane/AU), M. Brinkmann (Braunschweig/DE) P46 TRIM19/PML restricts HIV infection in a cell type-dependent manner B. Volkmann (Erlangen, Bonn/DE), T. Kahle, K. Eissmann, A. Herrmann (Erlangen/DE) S. Schmitt (Erlangen, Bonn/DE), S. Wittmann, L. Merkel, N. Reuter, T. Stamminger T. Gramberg (Erlangen/DE) p 56 Poster Session 1 • Innate Immunity I & II P48 RNA sensing induces a novel restriction to HIV infection in monocytes H. Hofmann, B. Vanwalscappel, N. Bloch, N. Landau (New York, NY/US) P49 Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus S. Bender, A. Reuter, F. Eberle, E. Einhorn, M. Binder, R. Bartenschlager (Heidelberg/DE) P50 E3 ubiquitin ligase and SUMO binding activity of KSHV-encoded RTA are crucial mediators of Toll-like receptor degradation H. Todt, K. Bussey, M. Brinkmann (Braunschweig/DE) P51 Antiviral activity of different interferon (sub-) types against hepatitis E virus replication D. Todt (Hanover/DE), C. François (Amiens/FR), Anggakusuma, P. Behrendt, M. Engelmann L. Knegendorf, G. Vieyres, H. Wedemeyer (Hanover/DE), R. Hartmann (Aarhus/DK) T. Pietschmann (Hanover/DE), G. Duverlie (Amiens/FR), E. Steinmann (Hanover/DE) P52 Intercellular transfer of cGAS-dependent innate immunity in the context of HIV-1 Env glycoprotein-mediated cell-cell fusion S. Xu, A. Ducroux, A. Ponnurangam (Hanover/DE), T. Zillinger (Bonn/DE), A. Malassa E. Ewald (Hanover/DE), V. Hornung (Munich/DE), W. Barchet (Bonn/DE) C. Goffinet (Hanover/DE) P53 Antiviral RNAi response in vector and non-vector cells against orthobunyaviruses I. Dietrich, X. Shi, M. McFarlane (Glasgow/GB), M. Watson (Edinburgh/GB) A.-L. Blomström (Glasgow/GB; Uppsala/SE), J. K. Skelton, R. M. Elliott, A. Kohl E. Schnettler (Glasgow/GB) P54 Establishment and characterisation of well-differentiated bat airway epithelial cell cultures R. Dijkman, H. R. Jonsdottir (Bern/CH), A. Moreira-Soto E. Corrales-Aguilar (Costa Rica/CR), M. Schwemmle (Freiburg/DE), V. Thiel (Bern/CH) p 57 Poster Session 1 • Innate Immunity I & II P55 Measles virus stimulates NK cell infiltration into infected tissue, but not NK cell activity V. Scheuplein (Langen/DE), S. Weil (Mainz/DE), J. Hanauer, A. H. Fiedler (Langen/DE) J. Koch (Mainz/DE), M. D. Mühlebach (Langen/DE) P56 A method pipeline for the detection of positively selected sites in silico – exemplarily shown for bat Mx1 M. Hölzer (Jena/DE), J. Fuchs, G. Kochs (Freiburg/DE), M. Marz (Jena/DE) P57 The human cytomegalovirus IE1 protein antagonises ND10-mediated intrinsic immunity via the inhibition of PML de novo SUMOylation E.-M. Schilling, M. Scherer, S. Klingl, J. Schweininger, J. Stump, Y. Muller, H. Sticht T. Stamminger (Erlangen/DE) P58 Perspectives of a HSV-1 d106S-based melanoma therapy S. Thomann, J. B. Boscheinen (Erlangen/DE), E. Klapproth, A. Rohrhofer (Regensburg/DE) S. Groß, B. Schuler-Thurner (Erlangen/DE), B. Schmidt, M. Werner-Klein P. Schuster (Regensburg/DE) P59 Differential activation of Toll-like receptor 3 by Hepatitis C and Hepatitis A virus K. Esser-Nobis, O. Grünvogel, V. Lohmann (Heidelberg/DE) P60 Viral suppressors of RNA silencing affect cellular RNA silencing in plant R. Pertermann, T. Selvaraj, T. Gursinsky, J. Schuck, S.-E. Behrens (Halle/Saale/DE) P61 IL-6 induction and regulation during influenza A virus and Staphylococcus aureus co-infection C. Klemm (Münster/DE), B. Löffler (Jena/DE), G. Peters, S. Ludwig C. Ehrhardt (Münster/DE) P62 A single nucleotide polymorphism located in the HLA-C promoter region and determining HLA-C expression levels is associated with protection from Hepatitis C virus infection F. M. Heinemann (Essen/DE), C. Thöns (Düsseldorf/DE), M. Lindemann, S. Ross, P. A. Horn N. Scherbaum (Essen/DE), J. Timm (Düsseldorf/DE), A. Heinold (Essen/DE) p 58 Poster Session 1 • Innate Immunity I & II P63 The receptor binding domain and appropriate N-linked glycosylation of the Ebola virus glycoprotein are required for tetherin counteraction C. Brinkmann, I. Nehlmeier (Göttingen/DE), J. Nehls, M. Schindler (Munich/DE) K. Walendy-Gnirß, S. Pöhlmann (Göttingen/DE) P64 Investigation of the cytosolic cGAS-mediated DNA sensing pathway in T-cells of mouse and human origin A. Ponnurangam, C. Goffinet (Hanover/DE) P65 The efficiency of virion incorporation of Env can determine SIV sensitivity to inhibition by IFITMs F. Wrensch, S.Gärtner, U. Sauermann, M. Winkler, S. Pöhlmann (Göttingen/DE) P66 Cleavage of MAVS and interference with innate immune signaling is conserved among hepaciviral NS3/4A proteases Anggakusuma, R. Brown, D. Banda, M. Engelmann, E. Steinmann T. Pietschmann (Hanover/DE) P67 Development of a FACS-FRET assay to analyse IFITM-IFITM interactions F. Wrensch, P. Bosch, M. Knoth, S. Gärtner (Göttingen/DE), M. Schindler (Tübingen/DE) S. Pöhlmann, M. Winkler (Göttingen/DE) P68 Modified vaccinia virus Ankara induces CXCL2 but not CCL2 in alveolar macrophage MH-S cells M. H. Lehmann, P. J. R. Price, C. Brandmüller, G. Sutter (Munich/DE) p 59 Poster Session 1 • Diagnostic Tools P69 Glucose detection using modified tobacco mosaic virus (TMV) particles as enzyme carriers C. Koch (Stuttgart/DE), M. Bäcker (Aachen/DE), S. Eiben, F. Geiger (Stuttgart/DE) H. Gliemann (Karlsruhe/DE), A. Poghossian, M. Schöning (Aachen/DE) C. Wege (Stuttgart/DE) P70 Exploring the virome of cattle with non-suppurative encephalitis of unknown etiology by metagenomics D. Wüthrich, C. Boujon, L. Truchet, S. Selimovic-Hamza, A. Oevermann, I. Bouzalas R. Bruggmann, T. Seuberlich (Bern/CH) P71 Comparison of 2 molecular assays designed for the quantification of HIV-1 in plasma samples A. Berger, M. Stürmer (Frankfurt a. M./DE), J. Becker (Frankfurt/DE), O. T. Keppler (Munich/DE) P72 Comparative analysis of different HBV-genotypes – establishment of a recombinant HBsAg panel M. Hassemer, M. Finkernagel (Langen/DE), K.-H. Peiffer (Frankfurt a. M./DE) D. Glebe (Giessen/DE), M. Chudy, C. M. Nübling, S. Akhras (Langen/DE) E. Hildt (Langen, Giessen, Marburg, Langen/DE) P73 New immunological methods for the detection of porcine herpesviruses E. Plotzki, M. Keller, D. Ivanusic, B. Ehlers, J. Denner (Berlin/DE) P74 Evaluation of two versions of a 4th generation HIV-rapid test (Alere™) for the detection of acute HIV infections H. Rabenau, I. Friedrichs, A. Berger (Frankfurt a. M./DE), D. Münstermann A. Lucht (Bad Salzuflen/DE), O. Keppler (Frankfurt a. M./DE) P75 Development of a protocol for simultaneous Hepatitis C Virus genotyping and resistance testing M. Bergmann, J. Camdereli, D. Häussinger, H. Bock, A. Walker, J. Timm (Düsseldorf/DE) P76 Serological testing of Hepatitis E – Evaluation of four different serological Hepatitis E assays I. Friedrichs, O. T. Keppler, H. F. Rabenau, A. Berger (Frankfurt/DE) p 60 Poster Session 1 • Diagnostic Tools P77 Validation of Illumina next generation sequencing for the molecular surveillance of recently acquired HIV-1 infections in Germany using dried serum spots K. Meixenberger, B. Altmann, A. Hauser, K. Hanke, C. Kuecherer, N. Bannert (Berlin/DE) P78 Plant virus-based nanopores for novel types of bio-inorganic hybrid membranes K. Altintoprak (Stuttgart/DE), A. Seidenstücker (Ulm/DE), A. Welle, P. Krolla-Sidenstein H. Gliemann (Karlsruhe/DE), A. Plettl, O. Marti (Ulm/DE), C. Wege (Stuttgart/DE) P79 Diagnostic assay development based on recombinant Theiler’s Murine Encephalomyelitis Virus (TMEV) expressed proteins K. Meissner, T. Vahlenkamp (Leipzig/DE) P80 Occurrence of goose hemorragic polyomavirus in waterfowl and wild birds in Germany K. Heenemann (Leipzig/DE), A. Hlinak (Frankfurt (Oder)/DE), T. Vahlenkamp (Leipzig/DE) P82 A cross-reactive monoclonal antibody raised against recombinant hepatitis E virus genotype 3 capsid antigen B. Kubickova (Greifswald/DE), J. Schenk (Potsdam/DE) K. Marcinkeviciute (Greifswald/DE; Vilnius/LT), J. Reetz (Berlin/DE), P. Dremsek (Greifswald/DE) P. L. Tamosiunas, R. Petraityte-Burneikiene (Vilnius/LT), J. F. Drexler (Bonn/DE) A. Andersson (Berlin/DE), D. Becher, M. H. Groschup (Greifswald/DE), F. Sellrie (Potsdam/DE) R. Johne (Berlin/DE), R. Ulrich (Greifswald/DE) P83 Pitfalls in PCR troubleshooting – Expect the unexpected? L. Schrick, A. Nitsche (Berlin/DE) P84 The potential of Droplet Digital PCR technology for the quantification of HIV-1 proviral DNA and replication competent virus in different CD4+ subsets G. Dunay, A.-D. Hüfner, O. Degen, E. Tolosa, J. Hauber, J. Schulze zur Wiesch (Hamburg/DE) P85 Development of a rapid detection method for viral infections by use of an optical biosensor technology D. Vollandt, P. Patel, P. Prüger (Berlin/DE), A. Hartjes, G. Markovic, F. Pröll G. Proll (Tübingen/DE), M. Niedrig (Berlin/DE) p 61 Poster Session 1 • Viral Replication I & II P86 Generation of a TB40/E-derived human cytomegalovirus genome with an intact US region and a self-excisable BAC cassette K. Laib Sampaio, M. Abdellatif, C. Sinzger (Ulm/DE) P87 Time course of HIV-1 early post-entry events in human monocyte-derived macrophages D. Bejarano, K. Peng, K. Börner, B. Müller, H.-G. Kräusslich (Heidelberg/DE) P88 Functional dissection of alternatively spliced herpesvirus genes by splice site mutagenesis T. Schommartz (Hamburg/DE), S. Loroch (Dortmund/DE), M. Alawi A. Grundhoff (Hamburg/DE), A. Sickmann (Dortmund/DE), W. Brune (Hamburg/DE) P89 Novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus A. W. Whisnant (Würzburg/DE; Durham, NC/US), T. Kehl, Q. Bao (Heidelberg/DE) M. Materniak, J. Kuzmak (Pulawny/PL), M. Löchelt (Heidelberg/DE) B. R. Cullen (Durham, NC/US) P90 The pestiviral NS4A kink domain is a dynamic regulator of RNA replication and virion morphogenesis D. Dubrau (Lübeck/DE), M. A. Tortorici (Paris/FR), O. Klemens (Lübeck/DE) F. Rey (Paris/FR), N. Tautz (Lübeck/DE) P91 A conserved influenza A virus NP code regulates viral genome packaging M. Juozapaitis, E. A. Moreira, A. Weber (Freiburg/DE), L. Kolesnikova (Marburg/DE) Step. Becker (Marburg/DE), H. Bolte, S. Giese (Freiburg/DE), S. Lakdawala (Pittsburgh, PA/US) M. Beer (Greifswald, Isle of Riems/DE), A. García-Sastre (New York, NY/US) M. Schwemmle (Freiburg/DE) P92 Role of protein phosphatase 1 (PP1) during Ebola virus transcription G. Stalmann, Step. Becker, N. Biedenkopf (Marburg/DE) P93 Tetraspanin CD63 interacts with gp41 – a key molecule for cell-cell transfer of HIV-1 D. Ivanusic, M. Eschricht, J. Denner (Berlin/DE) p 62 Poster Session 1 • Viral Replication I & II P94 Human norovirus polyprotein expression inhibits cell proliferation, causes membrane rearrangements and leads to increased caspase activity S. Doerflinger, V. Lohmann, G. Hansman (Heidelberg/DE) P95 Hepatitis C virus infection perturbs the lipid profile of the host cell S. Hofmann (Hamburg/DE), M. Krajewski (Borstel/DE), M. Klabes, M. Melling, P. Truschow C. Scherer (Hamburg/DE), D. Schwudke (Borstel/DE), E. Herker (Hamburg/DE) P96 Replication of neuropathogenic and non-neuropathogenic strains of equine herpesvirus 1 (EHV-1) in ED cell line J. Cymerys, A. Slonska, J. Brzezicka, T. Dzieciatkowski, M. W. Banbura (Warsaw/PL) P97 Infection and replication efficiency of different human cytomegalovirus glycoprotein O genotypes J. Kalser (Vienna/AT), B. Adler, I. Brizic (Munich/DE), H. Vietzen, E. Puchhammer-Stöckl I. Görzer (Vienna/AT) P98 Deciphering the RNA Chaperone activity of the West Nile Virus host factor AUF1 S. Friedrich, T. Schmidt, R. P. Golbik, S.-E. Behrens (Halle/Saale/DE) P99 Determinants of the broad cell tropism of Bungowannah virus – an atypical pestivirus I. Reimann, M. Richter, M. Beer (Greifswald, Isle of Riems/DE) P100 Transcomplementational analysis of viral proteins interacting with DDB1 M. Rückborn (Essen/DE), Se. Voigt (Berlin/DE), V. T. K. Le-Trilling, M. Trilling (Essen/DE) P101 Polycomb repressive complex 2 (PRC2) is important for efficient lytic replication of human cytomegalovirus A. Svrlanska, N. Reuter, T. Stamminger (Erlangen/DE) p 63 Poster Session 1 • Viral Replication I & II P102 Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs T. Laske, F. S. Heldt, T. Frensing, U. Reichl (Magdeburg/DE) P103 Monoclonal antibodies against nsp4 of porcine reproductive and respiratory syndrome virus (PRRSV) show cross-reactivity between genotypes L. J. Sinn, Be. Lamp, A. Proksch, H.-W. Chen, K. Buczolich, C. Riedel T. Rümenapf (Vienna/AT) P104 Influence of three-dimensional cell cultivation on virus infection studies R. Koban, M. Neumann, O. Bloch, A. Daugs, H. Ellerbrok (Berlin/DE) P105 Analysis of a Rec-deficient mutant of a reconstituted HERV-K(HML-2) S. Mostafa, O. Hohn, N. Bannert (Berlin/DE) P106 Type I interferon antagonistic properties of Influenza B virus polymerase proteins A. Schreiber, S. Liedmann, D. Anhlan, Y. Börgeling, C. Ehrhardt, S. Ludwig (Münster/DE) P107 Secondary structure and functional role of the human coronavirus 229E 5‘-terminal genome region R. Madhugiri (Giessen/DE), M. Fricke (Jena/DE), N. Karl, D. Petersen (Giessen/DE) M. Marz (Jena/DE), J. Ziebuhr (Giessen/DE) P108 Identification of cellular RNA binding proteins that interact preferentially with poorly spliced influenza virus mRNAs K. Nilsson, S. Abdurahman, N. Kajitani, S. Schwartz (Lund/SE) P109 Generation of an avian/mammalian rotavirus reassortant using a helpervirus-dependent reverse genetics system E. Trojnar, R. Johne, B. Kaufer (Berlin/DE) p 64 Poster Session 1 • Viral Replication I & II P110 Semen enhances infection of transmitted/founder and chronic/control HIV-1 strains with similar efficacy M. Zou (Guangzhou/CN, Ulm/DE), J. A. Müller, J. Münch (Ulm/DE) P111 The study of inclusion body fusion mechanism and function of human parainfluenza virus type 3 She. Zhang, Y. Jiang, Q. Yan, M. Chen (Wuhan/CN) VISIT OUR BOOTH FREE SAMPLES + SPECIAL MEETING PROMOTION Viral production: Dreamfect Gold, Calcium phosphate kit Capture, concentration and preservation of virus: Mag 4C Magnetic infection enhancers (up to 10 fold): ViroMag, AdenoMag Chemical transduction enhancers: LentiBlast and AdenoBlast Polybrene (10µg.ml-1) LentiBlast (1:100) MOI 0.5 MOI 1.0 www.ozbiosciences.com p 65 Poster Session 2 • Adaptive Immunity I & II P112 To the bat MHC! Antigen processing and presentation during viral infection A. Woon (Clayton/AU), J. Wynne (Geelong/AU), N. Dudek (Clayton/AU) J. Ng (Singapore/SG), B. Ho (Clayton/AU), M. Baker (Geelong/AU), Lin. Wang (Singapore/SG) A. Purcell (Clayton/AU) P113 Activation of Fcγ receptors by hepatitis B virus anti-capsid antibodies V. Falcone, M. Nassal (Freiburg/DE), E. Corrales-Aguillar (San José/CR) H. Hengel (Freiburg/DE) P114 Identification of quantitative binding motifs and Equine Herpesvirus-1-derived CTL epitopes of equine MHC class I loci To. Bergmann (Berlin/DE), R. M. Harman, D. M. Miller, D. F. Antczak (Ithaca, NY/US) J. Sidney, A. Sette (San Diego, CA/US), K. Osterrieder (Berlin/DE; Ithaca, NY/US) P115 Impact of human IgG1 heavy chain variants on the neutralisation capacity and antibody dependent cellular cytotoxicity against HCMV H. Vietzen, E. Puchhammer-Stöckl (Vienna/AT) P117 Immunisation with immune complexes modulates the fine-specificity of antibody responses to a flavivirus antigen G. Tsouchnikas, J. Zlatkovic, J. Jarmer, J. Strauß, O. Vratskikh, M. Kundi, K. Stiasny F. Heinz (Vienna/AT) P118 Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions S. Eickhoff, A. Brewitz (Bonn/DE), M. Y. Gerner (Bethesda, MD/US) F. Klauschen (Berlin/DE), K. Komander (Bonn/DE), H. Hemmi (Wakayama/JP) N. Garbi (Bonn/DE), T. Kaisho (Wakayama/JP), R. N. Germain (Bethesda, MD/US) W. Kastenmüller (Bonn/DE) P119 Cross-reactivity profiles of CD8+ T cells targeting an immunodominant epitope in the core protein of HBV J. Brinkmann (Düsseldorf/DE), H. Kefalakes (Essen/DE), A. Walker (Düsseldorf/DE) G. Gerken (Essen/DE), J. Timm (Düsseldorf/DE) p 66 * * coming soon Poster Session 2 • Adaptive Immunity I & II P120 Genetic ablation or pharmacological inhibition of acid sphingomyelinase enhances CD4+ Foxp3+ regulatory T cell activity C. Hollmann, D. Reuter, N. Müller, S. Werner, E. Avota (Würzburg/DE), L. Japtok B. Kleuser (Potsdam/DE), K. A. Becker, E. Gulbins (Essen/DE), N. Beyersdorf J. Schneider-Schaulies (Würzburg/DE) P121 Induction of TFH-like cells in vitro A. Kolenbrander (Bochum/DE), K. Überla, V. Temchura (Erlangen/DE) P122 Molecular footprints within HDV-protein lead to identification of novel CD8 T cell epitopes H. Karimzadeh (Munich/DE), B. Budeus (Essen/DE), A. Kosinska, T. Bauer (Munich/DE) A. Heinold, D. Hoffmann (Essen/DE), U. Protzer, M. Roggendorf (Munich/DE) P123 Identification of novel adenoviral peptide epitopes and their potential in adoptive transfer immunotherapy P. Günther, J. Peper, S. Kayser (Tübingen/DE), B. Faist (Munich/DE) G. Jahn (Tübingen/DE), M. Neuenhahn, D. Busch, T. Feuchtinger (Munich/DE) S. Stevanović, K. Dennehy (Tübingen/DE) P124 Specificities of human CD4+ T cell responses to the live attenuated yellow fever virus vaccine (17D-204) M. Koblischke, J. Schwaiger (Vienna/AT), M. Mackroth (Hamburg/DE), I. Fae (Vienna/AT) B. Knapp (Oxford/GB), G. Fischer, K. Stiasny (Vienna/AT), B. Fleischer (Hamburg/DE) F. X. Heinz, J. H. Aberle (Vienna/AT) P125 The role of cytotoxic CD4+ T cells in direct protective immunity against retrovirus infection A. Malyshkina, I. Akhmetzyanova, U. Dittmer (Essen/DE) p 68 Poster Session 2 • Emerging Viruses P126 Frequency of astrovirus infection in cattle with non-suppurative encephalitis S. Selimovic-Hamza, I. Bouzalas, A. Oevermann, L. Truchet, C. Boujon, T. Seuberlich (Bern/CH) P127 Sequencing of West-African Ebola viruses under outbreak conditions using a novel, pocket-sized nanopore sequencer T. Hoenen (Hamilton, MT/US; Greifswald, Isle of Riems/DE) P128 Detection of the first mesoniviruses in Europe F. Zirkel, R. Katrin, M. Marklewitz, C. Drosten, S. Junglen (Bonn/DE) P129 Novel atypical porcine pestivirus (APPV) associated with congenital tremor in newborn piglets A. Postel, F. Hansmann, C. Bächlein (Hanover/DE), N. Fischer, M. Alawi A. Grundhoff (Hamburg/DE), S. Derking, J. Tenhündfeld (Vreden/DE), V. M. Pfankuche V. Herder, W. Baumgärtner, M. Wendt, P. Becher (Hanover/DE) P130 Characterisation and inhibition of the Chikungunya virus (CHIKV) entry process C. Weber, L. Henß, K. Sliva, B. Schnierle (Langen/DE) P131 An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels B. L. Haagmans, J. M. A. van den Brand, V. S. Raj (Rotterdam/NL), A. Volz (Munich/DE) P. Wohlsein (Hanover/DE), S. L. Smits, D. Schipper, T. M. Bestebroer N. Okba (Rotterdam/NL), R. Fux (Munich/DE), A. Bensaid, D. S. Foz (Barcelona/ES) T. Kuiken (Rotterdam/NL), W. Baumgärtner (Hanover/DE), J. Segalés (Barcelona/ES) G. Sutter (Munich/DE), A. D. M. Osterhaus (Utrecht/NL) P132 Hendra virus attachment protein expression in a novel eukaryotic expression system based on Leishmania tarentolae K. Fischer, V. Pinho dos Reis, S. Finke (Greifswald, Isle of Riems/DE) L. Sauerhering (Marburg/DE), E. Stroh, A. Karger (Greifswald, Isle of Riems/DE) A. Maisner (Marburg/DE), H. Weingartl (Winnipeg/CA), M. H. Groschup, S. Diederich A. Balkema-Buschmann (Greifswald, Isle of Riems/DE) p 69 Poster Session 2 • Emerging Viruses P133 Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection Xu. Zheng (Changchun/CN), G. Wong (Beijing/CN), Y. Zhao, Hu. Wang (Changchun/CN) S. He (Winnipeg/CA), Y. Bi (Beijing/CN), W. Chen, H. Jin, W. Gai, D. Chu, Z. Cao C. Wang (Changchun/CN), Q. Fan (Kunming/CN), H. Chi, Y. Gao, T. Wang, N. Feng, F. Yan G. Huang, Y. Zheng, N. Li, Yue. Li, J. Qian, Y. Zou (Changchun/CN), G. Kobinger (Winnipeg/CA) G. F. Gao (Beijing/CN), X. Qiu (Winnipeg/CA), S. Yang, X. Xia (Changchun/CN) P134 Viral antigen distribution of Variegated Squirrel Bornavirus-1 (VSBV-1) in organs of naturally infected squirrels C. Herden, D. Nobach, J. Petzold (Giessen/DE), C. Fast, B. Hoffmann (Greifswald, Isle of Riems/DE) D. Tappe (Hamburg/DE), D. Höper, J. P. Teifke (Greifswald, Isle of Riems/DE) J. Schmidt-Chanasit (Hamburg/DE), R. G. Ulrich, M. Beer (Greifswald, Isle of Riems/DE) P135 Co-circulation of a novel phlebovirus and Massilia virus in sandflies, Portugal F. Amaro (Águas de Moura/PT), L. Ze-Ze (Águas de Moura, Lisboa/PT) M. J. Alves (Águas de Moura/PT), J. Börstler, J. Clos, S. Lorenzen (Hamburg/DE) Stefanie Becker Becker (Hanover/DE), J. Schmidt-Chanasit, D. Cadar (Hamburg/DE) P136 The glycoprotein Gn/Gc of severe fever with thrombocytopenia syndrome virus is cleaved by signal peptidase and cleavage is essential for host cell entry T. Plegge, M. Spiegel, H. Hofmann-Winkler, S. Pöhlmann (Göttingen/DE) P137 Loss of maternal MERS-CoV antibodies in camel calves triggers virus amplification in farmed camel herds B. Meyer, V. M. Corman, M. A. Müller (Bonn/DE), U. Wernery, P. Nagy (Dubai/AE) C. Drosten (Bonn/DE) P138 NFkappaB signalling pathway inhibition impairs Puumalavirus propagation O. Planz, U. Wulle, C. Hartmayer (Tübingen/DE), P. Witkowski, D. Krüger (Berlin/DE) P140 Characterisation of the non-coding control region of polyomavirus KI isolated from nasopharyngeal samples from patients with respiratory symptoms or infection and blood from healthy blood donors in Norway X. Song, M. Van Ghelue, M. Ludvigsen (Tromsø/NO), S. A. Nordbø (Trondheim/NO) B. Ehlers (Berlin/DE), U. Moens (Tromsø/NO) p 70 Poster Session 2 • Trafficking P141 HCV-induced oxidative stress triggers autophagy via impaired Nrf2 signaling R. Medvedev, D. Ploen, F. Elgner, H. Ren (Langen/DE) E. Hildt (Langen, Marburg-Giessen-Lagen/DE) P142 Molecular characterisation of the interaction between the Lassa virus matrix protein Z and the cellular motor protein KIF13A V. Heinecke, A. Meyer, L. Wendt, T. Strecker, S. K. Fehling P143 Intracellular trafficking of herpes simplex virus type 1 glycoprotein B in syncytial cells C. Fischer (Münster/DE), M. Vallbracht (Greifswald, Isle of Riems/DE), S. Imdahl J. Kühn (Münster/DE) P144 Subcellular trafficking and functional relationship of the HSV-1 Glycoproteins N and M H. Striebinger (Munich/DE), C. Funk (Stuttgart/DE), V. Raschbichler (Munich/DE) S. Bailer (Stuttgart, Munich/DE) Poster Session 2 • Virus Vectors and Gene Therapy P145 A novel pipeline to produce high-capacity adenoviral vectors for the delivery of the complete CRISPR machinery exemplified by targeting HPV genomes in cervical cancer cells E. Ehrke-Schulz, T. Leitner, S. Dávid, Jin. Liu, M. Schiwon, Th. Bergmann, A. Ehrhardt (Witten/ DE) P146 DARPins as CAR binding domains L. Patasic, J. Seifried, I. Schneider, C. Buchholz, C. Tondera, H. Schmitz (Langen/DE) A. Hombach, H. Abken (Cologne/DE), R. König (Langen/DE; La Jolla, San Diego CA/US) K. Cichutek (Langen/DE) p 71 Poster Session 2 • Virus Vectors and Gene Therapy P147 Layer-by-Layer technology as a supportive tool for virus infection studies U. Reibetanz, D. Hübner (Leipzig/DE), M. Jung (Halle/Saale/DE), U. G. Liebert C. Claus (Leipzig/DE) P148 Inhibition of Ad infection by use of AAV vectors expressing anti-adenoviral artificial microRNAs K. Schaar, A. Geisler, M. Kraus (Berlin/DE), C. Röger (Oldenburg/DE) H. Fechner (Berlin/DE) P149 Replacement of residual gag sequences by codon-optimised GFP in an HIV-1 vector leads to rev-independent expression and encapsidation but inhibits infectivity B. Grewe, B. Tippler (Bochum/DE), J. Bohne (Hanover/DE), R. Wagner B. Asbach (Regensburg/DE) Poster Session 2 • Structure and Assembly P150 Analysing epitope of Dengue virus serotype 1 and 2 as the basis for vaccine development: A descriptive study of partial envelope (Domain III) A. Basuki, A. Pramudita, B. E. Dewi (Jakarta/ID) P151 Influence of Nipah virus matrix protein on viral fusogenicity, particle stability and infectivity E. Dietzel, M. Weis, L. Kolesnikova, A. Heiner (Marburg/DE), B. Sawatsky V. von Messling (Langen/DE; Laval/FR), A. Maisner (Marburg/DE) P152 Transmembrane domains of the tick-borne encephalitis virus E protein in virus assembly J. Blazevic, F. X. Heinz, K. Stiasny (Vienna/AT) P153 Processing of GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) type 1: Efficiency of signal peptide cleavage is affected by glycosylation sites and dimerisation with M B. Thaa (Stockholm/SE; Berlin/DE), S. A. Neumann, B. Peibst, E. Krause, M. Veit (Berlin/DE) p 72 Poster Session 2 • Structure and Assembly P154 African bat henipavirus GH-M74a glycoprotein – Study on the functional importance of N glycans L. Behner, K. Wittwer, M. Weis, A. Maisner (Marburg/DE) P155 Functional characterisation of the N-terminal domain of the pseudorabies virus pUL31 protein T. Hellberg, P. Gawol, D. Sydow, L. Paßvogel, W. Fuchs, T. Mettenleiter B. Klupp (Greifswald, Isle of Riems/DE) P156 Mapping domains of the Schmallenberg virus nonstructural protein NSm F. Kraatz, K. Wernike, A. Aebischer, I. Reimann, M. Beer (Greifswald, Isle of Riems/DE) P157 Mutational analysis of the hepatitis B virus S protein oligomerisation S. Suffner, N. Gerstenberg (Neuherberg/DE) M. Schindler (Neuherberg, Tübingen, Hamburg/DE), V. Bruss (Neuherberg/DE) P158 Tubulins interact with S proteins of porcine and human coronaviruses and support successful assembly and release of infectious viral particles A.-T. Rüdiger (Hanover/DE), P. Mayrhofer (Munich/DE), I. Speckmann (Hanover/DE) Y. Ma-Lauer (Munich/DE), G. Pohlentz, J. Müthing (Münster/DE) A. von Brunn (Munich/DE), C. Schwegmann-Weßels (Hanover/DE) P159 A C-terminal tetra-lysine motif of the human cytomegalovirus tegument protein pUL71 augments secondary envelopment. C. Villinger, M. Schauflinger, D. Fischer, P. Walther, T. Mertens, J. von Einem (Ulm/DE) P160 Mapping and functional characterisation of self-association domains of pUL37 of herpes simplex virus type 1 W. Hafezi, A. Gossens, N. Kirschnick, J. Kühn (Münster/DE) p 73 Poster Session 2 • Structure and Assembly P161 The pUL94/pUL99 complex is a central regulator of human cytomegalovirus virion assembly Stefan Becker, C. Villinger, T. Mertens, J. von Einem (Ulm/DE) P162 Conserved tryptophan motifs in the large tegument protein pUL36 are required for efficient secondary envelopment of herpes simplex virus capsids L. Ivanova, A. Buch, K. Döhner, A. Pohlmann, A. Binz, U. Prank, M. Sandbaumhüter R. Bauerfeind, B. Sodeik (Hanover/DE) P163 A tyrosine-based trafficking motif of tegument protein pUL71 is crucial for human cytomegalovirus virion envelopment A. Dietz, Stefan Becker, J. Keck, C. Villinger, J. von Einem (Ulm/DE) P164 The herpes simplex virus protein pUL31 escorts nucleocapsids to sites of nuclear egress, a process coordinated by its N-terminal domain C. Funk (Stuttgart/DE), M. Ott, V. Raschbichler (Munich/DE), C.-H. Nagel, A. Binz B. Sodeik, R. Bauerfeind (Hanover/DE), S. Bailer (Stuttgart, Munich/DE) P165 Crystal structure of the papain-like protease 2 (PLP-2) of human coronavirus NL63 explains unique substrate specificity of the enzyme A. Lindae, J. Lei, R. Hilgenfeld (Lübeck/DE) P166 Glutamic acid residues in HIV-1 p6 regulate virus budding and membrane association of gag M. Friedrich, C. Setz, F. Hahn, A. Matthaei, K. Fraedrich, P. Rauch (Erlangen/DE) T. Fossen (Bergen/NO), U. Schubert (Erlangen/DE) P167 Extracellular maturation of secreted hepatitis C virus particles by incorporation of secreted Apoliporotein E confers enhanced infectivity and partial protection from neutralizing antibodies D. Bankwitz, R. Weller, K. Hueging, T. Pietschmann (Hanover/DE) p 74 Poster Session 2 • Structure and Assembly P168 MERS-coronavirus papain-like protease is a less efficient enzyme and binds ubiquitin differently compared to its SARS-CoV counterpart J. Lei, R. Hilgenfeld (Lübeck/DE) P169 Probing the main protease of Human Coronavirus NL63 with peptidomimetics reveals important differences between alpha-and betacoronavirus enzymes L. Zhang, D. Lin (Lübeck/DE), H. Liu (Shanghai/CN), R. Hilgenfeld (Lübeck/DE; Shanghai/CN) P170 Macrodomains of MERS Coronavirus R. Hilgenfeld (Lübeck/DE) P171 Acylation of human cytomegalovirus pUL99 regulates its function J. Keck, A.-L. Wild, C. Villinger, J. von Einem (Ulm/DE) P172 The hepatitis E virus intraviral interactome A. Osterman (Munich/DE), T. Stellberger (Karlsruhe, Oberschleissheim/DE) A. Gebhardt, M. Kurz, C. C. Friedel (Munich/DE), P. Uetz (Karlsruhe/DE; Richmond, VA/US) H. Nitschko (Munich/DE), A. Baiker (Oberschleissheim/DE) M. G. Vizoso-Pinto (Munich/DE; San Miguel de Tucumán/AR) Poster Session 2 • Tumor Viruses P173 Polyomavirus Infections and its clinical relevance in cancer patients – a prospective study S. Loutfy, M. Moneer (Cairo/EG), S. Salem, E. Abada, E. Ahmed, L. Ibrahim E.-C. Mohamed (Cairo, Helwan/EG) P174 MMTV DNA-like env sequences and its association with presence of BRCA1/2 genes mutations among familial and non-familial Egyptian breast cancer patients S. Loutfy, Z. Abdullah, M. Shaalan, L. Hegazy, A.-R. Zekri (Cairo/EG) p 75 Poster Session 2 • Tumor Viruses P175 Characteristics of Epstein Barr Virus variants associated with gastric carcinoma in Southern Tunisia D. Ben Ayed-Guerfali, W. Ayadi, A. Khabir, T. Sallemi-Boudawara R. Mokdad-Gargouri (Sfax/TN) P176 The ORF012 gene of Marek’s disease virus type 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth T. Schippers, N. Osterrieder (Berlin/DE) P177 hnRNP L interacts with HPV16 mRNAs and modulates viral RNA splicing N. Kajitani, J. Glahder, S. Schwartz (Lund/SE) P178 SUMO modification of adenovirus E1B-55K oncoprotein required for complete transformation of primary mammalian cells V. Kolbe, J. Bezgovsek, J. Berscheminski (Hamburg/DE), S. Schreiner (Munich/DE) M. H. Tatham, R. T. Hay (Dundee/GB), T. Dobner (Hamburg/DE) P179 Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection Q. Zhang, L. Wei, H. Yang, W. Yang, Q. Yang, Zhu. Zhang, K. Wu, J. Wu (Wuhan/CN) Poster Session 2 • Antiviral Therapy and Resistance P180 Immuno-modulating properties of anticancer/antiviral saliphenylhalamide, SNS-032, obatoclax, and gemcitabine S. Soderholm, D. Kainov (Helsinki/FI) P181 Virtual screening and molecular docking for discovering new small molecules against Ebola VP40 protein H. Alam El-Din, S. Loutfy (Cairo/EG), S. Kassem (Giza/EG), A. Mayla, M. Elberry N. Fathy (Cairo/EG), A. Naqvi (Agra/IN) p 76 Poster Session 2 • Antiviral Therapy and Resistance P182 Identification and generation of HCMV UL27-mutants with subsequent characterisation in regard to resistance to antiviral agents E. Imrich, K. Hamprecht, G. Jahn, K. Göhring (Tübingen/DE) P183 Aescin as a novel fusion inhibitor against herpes simplex virus type 1 (HSV-1) D. Ulrich, W. Hafezi, S. Brandt, A. Hensel, J. Kühn (Münster/DE) P184 LNAs vs. HIV-1 RNA expression – an alternative approach to knock-down viral replication F. Hillebrand, H. Schaal (Düsseldorf/DE) P185 Novel procedure to assess resistance relevance of mutations in the thymidine kinase gene of herpes simplex virus type 1 M. Kaspar, K. Bohn-Wippert, P. Bellstedt, M. Görlach, A. Sauerbrei (Jena/DE) P186 Coffee inhibits HCV entry and replication in vitro K. Singethan (Munich/DE), A. D. Keller, A. Wuestenberg, C. Loscher (Hamburg/DE) A. Herrmann (Munich/DE), V. Lohmann, R. Bartenschlager (Heidelberg/DE), M. Dandri G. Sass (Hamburg/DE), U. Protzer (Munich/DE), G. Tiegs (Hamburg/DE) P187 Inhibition of influenza B viruses with neuraminidase inhibitors S. Duwe, B. Schweiger (Berlin/DE) P188 Cytosolic phospholipase A2a is a potential drug target for combating infections caused by plus-strand RNA viruses C. Müller, M. Hardt, S. Pleschka, J. Ziebuhr (Giessen/DE) P189 Engineering a modified HsPUM1-HD in order to bind to internal ribosome entry site (IRES) of hepatitis C virus (HCV) S. J. Kiani, T. Taheri, M. Maleki, S. Rafati, K. Azadmanesh, S. M. Alavian, T. Mokhtari Azad K. Samimi-Rad (Tehran/IR) p 77 Poster Session 2 • Antiviral Therapy and Resistance P190 Resistance determinants of an orally bioavailable 5-amidino analog of oseltamivir and their impact on viral fitness – a reverse genetics study in the influenza virus N1 background A. Hoffmann (Jena/DE), D. Schade (Dortmund/DE), J. Kirchmair (Hamburg/DE) B. Clement (Kiel/DE), A. Sauerbrei, M. Schmidtke (Jena/DE) P191 SOCS3 mRNA expression, polymorphisms and response to treatment in HCV genotype 3a infected patients S. Khaliq, R. Aslam (Lahore/PK) P192 Cytomegalovirus blocks T cell cytotoxicity by UL36 and UL37x1 and thereby also evades HLA-independent killing of infected cells by CAR-T cells J. Proff (Vienna/AT; Erlangen/DE), C. Walterskirchen, C. Brey, R. Geyeregger (Vienna/AT) F. Full (Erlangen/DE; Chicago, IL/US), A. Ensser (Erlangen/DE), M. Lehner W. Holter (Vienna/AT) P193 AAV based heterologous replicon technology for detection and quantification of adeno-and herpesvirus infections S. Langer (Munich/DE), V. Kapper-Falcone (Freiburg/DE), H. Nitschko, G. Jäger (Munich/DE) A. Ehrhardt (Witten/DE), U. Koszinowski (Munich/DE), Z. Ruzsics (Freiburg/DE) P194 Vitamin D analogs lead to an inhibition of the release of hepatitis B virus in different genotypes M. Finkernagel, M. Hassemer, M. Biehl, K. Himmelsbach (Langen/DE), K.-H. Peiffer C. Lange (Frankfurt a. M./DE), D. Glebe (Marburg, Giessen, Langen/DE), M. Chudy M. C. Nübling (Langen/DE), E. Hildt (Marburg, Giessen, Langen/DE) P195 Enrofloxacin, a potent antiviral compound against African swine fever virus in vitro, lacks detectable antiviral activity in vivo G. Keil, J. Pietschmann, R. Portugal, S. Blome (Greifswald, Isle of Riems/DE) P196 Exploitation of PKR as a selector for the identification of immunostimulating influenza virus RNAs useful for antiviral therapy M. Budt, F. Jolmes, C. Mache, T. Wolff (Berlin/DE) p 78 Poster Session 2 • Antiviral Therapy and Resistance P197 Carboxylic acids of the trail of a slug to fight measles virus A. R. de Toledo-Piza, C. A. Figueiredo, G. Negri, R. Z. Mendonça (São Paulo/BR) P198 Tetrahalogenated benzimidazole D-ribonucleoside are active against RCMV in a 2-D as well as 3-D environment A. Dittmer, I. Woskobojnik (Berlin/DE), J. C. Drach, L. B. Townsend (Ann Arbor, MI/US), Se. Voigt E. Bogner (Berlin/DE) P199 HTCC – Broad range inhibitor of coronavirus entry A. Milewska, K. Pyrc (Krakow/PL) P200 Development of multiplex qPCR method for cell-culture based testing of antiviral compounds with potential activity against human adenovirus C M. Przybylski, T. Dzieciatkowski, R. Zahorska (Warsaw/PL), A. Gorski (Warsaw, Wroclaw/PL) P201 Antibody-based immunotherapy and prevention of HSV-induced ocular diseases A. Krawczyk, M. Dirks (Essen/DE), A. Buch (Hanover/DE), M. Alt, U. Dittmer (Essen/DE) L. Bagnewski, M. Busch, M. Henning (Münster/DE), A.-M. Eis-Hübinger (Bonn/DE) B. Sodeik (Hanover/DE), A. Heilogenhaus (Münster/DE) M. Roggendorf (Essen, Munich/DE), D. Bauer (Münster/DE) P202 KSHV thymidine kinase as a potential target for FDA approved kinase inhibitors G. Beauclair, J. Rückert, A. Dhingra, N. Samarina, S. Koch T. F. Schulz (Hanover, Braunschweig/DE) P203 Hepatitis C virus screening project of patients on current anti-HCV therapy E. Knops (Cologne/DE), P. Kalaghatgi (Saarbrücken/DE), M. Neumann-Fraune, E. Heger E. Schuelter (Cologne/DE), T. Lengauer (Saarbrücken/DE), V. Keitel (Düsseldorf/DE) D. Nierhoff (Cologne/DE), N. Schuebel (Osnabrück/DE), T. von Hahn (Hanover/DE) I. Peuser (Lüdenscheid/DE), N. Qurishi, K. Römer, S. Scholten (Cologne/DE) M. Daeumer (Kaiserslautern/DE), J. Schulze zur Wiesch (Hamburg/DE), A. Baumgarten M. Obermeier, H. Walter (Berlin/DE), R. Kaiser, S. Sierra (Cologne/DE) p 79 Poster Session 2 • Antiviral Therapy and Resistance P204 Drug susceptibility of BAC-derived HSV-1 with thymidine kinase variants A.-K. Brunnemann (Kiel/DE), K. Liermann, S. Deinhardt-Emmer (Jena/DE) G. Maschkowitz (Kiel/DE), A. Pohlmann, B. Sodeik (Hanover/DE), H. Fickenscher (Kiel/DE) A. Sauerbrei (Jena/DE), A. Krumbholz (Kiel/DE) P205 Docosanol and docosanoic acid reduce fusion activity of herpes simplex virus type 1 (HSV-1) glycoproteins A. Pettke, A. Pogodalla, D. Ulrich, W. Hafezi, J. Kühn (Münster/DE) P206 Synergistic resistance of group 2 influenza neuraminidase and structural basis of an oseltamivir-zanamivir hybrid inhibitor Ya. Wu, F. Gao, J. Qi, M. Pinto, G. F. Gao (Beijing/CN) P207 Low frequency of the R263K mutation in HIV-1 integrase in patients of the AREVIR cohort related to raltegravir or elvitegravir therapy failures N. Lübke (Düsseldorf/DE), E. Knops, E. Heger (Cologne/DE), B. Jensen (Düsseldorf/DE) T. Kümmerle (Cologne/DE), J. Timm (Düsseldorf/DE), R. Kaiser (Cologne/DE) P208 A method for the treatment of herpes simplex virus (HSV ½) C. Spinu, I. Spinu, P. Scoferta, V. Eder, A. Donos (Chisinau/MD) P209 Structure–activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication R. Filosa, S. Collarile, M. De Rosa (Naples/IT), A. Brancale (Naples/IT; Cardiff/GB), M. Scuotto C. Schiraldi (Naples/IT) P210 Features of HIV persistent viremia after the start and restart of antiretroviral treatment regimens M. Widera, M. Dirks, R. Jablonka (Essen/DE), M. Däumer (Kaiserslautern/DE) H. Walter (Berlin/DE), S. Esser, J. Verheyen (Essen/DE) p 80 Poster Session 2 • Antiviral Therapy and Resistance P211 Screening an FDA-approved drug library on a cell line that supports the full life cycle of hepatitis delta virus L. Nußbaum, F. Lempp, L. Rieble, Y. Ni, S. Urban (Heidelberg/DE) P212 Broad and potent antiviral activity of the NAE inhibitor MLN4924 V. T. K. Le-Trilling (Essen/DE), D. A. Megger (Bochum/DE), B. Katschinski, C. D. Landsberg M. U. Rückborn (Essen/DE), S. Tao (Düsseldorf/DE), A. Krawczyk, W. Bayer (Essen/DE) I. Drexler (Düsseldorf/DE), M. Tenbusch, B. Sitek (Bochum/DE), M. Trilling (Essen/DE) P213 A humanised neutralising antibody against MERS-CoV targeting the receptor-binding domain of the spike protein Yan. Li, G. F. Gao, J. Yan (Beijing/CN) P214 Novel inhibitors of herpes simplex virus type 1 M. Pachota, K. Pyrć (Krakow/PL) P215 Antiviral activity of sCAR-Fc against laboratory and clinical strains of coxsackievirus B serotypes S. Pinkert (Berlin/DE), M. Schmidtke (Jena/DE), S. Diedrich, H. Zeichhardt, H. Fechner (Berlin/DE) P216 AAV9 vector-mediated expression of a soluble coxsackievirus-adenovirus receptor inhibits coxsackievirus B3-induced chronic myocarditis in a therapeutic approach in mice S. Pinkert, R. Klopfleisch, B. Dieringer (Berlin/DE), M. Schmidtke (Jena/DE), K. Savvatis H. Fechner (Berlin/DE) P217 Repurposing of licenced drugs for anti influenza treatment – the clinically approved MEK inhibitor trametinib efficiently blocks IAV propagation T. Schräder, S. E. Dudek, A. Schreiber, C. Ehrhardt, S. Ludwig (Münster/DE) p 81 Poster Session 2 • Evolution of Viruses – Viruses in Evolution P218 Trends in mosquito infection rates at the rainforest edge – a multitaxa study on the dilution effect hypothesis M. Marklewitz, A. Kopp, H. Heidemann, K. Hermanns (Bonn/DE), D. Hobelsberger (Berlin/DE) I. B. Rwego (Kampala/UG, St. Paul, MN/US), A. Estrada (Veracruz/MX), F. H. Leendertz (Berlin/DE) L. Podsiadlowski (Bonn/DE), T. R. Gillespie (Atlanta, GA/US), C. Drosten, S. Junglen (Bonn/DE) P219 Genomic characterisation of human parainfluenza viruses types 1 -4 from Vietnam M. Linster, M. Moorthy (Singapore/SG), N. N. Q. Minh, D. L. A. Ha (Ho Chi Minh City/VN) Z. Zhe, D. d/o Ravichandran, L. Xing Yi (Singapore/SG), T. A. Tuan, H. M. Tuan (Ho Chi Minh City/VN), Y. Su (Singapore/SG), H. R. van Doorn (Ho Chi Minh City/VN) G. J. D. Smith (Singapore/SG) P220 Inactivation of multiple porcine endogenous retroviruses as a safety measure for xenotransplantation J. Denner (Berlin/DE) P221 Detection of koala retrovirus-B (KoRV-B) in animals in European zoos U. Fiebig, M. Keller, J. Denner (Berlin/DE) P222 Virulence of Eurasian H7N7 avian influenza viruses in chickens after acquisition of different hemagglutinin polybasic proteolytic cleavage site motifs E.-S. Abdelwhab, J. Veits, T. C. Mettenleiter (Greifswald, Isle of Riems /DE) P223 Discovery of a novel alphavirus in West Africa K. Hermanns, F. Zirkel, C. Drosten, S. Junglen (Bonn/DE) P224 Bovine ephemeral fever virus infection in Turkey T. C. Oguzoglu, A. Ertürk, Ş. G. Çizmeci (Ankara/TR), B. T. Koç (Aydın/TR), Y. Akca (Ankara/TR) P225 Impact of altered fidelity of DNA polymerase on herpesvirus genomic variability and pathogenicity in vivo J. Trimpert, D. Kunec, N. Osterrieder (Berlin/DE) p 82 Poster Session 2 • Signal Transduction P226 The G protein coupled receptor homolog pUS27 of human cytomegalovirus interacts directly with TRAF6 to induce PAR3-regulated canonical NF-kB activation I. Niemann, A. Reichel, M. Scherer, S. Mahmoudian, B. Krenz, J. Hofmann, B. Biesinger H. Sticht, T. Stamminger (Erlangen/DE) P227 Characterisation of MAPK signalling pathways after rubella virus infection P. Rennert, H. Geyer, N. Friedrich, A. Mankertz (Berlin/DE) P228 The mumps virus small hydrophobic protein decreases phosphorylation of p65, IKKβ and IκBα in the context of a virus infection St. Franz, N. Friedrich, H. Geyer, A. Mankertz (Berlin/DE) P229 Measles virus mediated sphingomyelinase activation targets T cell functionality at multiple levels E. Avota, L. Collenburg, N. Müller, C. Börtlein, J. Schmitt, A. Schulze S. Schneider-Schaulies (Würzburg/DE) P230 Hepatitis C virus (HCV) induces suppressors of cytokine signaling (SOCS) proteins: Revealing a novel immunomodulatory mechanism O. Convery, C. O’Farrelly, N. J. Stevenson (Dublin/IR) Poster Session 3 • Vaccines P231 Viral determinants of the bias in the HIV-Env specific antibody response R. Heß (Bochum/DE), M. Storcksdieck (Essen/DE), V. Stab (Bochum/DE) V. Temchura (Erlangen/DE), M. Tenbusch (Bochum/DE), K. Überla (Erlangen/DE) P232 Development of vaccination strategies for vector-based prophylactic and therapeutic immunisation in the Friend retrovirus model N. Bongard, U. Dittmer, W. Bayer (Essen/DE) P233 Generation of a broadly-protective AAV-based influenza vaccine K. Fiddeke, I. Sipo, M. Budt, T. Wolff, N. Bannert, S. Norley (Berlin/DE) p 83 Poster Session 3 • Vaccines P234 Steps towards replacing embryonated eggs for poultry vaccine production I. Jordan, V. Sandig (Berlin/DE) P235 HBV capsid-derived virus-like particles as a universal antigen carrier for the induction of robust B-and T-cell responses S. Akhras, K. Himmelsbach, M. Toda, S. Scheurer, K. Boller, S. Vieths E. Hildt (Giessen, Marburg, Langen/DE) P236 Protection of poultry with maternally derived α-NDV antibodies against highly pathogenic avian influenza and Newcastle disease C. Steglich, C. Grund, T. C. Mettenleiter, A. Römer (Greifswald, Isle of Riems/DE) P237 Antibody response against the envelope proteins of the feline foamy virus – Mapping of epitopes and neutralisation M. Mühle (Berlin/DE), A. Bleiholder, M. Löchelt (Heidelberg/DE), J. Denner (Berlin/DE) P238 Development of novel double-attenuated live vaccines against H1N1 and H3N2 influenza virus infection in swine S. Mamerow, R. Scheffter, T. C. Mettenleiter, J. Stech (Greifswald, Isle of Riems/DE) P239 Competition of adenovirus epitopes with transgene epitopes – investigation of particular mechanisms of immonusuppression in adenovirus-based immunisation C. Hrycak, D. Schöne, U. Dittmer, W. Bayer (Essen/DE) P240 Identification and characterisation of trimer stabilised HIV envelope proteins A. Kliche, J. Koop, C. Ziegler, D. Peterhoff, B. Asbach, S. Anja, V. Schmid R. Wagner (Regensburg/DE) P241 Identification of novel HIV-1 vaccine candidates using mammalian cell-surface display and FACS panning B. Zimmer, V. Grassmann, T.-H. Bruun, T. Schubert, A. Gabele, A. Kliche R. Wagner (Regensburg/DE) p 84 Poster Session 3 • Vaccines P242 Generation of HIV1 new envelope immunogens with optimised antigenicity profiles V. Grassmann, M. Glögl, D. Peterhoff, A. Kliche, R. Wagner (Regensburg/DE) P243 Expression of African swine fever virus proteins by a pseudorabies virus vector A. Hübner, W. Fuchs, G. Keil, S. Blome, T. C. Mettenleiter (Greifswald, Isle of Riems/DE) P244 Generation of inactivated influenza virus vaccines using low-energy electron irradiation J. Fertey, L. Wierich, T. Grunwald (Leipzig/DE), E. Hiller, S. Bailer, S. Rupp (Stuttgart/DE) A. Pohl, C. Wetzel (Dresden/DE), S. Ulbert (Leipzig/DE) P245 Influenza A (H7N9) vaccine based on the recombinant measles virus vaccine platform A. H. Fiedler, B. S. Bodmer, S. Hutzler, S. Vivian, A. L. Walz,, S. Prüfer, V. von Messlin M. D. Mühlebach (Langen/DE) P246 Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine – a randomised double-blind phase 1/2a clinical trial J. H. C. Kreijtz, M. Goeijenbier, F. M. Moesker, L. van den Dries, S. Goeijenbier H. L. M. De Gruyter (Rotterdam/NL), M. H. Lehmann (Munich/DE), G. de Mutsert D. A. M. van de Vijver (Rotterdam/NL), A. Volz (Munich/DE), R. A. M. Fouchier E. C. M. van Gorp, G. F. Rimmelzwaan (Rotterdam/NL), G. Sutter (Munich/DE) A. D. M. Osterhaus (Utrecht/NL) P247 Myristoylation increases the CD8+ T cell response to a green fluorescent protein prototype antigen delivered by modified vaccinia virus Ankara L. Marr, A. Luelf, A. Freudenstein, G. Sutter, A. Volz (Munich/DE) P248 The analysis of the humoral immune response and the reactivity pattern of monoclonal antibodies reveal molecular determinants involved in Schmallenberg virus neutralisation G. Roman-Sosa, K. Wernike, A. Karger (Greifswald/DE), E. Brocchi (Brescia/IT) H. Schirrmeier (Greifswald/DE), C. Schelp (Bern/CH), M. Beer (Greifswald/DE) P249 Attenuation of a very virulent Marek’s disease herpes virus by codon pair deoptimisation K. Eschke, N. Osterrieder, D. Kunec (Berlin/DE) p 85 Poster Session 3 • Vaccines P250 Codon pair deoptimisation of a major oncogene as an attenuation strategy for Marek’s disease herpes virus P. H. Khedkar, N. Osterrieder, D. Kunec (Berlin/DE) P251 Licensed adjuvants increase magnitude but not breadth of influenza vaccine-induced antibody responses R. Schmidt, R. Wagner, E. Holznagel, T. Enkirch, K. Pfeffermann, B. Sawatsky V. von Messling (Langen/DE) P252 Influenza A virus neuraminidase-expressing vesicular stomatitis virus replicons protect from challenge with matched strains L. Walz (Langen/DE), G. Zimmer (Mittelhaeusern/CH), V. von Messling (Langen/DE) P253 Human Cytomegalovirus-based therapeutic vaccine for human Papillomavirus-induced cancer M. Abdelaziz, M. Raftery, e. Voigt, A. Kaufmann, G. Schönrich (Berlin/DE) P254 Generation of a vaccinia virus MVA based vaccine candidate against HCMV E. Link, C. Brandmüller, S. Ameres, A. Moosmann, G. Sutter, M. H. Lehmann (Munich/DE) P255 Ex vivo evaluation of Sendaivirus vectors for delivery of CMV IE-1 and pp65 R. Kiener, C. Schwegler (Regensburg/DE), M. Wiegand (Martinsried/DE), B. Asbach R. Wagner (Regensburg/DE) P256 The viral vector vaccine VSV-GP as vaccine platform J. Kimpel, A. Bresk, R. Tober, M. Krismer, S. Schneider, T. Hofer (Innsbruck/AT) T. Grunwald (Leipzig/DE), H.-X. Liao, B. Haynes (Durham, NC/US), Z. Banki, L. Egerer D. von Laer (Innsbruck/AT) p 86 Poster Session 3 • Viral Pathogenesis and Persistence P257 tRNA retrograde transport in nuclear import of HIV-1 G. Adigbli, A. Fassati (London/GB) P258 A single amino acid change in the Marburg virus matrix protein VP40 provides a replicative advantage in a species-specific manner A. Köhler, L. Kolesnikova, U. Welzel, G. Schudt, A. Herwig, Step. Becker (Marburg/DE) P259 Old World Hantaviruses cause functional impairment in human podocytes S. Hägele (Heidelberg/DE), J. Reiser (Chicago, IL/US), M. Zeier, E. Krautkrämer (Heidelberg/DE) P260 Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration A. Maisa (Münster/DE; Melbourne/AU), A. C. Hearps, T. A. Angelovich, C. F. Pereira J. Zhou, M. D. Y. Shi, C. S. Palmer (Melbourne/AU), W. A. Muller (Chicago, IL/US) S. M. Crowe, A. Jaworowski (Melbourne/AU) P261 Highly sensitive PCR diagnostic systems revealed porcine cytomegalovirus (PCMV) in the blood of Göttingen minipigs to be used as donors of islet cells V. Morozov, J. Denner (Berlin/DE) P262 Establishment of a suitable cell line model for the investigation of Na,K-ATPase de-localisation during influenza A virus infection I. Kuznetsova, C. Peteranderl, S. Herold (Giessen/DE), T. Wolff (Berlin/DE) S. Pleschka (Giessen/DE) P263 Conserved death-receptor signaling inhibition identified by a chimeric mouse CMV expressing a homologous human CMV gene M. Z. Chaudhry, B. Kasmapour, M. Bajagic, R. Casalegno, L. Borkner (Braunschweig/DE) T. Lenac (Rijeka/HR), A. Scrima, A. Scrima (Braunschweig/DE), S. Jonjic (Rijeka/HR) L. Cicin-Sain (Braunschweig/DE) P264 Rat brain organotypic slice culture as a model for studying measles virus neurotropism S. Chey, U. G. Liebert, Jo. Busch (Leipzig/DE) p 87 Poster Session 3 • Viral Pathogenesis and Persistence P265 Binding of the immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 to human monocytes and B cells M. Mühle, T. Kroniger, K. Hoffmann, J. Denner (Berlin/DE) P266 Strain-specific cytopathogenicity of rubella virus appears to be related to viral impact on mitochondrial metabolism C. Claus, S. Rossmark, U. G. Liebert (Leipzig/DE) P267 Directed knockdown of cellular genes by rabies virus expressing shRNAs S. Nemitz, T. Nolden, S. Finke (Greifswald, Isle of Riems/DE) P268 Annotating the HSV-1 proteome by ribosome profiling and quantitative proteomics F. Erhard (Munich/DE), A. Rutkowski (Cambridge/GB), E. Wyler (Berlin/DE), H. Ayoubian J. Menegatti (Homburg/DE), A. L’Hernault (Cambridge/GB), M. Landthaler (Berlin/DE) C. Friedel, R. Zimmer (Munich/DE), F. Grässer (Homburg/DE), L. Dölken (Würzburg/DE) P269 The Newcastle disease virus W protein – an editing product of the phosphoprotein J. Karsunke, A. Karger, K. Franzke, M. Murr, T. C. Mettenleiter A. Römer-Oberdörfer (Greifswald, Isle of Riems/DE) P271 Experimental infection of horses with nonprimate hepacivirus mediates immune protection against re-infection S. Walter, S. Pfaender, D. Todt, E. Grabski, T. Gather, S. Möller, R. J. P. Brown, A. Postel K. Hahn, C. Puff, V. Pfankuche, F. Hansmann, P. Becher, U. Kalinke, W. Baumgärtner K. Feige, T. Pietschmann, J.-M. V. Cavalleri, E. Steinmann (Hanover/DE) P272 The phosphoprotein of Borna disease virus impairs human GABAergic neurogenesis C. Scordel (Munich/DE), A. Huttin, M. Cochet-Bernoin (Maisons-Alfort/FR) M. Szelechowski (Toulouse/FR), A. Poulet (Evry/FR), J. Richardson (Maisons-Alfort/FR) A. Benchoua (Evry/FR), D. Gonzalez-Dunia (Toulouse/FR), M. Eloit (Paris/FR) M. Coulpier (Maisons-Alfort/FR) p 88 Poster Session 3 • Viral Pathogenesis and Persistence P273 Avian nephritis virus is related with the runting-stunting syndrome in Brazil L. Nunez, S. Santander-Parra, D. De la Torre, C. Carranza, C. Astolfi-Ferreira A. Ferreira (Sao Paulo/BR) P274 Infection of porcine intestinal slices by different transmissible gastroenteritis virus strains T. Krimmling, A. Beineke, C. Schwegmann-Weßels (Hanover/DE) P275 Characterisation of feline coronavirus 7b accessory protein D. Florek, J. Ziebuhr, H.-J. Thiel, G. Tekes (Giessen/DE) P276 High prevalence of adeno-associated virus (AAV) in human peripheral blood mononuclear cells indicative of T-lymphocytes as sites of AAV persistence D. Khalid, D. Hüser, T. Lutter, M. Heßler, U. Kalus, Y. Tauchmann, K. Hensel-Wiegel D. Lassner, R. Heilbronn (Berlin/DE) P277 Generation and characterisation of the first molecular clone of deformed wing virus (DWV) – a major factor in honeybee colony collapse Be. Lamp, L. Sinn, K. Buczolich, H.-W. Chen, T. Rümenapf (Vienna/AT) P278 Mutations in measles virus fusion and matrix protein alter replication as well as cytopathology in cultured cells and promote infection of neuronal cells Jo. Busch, S. Chey, U. G. Liebert (Leipzig/DE) P279 Investigation of virus infection-related congenital disorders and miscarriage events through induced pluripotent stem cells D. Hübner (Leipzig/DE), M. Jung (Halle/Saale/DE), U. G. Liebert, C. Claus (Leipzig/DE) P280 Successful generation of human peripheral neurons to study varicella zoster virus S. Zhu, B. Ritter, N. Stanslowsky (Hanover /DE), B. Kaufer, K. Osterrieder (Berlin/DE) G. M. G. Verjans (Rotterdam/NL; Hanover/DE), A. Leffler, F. Wegner A. Viejo-Borbolla (Hanover/DE) p 89 Poster Session 3 • Viral Pathogenesis and Persistence P281 Genetic contribution of H7N9 virus to the virulence in mice Y. Bi, G. Wong, Shu. Zhang, Yun Li, Ya. Wu, L. Fu, J. Haywood (Beijing/CN), Hai. Xiao (Tianjin/CN) Ju. Liu (Beijing/CN), Yingx. Liu (Shenzhen/CN), W. Liu (Beijing/CN) G. F. Gao (Beijing, Shenzhen/CN) P282 In vitro evolution of persistent rabies virus A. Ghanem, M. F. Eizinger, K.-K. Conzelmann (Munich/DE) P283 Animal model for Ebola virus research in BLS 2 lab X. Zhao, X. Qu, Wei Zhang, X. Zhou, G. F. Gao (Beijing/CN) P284 Proteasome inhibition alters cell viability and inhibits Cowpox virus replication M. Grossegesse, A. Fritsch, J. Döllinger, A. Nitsche (Berlin/DE) P285 Cholestasis in mice reduces anticytomegaloviral immune responses A.-K. Schupp, S. Rattay, A. Kislat, B. Homey, D. Häussinger, D. Graf A. Zimmermann (Düsseldorf/DE) P286 Alveolar macrophages are infected and depleted during pneumovirus infection in vivo L. Prager, C. D. Krempl (Würzburg/DE) P287 Dengue serotype determined by neutralisation and anti-ED3 responses is not correlated to the Dengue serotype present in acute infection H. Auerswald, L. Klepsch (Hamburg/DE), V. Duong, B. Y, P. Buchy P. Dussart (Phnom Penh/KH), M. Schreiber (Hamburg/DE) P288 Characterisation of Cowpox virus proteins based on protein interaction studies I. Schlenther, L. Schrick, J. Döllinger, A. Nitsche (Berlin/DE) P289 The secreted Pestiviral ribonuclease Erns forms high molecular weight complexes reminiscent of Dengue virus NS1 T. Ruemenapf, Be. Lamp (Vienna/AT), T. Krey (Hanover/DE), M. Schweizer (Bern/CH) B. Raynal (Paris/FR), B.-J. Bosch (Utrecht/NL), D. Veesler (Seattle, WA/US) p 90 Poster Session 3 • Host Cell Factors and Modulation I & II P290 Marburg virus VP30 counteracts the induction of the unfolded protein response C. Rohde, Step. Becker, V. Krähling (Marburg/DE) P291 L-Particles transmit viral proteins from HSV-1-infected mDC to uninfected bystander cells inducing CD83 downmodulation C. Heilingloh, M. Kummer, P. Mühl-Zürbes, C. Draßner, C. Daniel, M. Klewer A. Steinkasserer (Erlangen/DE) P292 Modulation of dendritic cell adhesion and migration by herpes simplex virus type 1 and human cytomegalovirus L. Grosche, C. Draßner, A. Steinkasserer, C. S. Heilingloh (Erlangen/DE) P293 Annexin A8 and its diverse function during influenza A virus infection S. Schloer, V. Gerke, C. Ehrhardt, S. Ludwig, U. Rescher (Münster/DE) P294 Mammalian haploid genetic screen to identify host factors essential for Rift Valley fever virus S. Devignot (Giessen/DE), A. Leibbrandt, T. Burkard, J. Penninger (Vienna/AT) F. Weber (Giessen/DE) P295 Development of arenavirus lifecycle modelling systems for screening of host cells factors involved in virus replication E. Dunham, K. Shifflett, A. Watt, H. Feldmann (Hamilton, MT/US), T. Hoenen A. Groseth (Greifswald, Isle of Riems/DE; Hamilton, MT/US) P296 Protein signatures of permissive vs. non-permissive influenza A virus infections in human host cells identified by quantitative proteomics A. Sadewasser, K. Paki, K. Eichelbaum, B. Bogdanow, A. Karlas, M. Lesch, M. Selbach T. Wolff (Berlin/DE) P297 Genetic variations in Cytokine genes (IL10 and IL6) and toll like receptors (TLRs 3, 4, 7 and 8) in patients with DF and DHF S. Khaliq, M. Raza (Lahore/PK) p 91 Poster Session 3 • Host Cell Factors and Modulation I & II P298 First demonstration of a kinase activity-dependent interaction between the herpesviral CDK ortholog pUL97 and human cyclin B1 M. Steingruber, E. Socher, H. Sticht (Erlangen/DE), Y. Couté, A. Kraut (Grenoble/FR) C. Hutterer, M. Marschall (Erlangen/DE) P299 Peptidyl-prolyl isomerase Pin1 is an important effector in the phosphorylation-triggered reorganisation of the nuclear lamina during herpesvirus nuclear egress J. Milbradt, C. Hutterer, H. Bahsi, S. Wagner, A. C. Horn (Erlangen/DE) B. B. Kaufer (Berlin/DE), Y. Mori (Kobe/DE), H. Sticht (Erlangen/DE), T. Fossen (Bergen/DE) M. Marschall (Erlangen/DE) P300 IFN treatment induces post-transcriptional regulation of SAMHD1 mRNA by regulation of miR-181a and miR-30a M. Rieß, N. V. Fuchs (Langen/DE), A. Idica, M. Hamdorf (Irvine, CA/US), H. Schmitz C. Tondera, K. Cichutek, E. Flory (Langen/DE), I. Munk Pedersen (Irvine, CA/US) R. König (Langen/DE; La Jolla, San Diego, CA/US) P301 Establishment of a HEV replication system for screening of substances interfering with hepatitis E virus replication K. Funke (Langen/DE), E. Hildt (Giessen, Marburg, Langen/DE) K. Himmelsbach (Langen/DE) P302 The autophagosomal SNARE protein syntaxin 17 is an essential factor for the hepatitis C virus life cycle H. Ren, F. Elgner, B. Jiang, K. Himmelsbach, R. Medvedev, D. Ploen, E. Hildt (Langen/DE) P303 Mechanism of Selective Autophagy of NEMO by Murine Cytomegalovirus M45 E. Muscolino, R. Brost, E. Krause (Hamburg/DE), S. Loroch (Dortmund/DE), A. Gallo W. Brune (Hamburg/DE) P304 Nrf2 activation in HBV replicating cells and its effect on T cell-mediated immune response M. Biehl (Langen/DE), K. Wisskirchen, U. Protzer (Munich/DE), E. Hildt (Langen/DE) p 92 Poster Session 3 • Host Cell Factors and Modulation I & II P305 Herpes simplex virus 1 infection leads to widespread induction of antisense transcripts on the host cell genome E. Wyler, V. Franke (Berlin/DE), J. Menegatti (Homburg/DE), A. Boltengagen, L. Münster A. Akalin, N. Rajewsky, C. Kocks (Berlin/DE), F. Grässer (Homburg/DE), M. Landthaler (Berlin/DE) P306 The mouse cytomegalovirus encoded adapter protein m42 targets the receptor tyrosine phosphatase CD45 for lysosomal degradation in myeloid cells affecting viral pathogenesis N. Thiel, K. Keyser (Hanover/DE), I. Dekhtiarenko (Braunschweig/DE), C. Zimmermann A. Halenius (Freiburg/DE), N. Lemmermann (Mainz/DE), L. Cicin-Sain (Braunschweig/DE) M. Messerle (Hanover/DE) P307 Perilipin-2 regulates lipid droplet morphology and hepatitis C virus replication S. Lassen, C. Grüttner, E. Herker (Hamburg/DE) P308 FG repeats are general binding motifs of nuclear pore proteins to the HIV-1 capsid T. Fricke (New York, NY/US; Warsaw/PL), F. Di Nunzio (Paris/FR) F. Diaz-Griffero (New York, NY/US) P309 Expression of IL-1β mRNA in primary murine neurons infected with different strains of equine herpesvirus type 1 (EHV-1) A. Golke, J. Cymerys, T. Dzieciatkowski, A. Chmielewska, A. Tucholska, A. Slonska M. W. Banbura (Warsaw/PL) P310 Rift Valley fever virus NSs virulence factor blocks the nuclear export of host mRNAs S. Lau (Marburg, Giessen/DE), M. Habjan (Martinsried, Munich/DE), G. Superti-Furga (Vienna/AT) A. Pichlmair (Martinsried, Munich/DE), M. Kainulainen (Marburg/DE), F. Weber (Marburg, Giessen/DE) P311 The MCMV tegument protein M25 is targeted to PLM bodies by sumoylated host proteins I. Kutle, M. Dezeljin, K. Keyser, R. Niedenthal, M. Messerle (Hanover/DE) P312 Comparative identification of cellular interaction factors of the PB2 proteins of H5N1 and H3N2 influenza A viruses in human cells by mass spectrometry U. Arnold, T. Wolff (Berlin/DE) p 93 Poster Session 3 • Host Cell Factors and Modulation I & II P313 Role of caspase-2 during human cytomegalovirus infection J. Tang, E. Ostermann (Hamburg/DE), R. J. Lebbink (Utrecht/NL), W. Brune (Hamburg/DE) P314 Herpes simplex virus 1 VP1-2 tegument protein interferes with the DNA damage response T. Hennig (Würzburg/DE; London/GB), R. Serwa (London/GB), L. Dölken (Würzburg/DE) P. O‘Hare (London/GB) P315 HIV-1 gene expression is not inhibited by type-1 interferon responses in the absence of accessory genes Han. Xiao (Erlangen/DE), L. Legewie, B. Grewe (Bochum/DE), K. Überla (Erlangen/DE) P316 Restrictive influence of SAMHD1 on hepatitis B virus life cycle A. Sommer, L. Rivière, K. Schott (Langen/DE), Y. Ni (Heidelberg/DE), M. Rieß, E. Schnellbächer N. Kettern (Langen/DE), C. Münk (Düsseldorf/DE), C. Donnerhak, E. Flory (Langen/DE) S. Urban (Heidelberg/DE), E. Hildt (Langen/DE), R. König (La Jolla, San Diego, CA/US; Langen/DE) P317 Analysis of host factors in measles virus replication V. Tiwarekar, J. Wohlfahrt, S. Kendl, M. Fehrholz, J. Schneider-Schaulies (Würzburg/DE) P318 T-cells expressing reduced restriction factors are preferentially HIV-1 infected in vivo S. Bolduan, H. Koppensteiner, R. Brack-Werner, R. Draenert (Munich/DE) M. Schindler (Tübingen, Munich/DE) P319 Identification and characterisation of cellular interaction partners of Schmallenberg virus NSs A. Aebischer, F. Kraatz, K. Wernike, I. Reimann, M. Beer (Greifswald, Isle of Riems/DE) P320 Interactions of prototype foamy virus capsids with host cell polo-like kinases are important for efficient virus entry I. Zurnic, S. Hütter, N. Stanke, R. Helbig, U. Lehmann, G. Gerresheim, F. Lindel D. Lindemann (Dresden/DE) p 94 Poster Session 3 • Host Cell Factors and Modulation I & II P321 Identification of macrophage host range factors of Cowpox virus D. Bourquain, J. Yeonhwa, A. Nitsche (Berlin/DE) P322 Preliminary comparison of differentially expressed ncRNAs in bat and human cells infected with Ebola Zaire virus and Marburg virus N. F. Mostajo Berrospi (Jena, Marburg/DE), M. Hoelzer (Jena/DE), Step. Becker (Marburg/DE) M. Marz (Jena/DE) P323 Virulence factor NSs of La Crosse virus sequesters Elongin C – a possible mechanism for inducing degradation of the largest subunit of RNA polymerase II A. Schoen (Marburg/DE), P. Verbruggen (Freiburg/DE), F. Weber (Giessen/DE) P324 ESCRT requirements for Murine Leukemia virus release C. Bartusch, R. Prange (Mainz/DE) P325 Non-pathogenic Tacaribe virus and human pathogenic Junín virus differ in apoptosis induction during infection S. Wolff (Marburg/DE), A. Groseth (Greifswald, Isle of Riems/DE) B. Meyer (Twin Cities, MN/US), D. Jackson (St. Andrews/GB), T. Strecker, A. Kaufmann Step. Becker (Marburg/DE) P326 Mutational analysis of the MCMV-encoded interferon antagonist dissects pM27 interactions with DDB1 and STAT2 V. T. K. Le-Trilling, T. Becker, C. Landsberg, M. Trilling (Essen/DE) P327 Merkel cell polyomavirus (MCPyV) replication is negatively regulated by the host restriction factor Kap1/TRIM28 S. Siebels, M. Czech-Sioli, C. Schmidt, F. Neumann, A. Grundhoff, N. Fischer (Hamburg/DE) P328 DNA damage-binding protein 1 promotes transcription from covalently closed circular DNA in hepatitis B virus infection B. Qu (Heidelberg/DE), J. Sonnabend (Frankfurt a. M./DE), P. Hezel (Nuremberg/DE) S. Urban (Heidelberg/DE) p 95 Poster Session 3 • Host Cell Factors and Modulation I & II P329 Cholesterol and related host factors in influenza A virus infection A. Kühnl, A. Musiol, C. Ehrhardt, S. Ludwig (Münster/DE), T. Grewal (Sydney/AU), V. Gerke U. Rescher (Münster/DE) P330 Interaction of matrix proteins with nuclear ANP32B is conserved among Henipa-and Avulaviruses M. Günther, A. Bauer, L. Zaeck, A. Römer-Oberdörfer, S. Finke (Greifswald, Isle of Riems/DE) P331 Discovery of a novel chemokine binding activity in varicella zoster virus V. Gonzalez-Motos, B. Ritter (Hanover/DE), T. Lenac, S. Jonjic (Rijeka/HR), U. Kalinke A. Viejo-Borbolla (Hanover/DE) P332 Regulation of cell death upon influenza A virus and Staphylococcus aureus super-infection A. van Krüchten, C. Klemm (Münster/DE), B. Löffler (Jena/DE), S. Niemann, G. Peters S. Ludwig, C. Ehrhardt (Münster/DE) P333 The SAMHD1-mediated inhibition of LINE-1 retroelements is regulated by phosphorylation A. Herrmann, S. Wittmann (Erlangen/DE), N. Gilbert (Montpellier/FR), C. Shepard (Atlanta, GA/US) D. Thomas, N. F. Bouzas (Frankfurt/DE), B. Kim (Atlanta, GA/US), T. Gramberg (Erlangen/DE) P334 Herpes simplex virus type 1 infection in brain cells leads to an up-regulation of neurotrophic fibroblast growth factors V. Lübben, B. Förthmann, N. Hensel, A. Buch, M. Ciurkiewicz, A. Beineke, B. Sodeik P. Claus (Hanover/DE) P335 Screening for IFN signaling antagonists – Stathmin-1 as a potential cellular regulator? M. Maywald (Düsseldorf/DE), H. Hengel (Freiburg/DE), A. Zimmermann (Düsseldorf/DE) P336 Phosphorylation of murine SAMHD1 regulates its antiretroviral activity S. Wittmann (Erlangen/DE), R. Behrendt (Dresden/DE), K. Eissmann B. Volkmann (Erlangen/DE), D. Thomas (Frankfurt/DE), T. Ebert, V. Hornung (Bonn/DE) A. Cribier, M. Benkirane (Montpellier/FR), N. Ferreirós Bouzas (Frankfurt/DE) T. Gramberg (Erlangen/DE) p 96 Poster Session 3 • Host Cell Factors and Modulation I & II P337 Virus supportive function of the macroautophagy-related proteins Beclin1 and Atg7 during influenza A virus infection S. Dudek, S. Ludwig (Münster/DE) P338 A bifunctional element in β-herpesviral kinases mediates cross-regulation with cyclin A and inhibition of cellular DNA synthesis M. Schmidt, H. Weisbach, I. Gruska, B. Vetter, B. Bogdanow, K. Imami, M. Selbach C. Hagemeier, L. Wiebusch (Berlin/DE) Poster Session 3 • Epidemiology and Public Health P339 Scanning surveillance of neuroinfectious viruses in cattle livestock L. Truchet, J. Walland, C. Boujon, S. Selimovic-Hamza, H. Posthaus, G. Schüpbach A. Oevermann, T. Seuberlich (Bern/CH) P340 Molecular detection and prevalence of viruses in wild boar population of eastern Saxony: Potential risks for transmission to domestic pigs and humans A. Muluneh, S. Jäckel (Dresden/DE) P341 Proportion of recent HIV-1 Subtype A infections is increasing in Germany (2013 to 2015/I) A. Hauser, A. Hofmann, K. Hanke, V. Bremer, B. Bartmeyer, C. Kuecherer N. Bannert (Berlin/DE) P342 High proportion of HIV-1 non-B subtypes in lately diagnosed HIV-patients S. Girra, A. E. Alemayehu, A. Hoffmann, V. Bremer, B. Bartmeyer, C. Kuecherer, N. Bannert A. Hauser (Berlin/DE) P343 High prevalence of human papillomaviruses in Ghanaian pregnant women S. Silling, H. Pfister (Cologne/DE), F. Völker, R. Lugert (Göttingen/DE) P. Cooper (Eikwe via Axim/GH), U. Groß, M. Schulze (Göttingen/DE) p 97 Poster Session 3 • Zoonoses P344 A varicella-zoster virus-like herpes virus in a great ape species – The first genomic sequence of a varicella virus infecting gorillas J. Kühn, C. Ludwig (Münster/DE), S. Calvignac-Spencer, B. Ehlers (Berlin/DE) P345 Detection of porcine cytomegalovirus (PCMV) in a baboon after transplantation of a pig heart V. A. Morozov (Berlin/DE), J.-M. Abicht, B. Reichart, T. Mayr, S. Guethoff (Munich/DE) J. Denner (Berlin/DE) P346 Immunogenicity and protective efficacy of recombinant modified vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens A. Volz (Munich/DE), S. Lim (Utrecht/NL), M. Kaserer, A. Luelf, L. Marr, S. Jany C. Deeg (Munich/DE), G. Pijlmann (Wageningen/NL), A. D. M. Osterhaus B. Martina (Utrecht/NL), G. Sutter (Munich/DE) P347 Phylogenetic analysis of novel strains of Puumala hantavirus associated with its reservoir rodent host, bank vole (Myodes glareolus), in Central Europe R. Szabó (Bratislava/SK), L. Radosa (Berlin/DE), M. Ličková, M. Sláviková (Bratislava/SK) M. Heroldová (Brno/CZ), M. Stanko (Košice/SK), M. Pejčoch (Prague/CZ) D. H. Kruger (Berlin/DE), S. Essbauer (Munich/DE), B. Klempa (Bratislava/SK, Berlin/DE) Poster Session 3 • Clinical Virology P348 Primary vs secondary HCMV infection in pregnancy and outcome in the newborn G. Jahn (Tübingen/DE), L. Ye, J. Xu (Shanghai/CN) P349 Correlation of chikungunya viral load with observed clinical features B. Siva Raghavendhar, P. Ray (New Delhi/IN) P350 Identification of coxsackievirus A6 in adult patients with hand foot and mouth disease A. Osterman, L. Jakob, H. Nitschko, G. Jäger (Munich/DE) p 98 Poster Session 3 • Clinical Virology P351 Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic hematopoietic stem cell transplantation and severe graft versus host disease M. Karrasch (Jena/DE), V. Schmidt (Jena, Erfurt/DE), A. Hammer, B. Hermann A. Sauerbrei (Jena/DE) P352 Transmission of a ganciclovir resistant CMV variant from a pregnant renal transplant patient to her child J. Korth, O. Witzke, J. Verheyen (Essen/DE) P353 A rare case of severe enterovirus 71-induced rhombencephalitis and acute heart failure following hand, foot, and mouth disease M. Karrasch, E. Fischer, M. Scholten, A. Sauerbrei, A. Henke, D. Renz H.-J. Mentzel (Jena/DE), A. Krumbholz (Jena, Kiel/DE), S. Böttcher (Berlin/DE) S. Diedrich (Berlin/DE), R. Zell (Jena/DE) P354 Next generation sequencing of human cytomegalovirus genomes from sequentially sampled immunocompromised patients suggests turnover of viral strains E. Hage (Hanover/DE), G. S. Wilkie (Glasgow/GB), S. Linnenweber-Held, A. Dhingra E. Mischak-Weissinger, A. Schwarz, A. Heim (Hanover/DE), A. J. Davison (Glasgow/GB) T. F. Schulz, T. Ganzenmueller (Hanover/DE) P355 Clinical outcome and HBsAg variability of hepatitis B virus induced acute liver failure O. E. Anastasiou, M. Widera, A. Canbay, J. Verheyen (Essen/DE) P356 Isolation and characterisation of aviadenoviruses from commercial poultry in Germany D. Lüschow, A. Kleine, H. M. Hafez (Berlin/DE) P357 Prevalence and type of human parechovirus in stool samples from Ghanaian children S. Graul (Freiburg/DE), D. Eibach, R. Krumkamp, J. Käsmaier (Hamburg/DE) Y. Adu-Sarkodie (Kumasi/GH), J. May, E. Tannich (Hamburg/DE), M. Panning (Freiburg/DE) P358 Detection of BK virus in patients after kidney transplantation J. Korth, M. Widera, O. Witzke, J. Verheyen (Essen/DE) p 99 Poster Session 3 • Clinical Virology P359 Rusa alfredi papillomavirus 1 – a novel deltapapillomavirus inducing endemic papillomatosis in the endangered Visayan spotted deer R. Fux, M. C. Langenmayer (Munich/DE), D. Jörgens, C. Schubert J.-O. Heckel (Landau i. d. Pfalz/DE), G. Sutter (Munich/DE) P360 Influence of different blood collection tubes on virus diagnostics J. Klenner, C. Kohl, A. Nitsche (Berlin/DE) P361 Human polyomavirus JC and BK serum antibody response in patients with progressive multifocal leucoencephalopathy O. Adams, M. Andree, C. Warnke (Düsseldorf/DE) P362 Routine sequencing of enteroviruses in clinical materials identifies “new” group C-enterovirus types in the Netherlands C. Van Leer-Buter, R. Poelman, R. Borger, B. Niesters (Groningen/NL) P363 An unusual course of parvovirus B19 infection U. Reber, S. Aldabbagh, S. Pietzonka, O. Moser, A. Simon (Bonn, Homburg/Saar/DE) A. Eis-Hübinger (Bonn/DE) P364 Evidence of human herpesvirus-6 and -7 reactivation in miscarrying women with pityriasis rosea F. Drago, G. Ciccarese, F. Broccolo, F. Drago, A. Parodi (Genoa/IT) P365 Encephalitis caused by a novel human adenovirus type of species D in an adult allogeneic haematopoietic stem cell transplant recipient E. Hage (Hanover/DE), A. Turki (Essen/DE), T. Ganzenmüller (Hanover/DE), R. Trenschel S. Ross (Essen/DE), A. Heim (Hanover/DE) P366 Macromolecular prodrugs of HDACi, panobinostat, against HIV latency K. Zuwala, A. A. A. Smith, M. Tolstrup, A. N. Zelikin (Aarhus/DK) p 100 Did you Know? Conventus is the professional Congress Organiser for the GfV 2016* *Gesellschaft für Virologie e. V. Sponsors We would like to give our sincere thanks to the following sponsors: Platin Sponsor Hologic Deutschland GmbH (Wiesbaden/DE) Gold Sponsor Qiagen GmbH (Hilden/DE) Silver Sponsors Abbot GmbH & Co. KG (Wiesbaden/DE) Beckman Coulter GmbH (Krefeld/DE) Cepheid GmbH (Frankfurt a. M./DE) Luminex B. V. (`s-Hertogenbosch/NL) Zymo Research Europe (Freiburg/DE) Bronze Sponsors Acris Antibodies GmbH (Herford/DE) BIOMOL GmbH (Hamburg/DE) Li-COR Biosciences GmbH (Bad Homburg/DE) OZ BIOSCIENCES (Marseille/FR) Further Sponsors AiCuris GmbH & Co. KG (Wuppertal/DE) Biotest AG (Dreieich/DE) Caister Academic Press (Poole/UK) Carl Zeiss Microscopy GmbH (Jena/DE) Siemens Healthcare Diagnostics GmbH (Eschborn/DE) state at printing p 102 Media Cooperations and Scientific Sponsors We would like to thank the following media partners and scientific sponsors for their great support: Media Cooperations Springer-Verlag GmbH (Vienna/AT) Archives of Virology European Journal of Clinical Microbiology & Infectious Diseases Virus Genes succidia AG (Darmstadt/DE) labor&more TRILLIUM GmbH (Grafrath/DE) Trillium Diagnostik Scientific Sponsors Cluster of Excellence „Cells in Motion“ (CiM) Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V. (DVV, German Association for the Control of Virus Diseases) Gesellschaft für Virologie e. V. (GfV, Society for Virology) Münster Graduate School of Evolution (MGSE) German Research Platform for Zoonoses (Berlin/DE) University of Münster (WWU) state at printing p 103 Industrial Exhibition 2nd Floor Entrance 5 15 27 7 6 13 17 14 16 26 8 12 18 9 11 10 19 25 24 23 22 21 20 Ground Floor 30 29 28 4 3 2 1 state at printing p 104 Exhibitors (in alphabetical order) • Vom-Stein-Haus – Schlossplatz 34 The following exhibitors are looking forward to welcoming you at their booth: Exhibitors Abbot GmbH & Co. KG (Wiesbaden/DE) Acris Antibodies GmbH (Herford/DE) altona Diagnostics GmbH (Hamburg/DE) Analytik Jena AG (Jena/DE) Beckman Coulter GmbH (Krefeld/DE) Becton Dickinson GmbH (Heidelberg/DE) Biocartis NV (Mechelen/BE) Biomol GmbH (Hamburg/DE) BIO-SYS GmbH (Karben/DE) Biozol Diagnostica Vertrieb GmbH (Eching/DE)/BioLegend (San Diego, CA/US) Biozym Scientific GmbH (Hessisch Oldendorf/DE) Cepheid GmbH (Frankfurt a. M./DE) GATC Biotech AG (Konstanz/DE) German Research Platform for Zoonoses (Berlin/DE) German Society for Immunology – DGfI (Berlin/DE) Greiner Bio-One GmbH (Leipzig/DE) Hologic Deutschland GmbH (Wiesbaden/DE) Implen GmbH (Munich/DE) Li-COR Biosciences GmbH (Bad Homburg/DE) Luminex B. V. (`s-Hertogenbosch/NL) New England BioLabs GmbH (Frankfurt a. M./DE) OZ Biosciences (Marseille/FR) PlasmidFactory GmbH & Co. KG (Bielefeld/DE) Qiagen GmbH (Hilden/DE) Sanofi Pasteur MSD GmbH (Berlin/DE) SERVA Electrophoresis GmbH (Heidelberg/DE) Takara Clontech (Saint-Germain-en-Laye/FR) TIB Molbiol Syntheselabor GmbH (Berlin/DE) Visitron Systems GmbH (Puchheim/DE) Zymo Research Europe (Freiburg/DE) Booth No. 6 8 9 27 11 13 2 23 20 17 19 1 26 28 29 16 10 4 14 7 21 24 30 15 25 12 18 22 3 5 The member companies of the „Voluntary Self-Regulation of the Pharmaceutical Industry (FSA) e. V.“ have more narrowly defined the FSA code to ensure more transparency. Congress organisers are obliged to inform potential congress participants in advance about the scope and terms of the support of the pharmaceutical industry. We fulfil this obligation and inform you about the amount of the sponsorship of companies involved: Abbott GmbH & Co. KG (Wiesbaden/DE) • Silver Sponsor • 3.500 EUR Sanofi Pasteur MSD GmbH (Berlin/DE) • Industrial Exhibition • 1.650 EUR state at printing p 105 Floor Plan 2nd Floor 1st Floor Industrial Exhibition Catering Poster Exhibition Ground Floor Registration Desk Information Booth Industrial Exhibition Conference Bags Internet-Point Catering ENTRANCE CONFERENCE Basement Poster Exhibition Foyer Hall p 106 Site Map 1 Vom-Stein Haus 2 Lecture Halls/Speakers Ready Room Bäc kerg asse 1 P Promenade er Tim 2 Schlossplatz H Krum m 3 min pen Wilme rgasse e ß stra lder e f e Jüd Frauenstraße Überwasserstraße n hage Katt P Promenade Schlossplatz 5 Schlossgarten p 107 General Information Conference Website You will find current information on our website at www.virology-meeting.de. Language The conference language is English. Registration Registration Fees on-site Regular (GfV-Member) Regular (Non-Member) Day ticket Student*(GfV-Member) Student* (Non-Member) Conference Dinner (8 April 2016) Regular Student* Accompanying Person * Confirmation of status is required. General Terms and Conditions Please find all details on our website at www.virology-meeting.de. 200 EUR 250 EUR 120 EUR 100 EUR 170 EUR 40 EUR 20 EUR 40 EUR Opening Hours Wednesday Thursday Friday Saturday Industrial Exhibition 11.30–21.30 08.00–17.30 08.00–19.3008.00–10.45 Poster Exhibition 19.00–21.30 08.30–19.00 08.30–19.30 – Registration Desk/ 10.00–19.15 07.30–19.00 07.30–17.3007.30–13.00 Speakers Ready Room/Cloakroom Education Credits and Certification The conference is requested by the “Medical Chamber of Westfalen-Lippe” (Ärztekammer Westfalen-Lippe) as follows: 6 April 2016 Category B 3 Points 7 April 2016 Category B 6 Points 8 April 2016 Category B 6 Points 9 April 2016 Category B 3 Points For certification all attendants are required to sign the certification list near the registration daily. Certificates of attendance may be picked up upon leaving the conference at the registration desk. state at printing p 108 WIRED FOR TRANSFORMATION Serologische und Molekulare Diagnostik in der Infektiologie – State of the Art CHOOSE TRANSFORMATION ADD-00057551_DE Mar 2016 General Information Poster Prizes All posters will be rated according to scientific basis and visual appearance. The three best posters will be awarded. Abstracts All abstracts will be provided as a pdf-file on a memory stick. You will receive one at the booth from Hologic Deutschland GmbH, booth number 10. The pdf-file is also available on the website at www.virology-meeting.de. Catering and Lunch Tea, coffee, refreshments and snacks will be provided during the official programme breaks and poster sessions within the industrial exhibition areas (please refer to pages 108–110). Free lunch boxes will be offered on Thursday and Friday during the industrial symposia as well as within the industrial exhibition areas. Cloakroom The cloakroom can be found in the Central Auditorium Building – Schlossstraße 2. Coats and luggage can be dispensed for free. Internet A wireless internet access (wifi) is available in the main building. You will receive detailed information at the registration desk. Furthermore, internet points are provided within the industrial exhibition on the ground floor (please see pages 108–110). Public Transport All participants will receive a free ticket which entitles to any number of bus and rail rides within the municipal area of Münster including night busses from 6–9 April 2016. Tickets of public transport as well as a map of Münster are available at the registration desk. p 110 27th Annual Meeting of the Society for Virology Save the Date © PhilippN l wikimedia.com DVV Gesellschaft für Virologie e. V. (GfV) und Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e. V. (DVV) © 99173780 l Blackosaka • 90481797 l yurkaimmortal l fotolia.com 22–25 March 2017 Marburg • Germany Philipps-University Marburg www.virology-meeting.de Keynote speaker Adolfo Garcia-Sastre │New York, USA Thijs Kuiken │Rotterdam, the Netherlands Andrew Mehle │Wisconsin, USA Kanta Subbarao │Bethesda, USA Jeffrey Weiser │ New York, USA Registration Open! For Registration and Abstract submission please visit the website of the FluResearchNet: www.fluresearchnet.de Symposium 2016 National on Zoonoses Research 13 – 14 October | Berlin Steering Committee Stephan Ludwig | Münster Martin H. Groschup | Isle of Riems Sebastian C. Semler | Berlin Social Programme Get-Together • Wednesday, 6 April 2016 We are looking forward to welcoming you to the Get-Together on Wednesday at 19.15 within the industrial exhibition in the Vom-SteinHaus. Enjoy a first meet and greet with your colleagues and other delegates in a relaxed atmosphere. The Get Together is included in the registration fee. At the same time, you can visit the Poster Session 1 and meet the presenting authors at their posters for inspiring discussion. © Jan Reichel - Fotolia.com Social Evening • Friday, 8 April 2016 We would like to welcome you to our conference dinner which will be held at the “Speicher 10” in Münster! During the evening you are invited to exchange and discuss current work and research findings with your colleagues and friends while you enjoy the buffet. Later you simply can relax or dance to the music of “Daniel Ligges & Band”. These four professional musicians guarantee prime entertainment and a ripping stage show. Location Speicher 10 An den Speichern 10 48157 Münster Date Friday, 8 April 2016 Time20.00–02.00 © Daniel Ligges & Band There will be a bus shuttle provided for the ride from the venue to the “Speicher 10” and back at the following times: Forward Run Way Back p 114 19.40 (meeting point: Central Auditorium Building – Schlossplatz 34) from 22.00–02.00 9th International Filovirus Symposium SEPTEMBER 2017 13–16 MARBURG www.filovirus-meeting.com SAVE the DATE © pkproject - #93622169/yurkaimmortal - #90481833 - fotolia.com Index of Presenting Authors and Chair Persons A Abada, E. 75 Abdelaziz, M. 86 Abdellatif, M. 62 Abdelwhab, E.-S. 82 Abdelwhab, E.-S. M. 40 Abdullah, Z. 75 Abdurahman, S. 64 Aberle, J. H. 68 Abicht, J.-M. 98 Abken, H. 71 Abraham, L. 25 Adams, O. 39, 45, 100 Adigbli, G. 86 Adler, B. 63 Adler, H. 37, 43 Adu-Sarkodie, Y. 99 Aebischer, A. 73, 94 Ahmed, E. 75 Ahola, T. 41 Akalin, A. 93 Akca, Y. 82 Akgül, B. 37 Akhmetzyanova, I. 33, 68 Akhras, S. 60, 84 Akoua-Koffi, C. G. 45 Alam El-Din, H. 76 Alavian, S. M. 77 Alawi, M. 30, 62, 69 Albrecht, J.-C. 41 Aldabbagh, S. 100 Alemayehu, A. E. 97 Alexandrov, A. 48 Alt, M. 79 Altintoprak, K. 61 Altmann, B. 61 Alves, M. J. 70 Amaro, F. 70 Ambiel, I. 25 Ameres, S. 86 Ampofo, W. K. 46 Anastasiou, O. E. 99 Anders-Össwein, M. 26 Anderson, F. 21 Andersson, A. 61 p 116 Andino, R. 15, 49 Andreas, Z. 36 Andree, M. 100 Angelovich, T. A. 87 Anggakusuma 57, 59 Anhlan, D. 64 Anja, S. 84 Antczak, D. F. 66 Arias, A. A. 47 Arnold, U. 93 Asante, I. A. 46 Asbach, B. 72, 84, 86 Aslam, R. 78 Astolfi-Ferreira, C. 89 Ataíde, M. 29 Auerswald, H. 90 Avota, E. 68, 83 Awuni, J. 46 Ayadi, W. 76 Aydilllo, T. 21 Aydin, I. 21 Ayoubian, H. 88 Azadmanesh, K. 77 Azucena, C. 36 B Bächlein, C. 30, 69 Bäcker, M. 60 Backes, S. 56 Bader, M. 21 Bagnewski, L. 79 Bahsi, H. 92 Baiker, A. 75 Bailer, S. 71, 74, 85 Bajagic, M. 87 Baker, M. 66 Baldauf, H.-M. 25 Balistreri, G. 41 Balkema-Buschmann, A. 69 Banbura, M. W. 63, 93 Banda, D. 59 Banki, Z. 32, 86 Bankwitz, D. 38, 74 Bannach, C. 52 Bannert, N. 23, 40, 61, 64 83, 97 Banning, C. 25 Banse, P. 51 Bao, Q. 62 Barchet, W. 22, 57 Barhoumi, W. 46 Bartenschlager, R. 22, 24 57, 77 Barth, E. 55 Barthel, S. 43 Bartikowski, H. 25 Bartmeyer, B. 23, 97 Bartusch, C. 95 Basuki, A. 72 Bauer, A. 96 Bauer, D. 79 Bauer, T. 68 Bauerfeind, R. 21, 36, 74 Baumann, A. 51 Baumgarten, A. 79 Baumgärtner, W. 69, 88 Bayer, K. 25 Bayer, W. 32, 81, 83, 84 Beauclair, G. 79 Becher, D. 61 Becher, P. 30, 69, 88 Becherel, O. 56 Beck, S. 15, 22, 30, 31, 32, 46 47, 54, 62, 70, 74, 87, 91, 95 Becker, C. 30 Becker, D. 22 Becker, J. 43, 60 Becker, K. A. 68 Becker, M. 54 Becker, Stefan 74 Becker, Stefanie 46, 70 Becker, Stephan 22, 30, 32, 47 62, 87, 91, 95 Becker, T. 95 Beckers, J. 43 Beer, M. 15, 23, 30, 46, 62 63, 70, 73, 85, 94 Behner, L. 73 Index of Presenting Authors and Chair Persons Behrendt, P. 38, , 57 Behrendt, R. 96 Behrens, S.-E. 58, 63 Beineke, A. 89, 96 Bejarano, D. 62 Bell-Sakyi, L. 30 Bellstedt, P. 77 Belov, V. 26 Belshaw, R. 15, 49 Ben ayed-Guerfali, D. 76 Benchoua, A. 88 Benda, C. 24 Bender, S. 22, 57 Benkirane, M. 96 Bensaid, A. 69 Bergelson, J. 55 Berger, A. 60 Berger, E. 30 Bergmann, M. 60 Bergmann, Th. 71 Bergmann, To. 66 Bergs, S. 40 Berre, S. 47 Berscheminski, J. 47, 76 Bertram, S. 44, 46 Bestebroer, T. M. 69 Beyersdorf, N. 68 Bezgovsek, J. 76 Bi, Y. 70, 90 Bialy, D. 21 Biasiotto, R. 41 Biedenkopf, N. 62 Biehl, M. 78, 92 Biesinger, B. 15, 37, 41, 83 Binder, M. 24, 57 Binz, A. 21, 36, 74 Blaas, D. 51 Blank, A. 48 Blazevic, J. 72 Bleiholder, A. 84 Bloch, N. 57 Bloch, O. 64 Blome, S. 78, 85 Blomström, A.-L. 57 Bock, C. T. 38 Bock, H. 60 Bodmer, B. S. 85 Boehme, P. 33 Bogdanow, B. 91, 97 Bogner, E. 36, 79 Bogomolov, P. 48 Bohn-Wippert, K. 77 Bohne, J. 33, 72 Bokorova, S. 40 Bolduan, S. 94 Bollenbach, A. 36 Boller, K. 31, 84 Bolte, H. 28, 44, 62 Boltengagen, A. 93 Bongard, N. 83 Börgeling, Y. 64 Borger, R. 100 Borkner, L. 29, 87 Börner, K. 62 Borst, E. M. 28, 42 Börstler, J. 70 Börtlein, C. 83 Bosch, B.-J. 90 Bosch, P. 59 Boscheinen, J. B. 58 Bosse, J. B. 25 Böttcher, S. 48, 99 Boujon, C. L. 60, 69, 97 Boukhallouk, F. 53 Boulant, S. 15, 21, 22, 25 Boulos, R. E. 55 Bourquain, D. 95 Bouzalas, I. 60, 69 Bouzas, N. F. 96 Bracher, F. 47 Brack-Werner, R. 94 Brady, N. 52 Brancale, A. 80 Brandariz-Nuñez, A. , 44 Brandmüller, C. 59, 86 Brandt, S. 77 Brangwynne, C. 25 Braun, P. 47 Bremer, B. 29, 38 Bremer, C. 29 Bremer, V. 23, 97 Brennan, A. 42, 45 Brennan, C. A. 45 Bresk, A. 86 Brewitz, A. 29, 66 Brey, C. 78 Brillen, A.-L. 23 Bringolf, F. 36, 51 Brinkert, P. 52 Brinkmann, C. 59 Brinkmann, J. 66 Brinkmann, M. M. 56 Britten, C. 42 Brizic, I. 63 Brocchi, E. 85 Broccolo, F. 100 Brockmeyer, N. 48 Brodbeck, S. 37 Broering, R. 43, 56 Brönstrup, M. 54 Brost, R. 92 Brown, R. J. P. 36, 38, 88 Bruening, J. 51 Bruggmann, R. 60 Brune, W. 41, 43, 62, 92, 94 Brunnemann, A.-K. 80 Brunotte, L. 44 Bruss, V. 25, 73 Bruun, T.-H. 84 Brzezicka, J. 63 Buch, A. 21, 36, 74, 79, 96 Buchholz, C. 71 Büchner, S. M. 43 Buchy, P. 90 Bücker, R. 46 Buczolich, K. 64, 89 Budeus, B. 68 Budt, M. 15, 24, 78, 83 Bürck, C. 47 Burger, B. 47 Burkard, T. 91 Busch, D. 68 p 117 Index of Presenting Authors and Chair Persons Busch, Jo. Busch, Ju. Busch, M. Bussey, K. A. 87, 89 33 79 56 C Cadar, D. 46, 70 Cai, X. 21 Calvignac-Spencer, S. 98 Camdereli, J. 60 Canbay, A. 99 Cao, Y. 44 Cao, Z. 70 Carranza, C. 89 Casalegno, R. 87 Casanova, J.-L. 47 Cattaneo, R. 53 Cavalcanti-Adam, A. 21 Cavalleri, J.-M. V. 88 Chan, B. 24, 56 Chaudhry, M. Z. 87 Chelbi, I. 46 Chemin, I. 54 Chen, H.-W. 64, 89 Chen, M. 65 Chen, S. 43 Chen, W. 64, 70, 89 Chen, X. 43 Chen, Y. 38 Cherni, S. 46 Chey, S. 87, 89 Chi, H. 20, 54, 69, 70, 82 Chiang, C.-M. 37 Chin, Y. E. 28 Chmielewska, A. 93 Chu, D. 70 Chudy, M. 60, 78 Cichutek, K. 71, 92 Čičin-Šain, L. 29 Ciurkiewicz, M. 96 Çizmeci, Ş. G. 82 Claus, C. 15, 47, 72, 88, 89 Claus, P. 96 Clement, B. 78 p 118 Clos, J. Cochet-Bernoin, M. Cojocaru, R. Colinge, J. Collarile, S. Collenburg, L. Colonna, M. Colston, J. Commey, A. N. O. Convery, O. Conzelmann, K.-K. Cooper, P. Corall, S. Cordes, N. Corman, V. M. Cornberg, M. Corrales-Aguillar, E. Couderc, T. Coulpier, M. Couté, Y. Crequer, A. Cribier, A. Crowe, S. M. Cui, S. Culig, Z. Cullen, B. R. Cymerys, J. Czech-Sioli, M. 46, 70 88 45 55 80 83 29 32 46 83 90 97 37 21 70 29, 38 66 47 88 92 47 96 87 41 34 62 63, 93 28, 95 D Dachraoui, K. Daeumer, M. Damas, M. Dandri, M. Daniel, C. Daniels-Haardt, I. Dapa, S. Daugs, A. Däumer, M. Daumke, O. Dávid, S. Davison, A. J. De Gruyter, H. L. M. de Jong, S. J. 46 79 43 77 91 45 54 64 80 55 71 99 85 47 De la Torre, D. 89 de Mutsert, G. 85 De Rosa, M. 80 de Toledo-Piza, A. R. 79 Deeg, C. 98 Degen, O. 61 Deinhardt-Emmer, S. 80 Dekhtiarenko, I. 93 Delcuratolo, M. 37 Demminger, D. 42 Deng, W. 23 Dennehy, K. 68 Denner, J. 46, 60, 62, 82, 84 87, 88, 98 Denton, A. E. 32 Derking, S. 69 Derua, R. 44 Desrosiers, R. 52 Devignot, S. 91 Dewi, B. E. 72 Dezeljin, M. 93 Dhingra, A. 79, 99 Di, Nunzio, F. 93 Diaz-Griffero, F. 44, 93 Dick, A. 55 Dickow, J. 24 Diederich, S. 69 Diedrich, S. 48, 81, 99 Dieringer, B. 81 Dietrich, I. 57 Dietrich, U. 40 Dietz, A. 74 Dietzel, E. 72 Dijkman, R. 57 Diken, M. 42 Dilcher, M. 40 Ding, Q. 47 Dirks, M. 79, 80 Dittmer, A. 79 Dittmer, U. 15, 24, 32, 33, 39 68, 79, 83, 84 Dobner, T. 28, 47, 76 Doerflinger, S. 63 Doerrbecker, J. 36 Index of Presenting Authors and Chair Persons Döhner, K. 21, 36, 74 Dold, C. 34 Dölken, L. 88, 94 Döllinger, J. 90 Dolnik, O. 32 Donhauser, N. 32 Donnerhak, C. 94 Donos, A. 45, 80 Douam, F. 47 Drabczyk, M. 33 Drabig, A. 29 Drach, J. C. 79 Draenert, R. 94 Drago, F. 100 Draßner, C. 91 Dreer, M. 37 Dremsek, P. 61 Drewes, S. 46 Drexler, I. 15, 29, 81 Drexler, J. F. 15, 30, 40, 53, 61 Drosten, C. 30, 40, 53 69, 70, 82 Dubrau, D. 62 Ducroux, A. 22, 57 Dudek, A. 28 Dudek, N. 66 Dudek, S. E. 81 Dunay, G. A. 48, 61 Dunder, J. 25 Dunham, E. 91 Duong, V. 90 Dussart, P. 90 Duverlie, G. 57 Duwe, S. 77 Dzieciatkowski, T. 63, 79, 93 E Ebell, W. Eber, F. J. Eberle, F. Ebert, T. Eckerle, I. Eder, V. Egerer, L. 48 36 57 96 46 45, 80 86 Ehlers, B. 60, 70, 98 Ehrhardt, A. 15, 33, 71, 78 Ehrhardt, C. 15, 32, 41, 58, 64 81, 91, 96 Ehrke-Schulz, E. 71 Eibach, D. 99 Eiben, S. 36, 60 Eichelbaum, K. 91 Eickhoff, S. 29, 66 Eickmann, M. 22, 30 Einhorn, E. 57 Eis-Hübinger, A.-M. 79 Eissmann, K. 56, 96 Eizinger, M. F. 90 Elberry, M. 76 Elgner, F. 31, 71, 92 Ellerbrok, H. 64 Elliott, R. M. 57 Eloit, M. 88 Elsner, C. 33 Elvert, M. 51 Emerman, M. 25 Eng, K. 41 Engelhardt, J. 26 Engelmann, M. 57, 59 Enkirch, T. 86 Enquist, L. W. 25 Ensser, A. 25, 41, 52, 78 Erbar, S. 42 Erfle, H. 24 Erhard, F. 88 Erikson, E. 25 Erlmann, P. 34 Eroğlu, Y. 22 Erster, O. 40 Ertürk, A. 82 Eschke, K. 85 Eschricht, M. 62 Esly, N. 44 Espenlaub, S. 33 Essbauer, S. 45, 98 Esser, S. 80 Esser-Nobis, K. 24, 58 Estrada, A. 30, 82 Ewald, E. 22, 57 F Fabienne, J.-H. 47 Fackler, O. T. 25 Fae, I. 68 Faist, B. 68 Falcone, V. 66 Falk, C. 29 Falk, J. J. 22 Fan, Q. 70 Fares, W. 46 Fassati, A. 86 Fast, C. 46, 70 Fathy, N. 76 Fearon, D. T. 32 Fechner, H. 55, 72, 81 Fehling, S. K. 53, 71 Fehrholz, M. 94 Feige, K. 88 Feldmann, H. 15, 31, 91 Feng, N. 70 Feric, M. 25 Ferreira, A. 89 Fertey, J. 37, 85 Feuchtinger, T. 68 Fickenscher, H. 80 Fiddeke, K. 83 Fiebig, U. 82 Fiedler, A. H. 58, 85 Fiegl, H. 34 Figueiredo, C. A. 79 Filosa, R. 80 Finke, S. 25, 69, 88, 96 Finkernagel, M. 60, 78 Fischer, C. 71 Fischer, D. 73 Fischer, E. 99 Fischer, G. 68 Fischer, K. 69 Fischer, M. 55 Fischer, N. 28, 30, 43, 69, 95 Flamand, M. 21 Fleckenstein, H. 52 p 119 Index of Presenting Authors and Chair Persons Fleischer, B. 68 Florek, D. 89 Florin, L. 52, 53 Flory, E. 92, 94 Förthmann, B. 96 Fossen, T. 28, 74, 92 Foster, R. 36 Fouchier, R. A. M. 85 Foz, D. S. 69 Fraedrich, K. 74 Fraihi, W. 46 François, C. 57 Frank, L. 33 Franke, V. 93 Franz, Se. 54 Franz, St. 83 Franzke, K. 88 Frascaroli, G. 29 Fratini, M. 21 Fregoso, O. 25 Frensing, T. 28, 64 Freudenstein, A. 85 Fricke, M. 36, 64 Fricke, T. 93 Friedel, C. C. 75 Friedrich, M. 74 Friedrich, N. 83 Friedrich, S. 63 Friedrichs, I. 60 Fritsch, A. 90 Fu, J. 22, 33, 58 Fu, L. 12, 57, 83, 90 Fuchs, J. 22, 58 Fuchs, N. V. 92 Fuchs, W. 52, 73, 85 Full, F. 78 Funk, C. 71, 74 Funke, K. 92 Fux, R. 30, 69, 100 G Gabele, A. Gabriel, G. Gai, W. p 120 84 15, 44, 46 70 Gallo, A. 43, 92 Gan, T. 23, 99, 100 Gangneux, N. 47 Ganzenmüller, T. 100 Gao, F. 80 Gao, G. F. 20, 21, 81, 90 Gao, Y. 70 Garbi, N. 66 García-Sastre, A. 21, 62 Garrod, T. 42 Gärtner, B. 15, 45 Gärtner, S. 59 Gather, T. 88 Gawol, P. 73 Gebhardt, A. 75 Geiger, F. 36, 60 Geisler, A. 72 Gerke, C. 33 Gerke, V. 91, 96 Gerken, G. 56, 66 Germain, R. N. 66 Gerner, M. Y. 66 Gerold, G. 51 Gerresheim, G. 94 Gerstenberg, N. 73 Gettemans, J. 37 Geyer, H. 83 Geyeregger, R. 78 Ghanem, A. 90 Gibbert, K. 15, 21, 24, 33 Giese, S. 28, 62 Gilbert, N. 96 Gillespie, T. R. 82 Girra, S. 97 Gisa, A. 38 Glahder, J. 76 Glebe, D. 29, 60, 78 Gliemann, H. 36, 60, 61 Glögl, M. 85 Goeijenbier, M. 85 Goeijenbier, S. 85 Goffinet, C. 22, 54, 57, 59 Göhring, K. 77 Golbik, R. P. 63 Goldner, T. 28 Golemac, M. 42 Golke, A. 93 Gonzalez, Hernandez, M. 54 González, Hernández, M. 30 Gonzalez-Dunia, D. 88 Gonzalez-Motos, V. 96 Görlach, M. 77 Gorski, A. 79 Görzer, I. 63 Gosert, R. 24 Gossens, A. 73 Gostev, I. 45 Götte, B. 41 Göttfert, F. 26 Götz, V. 28 Gowans, E. 42 Grabski, E. 88 Graf, D. 90 Graf, L. 55 Graham, B. 38 Gramberg, T. 15, 32, 56, 96 Grasse, W. 24 Grässer, F. 88, 93 Grassmann, V. 84, 85 Graul, S. 99 Greiner, E. 41 Grethe, C. 38 Greune, L. 52, 54 Grewal, T. 96 Grewe, B. 72, 94 Griffin, S. 36 Grimm, D. 29, 54 Grimm, M. 37 Gronenborn, B. 28 Groß, S. 58 Groß, U. 97 Grosche, L. 91 Groschup, M. H. 61, 69 Groseth, A. 91, 95 Großkopf, A. 25, 52 Gross, C. 37 Grossegesse, M. 90 Grubor-Bauk, B. 42 Index of Presenting Authors and Chair Persons Grund, C. 84 Grundhoff, A. 15, 28, 30, 37 43, 62, 69, 95 Grünvogel, O. 58 Grunwald, T. 15, 32, 38, 85, 86 Gruska, I. 97 Grüttner, C. 24, 93 Guethoff, S. 98 Gulbins, E. 68 Gummow, J. 42 Gunasekharan, V. K. 47 Günther, M. 96 Günther, P. 68 Günther, T. 37 Günzer, M. 23 Guo, D. 38, 44 Guo, M. 23 Gursinsky, T. 58 Guzman, C. 42 H Ha, D. L. A. 82 Haag, M. 48 Haagmans, B. L. 69 Haarmann, T. 40 Haas, D. 24 Haas, R. 48 Habjan, M. 22, 55, 93 Haefeli, W. E. 48 Hafez, H. M. 99 Hafezi, W. 53, 73, 77, 80 Hage, E. 40, 43, 99, 100 Hägele, S. 87 Hagemeier, C. 97 Hahn, A. 25, 52 Hahn, F. 74 Hahn, K. 88 Haid, S. 38 Halenius, A. 32, 33, 93 Halwe, S. 32 Hamdorf, M. 92 Hammer, A. 99 Hampe, L. 53 Hamprecht, K. 77 Hanauer, J. 42, 58 Hanke, K. 61, 97 Hannaman, D. 32, 42 Hanne, J. 26 Hansman, G. 51, 55, 63 Hansmann, F. 69, 88 Harder, T. 23 Hardt, M. 77 Harman, R. M. 66 Hartjes, A. 61 Hartmann, E. 21 Hartmann, R. 57 Hartmayer, C. 70 Hasenberg, A. 32 Haslwanter, D. 51 Hassemer, M. 60, 78 Hauber, J. 61 Hauser, A. 23, 61, 97 Häussinger, D. 48, 60, 90 Hay, R. T. 76 Haynes, B. 86 Haywood, J. 90 He, S. 28, 37, 46, 57, 61, 64 70, 77, 85, 86, 87, 91 Hearps, A. C. 87 Heckel, J.-O. 100 Heenemann, K. 61 Hegazy, L. 75 Hegemann, M. 36 Heger, E. 79, 80 Heidemann, H. 82 Heikenwalder, M. 29 Heilbronn, R. 89 Heilingloh, C. S. 91 Heilmann, M. 56 Heilogenhaus, A. 79 Heim, A. 40, 99, 100 Heinecke, V. 71 Heinemann, F. M. 58 Heinemann, P. 45 Heiner, A. 72 Heinold, A. 56, 58, 68 Heinrich, T. 43 Heinrichs, G. 46 Heinz, F. X., 51, 52, 68, 72 Helbig, R. 94 Heldt, F. S. 28, 64 Hell, S. W. 26 Hellberg, T. 73 Hellmich, M. 48 Hemmi, H. 66 Hengel, H. 32, 33, 66, 96 Henke, A. 99 Hennig, T. 94 Henning, M. 79 Henritzi, D. 23 Henß, L. 69 Hensel, A. 77 Hensel, N. 96 Hensel-Wiegel, K. 89 Herden, C. 42, 46, 70 Herder, V. 69 Herker, E. 24, 63, 93 Hermann, B. 99 Hermanns, K. 82 Herold, S. 87 Heroldová, M. 98 Herren, M. 36, 51 Herrler, G. 53 Herrmann, A. 56, 77, 96 Herrmann, A. 56, 77, 96 Herrmann, J. 54 Herwig, A. 22, 87 Herzog, S. 46 Heß, R. 83 Heßler, M. 89 Heuser, S. 37 Hezel, P. 95 Hildt, E. 31, 43, 60, 71, 78 84, 92, 94 Hilgenfeld, R. 74, 75 Hillebrand, F. 77 Hiller, E. 85 Himmelsbach, K.31, 78, 84, 92 Hinz, A. 21 Hipp, K. 28 Hlinak, A. 61 Ho, B. 25, 46, 66, 70, 90 p 121 Index of Presenting Authors and Chair Persons Hobelsberger, D. 30, 82 Hochdorfer, D. 52 Hoelzer, M. 95 Hoenen, T. 22, 69, 91 Hofemeier, A. 53 Hofer, T. 86 Hoffmann, A. 52, 78, 97 Hoffmann, A. 52, 78, 97 Hoffmann, B. 46, 70 Hoffmann, D. 46, 68 Hoffmann, D. 46, 68 Hoffmann, K. 88 Hoffmann, M. 30, 53, 54 Hoffmeister, A. 33 Hofmann, A. 23, 97 Hofmann, H. 57, 70 Hofmann, J. 48, 83 Hofmann, S. 24, 63 Hofmann-Winkler, H. 70 Hogue, I. B. 25 Hohn, O. 64 Hollmann, C. 68 Holm-von Laer, D. 32 Holter, W. 78 Höltig, D. 30 Holze, C. 24 Holzenburg, A. 36 Holzer, A. 55 Hölzer, M. 22, 46, 58 Holzki, J. 32 Holznagel, E. 86 Hombach, A. 71 Homeier-Bachmann, T. 46 Homey, B. 90 Höner zu Siederdissen, C. 29 Höper, D. 46, 70 Hopfensperger, K. 33 Horn, A. C. 92 Horn, G. 28 Horn, P. A. 58 Hornung, V. 22, 57, 96 Hrebikova, G. 47 Hrycak, C. 84 Hu, L. 21, 41 p 122 Huang, G. Huang, L. Huang, X. Huang, X. Hubel, P. Hüber, C. Hübner, A. Hübner, D. Hübschen, J. Hudjetz, B. Hueging, K. Hufbauer, M. Hüfner, A.-D. Hügel, S. Hüser, D. Hütter, S. Hutterer, C. Huttin, A. Hüttmann, J. Hutzler, S. Hydes, T. 70 21, 41 43 43 44 24 30, 85 72, 89 47 37 74 37 61 21 89 94 92 88 41 42, 85 56 I Ibrahim, L. Idica, A. Iftner, T. Imahorn, E. Imami, K. Imdahl, S. Imler, J.-L. Imrich, E. Irmler, M. Ivanova, L. Ivanusic, D. 75 92 31, 37 47 97 71 55 77 43 36, 74 60, 62 J Jablonka, R. Jabulowsky, R. A. Jäckel, S. Jackson, D. Jaeger, C. Jäger, G. Jahn, G. Jahn, K. 80 42 97 95 29 78, 98 68, 77, 98 47 Jakob, L. 98 Janssens, V. 44 Jany, S. 30, 98 Japtok, L. 68 Jarmer, J. 66 Jarvis, M. 29 Jaworowski, A. 87 Jenckel, M. 46 Jensen, B. 48, 80 Jeske, H. 28, 36 Jia, L. 55 Jiang, B. 31, 92 Jiang, Y. 65 Jin, H. 70 Johne, R. 61, 64 Jolmes, F. 78 Jonjic, S. 24, 42, 56, 87, 96 Jonsdottir, H. R. 57 Jordan, I. 30, 84 Jörgens, D. 100 Jose, Luis, F. 47 Jouanguy, E. 47 Jung, M. 72, 89 Junglen, S. 24, 30, 69, 82 Jungnickl, D. 25 Juozapaitis, M. 21, 62 Juranic, Lisnic, V. 56 Jürgensen, C. 46 Jurke, A. 45 K Kaderali, L. 24 Kahl, S. 51 Kahle, T. 56 Kainov, D. 76 Kainulainen, M. 93 Kaiser, R.15, 38, 45, 48, 79, 80 Kaisho, T. 66 Kajitani, N. 64, 76 Kalaghatgi, P. 79 Kalinke, U. 88, 96 Kallies, R. 40 Kalser, J. 63 Kalus, U. 89 Index of Presenting Authors and Chair Persons Kapper-Falcone, V. 78 Karger, A. 69, 85, 88 Karimzadeh, H. 68 Karl, N. 64 Karlas, A. 15, 47, 91 Karo-Astover, L. 47 Karrasch, M. 99 Karsunke, J. 88 Kaserer, M. 98 Käsmaier, J. 99 Kasmapour, B. 87 Kaspar, M. 77 Kassem, S. 76 Kastenmüller, W. 29, 66 Katrin, R. 69 Katschinski, B. 81 Kaufer, B. B. 92 Kaufmann, A. 86, 95 Kawaoka, Y. 15, 31 Kayser, S. 68 Kchinich, E. 40 Keck, J. 74, 75 Kefalakes, H. 66 Kehl, T. 62 Keil, G. M. 23, 52, 78, 85 Keitel, V. 79 Keller, A. D. 77 Keller, M. 60, 82 Kemper, T. 23 Kendl, S. 94 Keppler, O. T. 25, 60 Kerber, R. 22 Kettern, N. 43, 94 Keyser, K. 93 Khabir, A. 76 Khakoo, S. 56 Khalid, D. 89 Khaliq, S. 78, 91 Khedkar, P. H. 86 Kiani, S. J. 77 Kiener, R. 86 Kieser, A. 15, 37, 41 Kieweg, L. 47 Kim, B. 25, 96 Kimpel, J. 34, 86 Kirchmair, J. 78 Kirschnick, N. 73 Kischnick, C. 22 Kislat, A. 90 Klabes, M. 63 Klapproth, E. 58 Klauschen, F. 66 Klause, T. 33 Kleine, A. 99 Klemens, O. 62 Klemm, C. 58, 96 Klemm, U. 47 Klempa, B. 15, 40, 45, 46, 98 Klenerman, P. 32 Klenner, J. 100 Klepsch, L. 90 Kleuser, B. 68 Klewer, M. 91 Kliche, A. 84, 85 Klingl, S. 22, 58 Klopfleisch, R. 81 Klupp, B. G. 51, 52 Klüver, M. 47 Knapp, B. 24, 68 Knapp, B. 24, 68 Knebel-Mörsdorf, D. 53 Knegendorf, L. 57 Knops, E. 45, 48, 79, 80 Knoth, M. 59 Koban, R. 64 Kobbe, G. 48 Kobinger, G. 70 Koblischke, M. 68 Koç, B. T. 82 Koch, C. 36, 60 Koch, J. 58 Koch, S. 37, 43, 79 Kochs, G. 15, 22, 40 46, 55, 58 Kocks, C. 93 Koepke, J. 53 Koethe, S. 23 Koether, K. 33 Kohl, A. 57 Kohl, C. 100 Köhler, A. 87 Koithan, T. 21 Kokina, K. 48 Kolanus, W. 29 Kolbe, V. 76 Kolenbrander, A. 68 Kolesnikova, L. 62, 72, 87 Koltzenburg, M. 36 Komander, K. 29, 66 König, P. 23 König, R. 15, 44, 71, 92, 94 Koop, J. 84 Kopp, A. 30, 82 Koppensteiner, H. 94 Korries, M. 24 Korth, J. 99, 100 Kosinska, A. 29, 68 Kosowicz, K. 54 Koszinowski, U. 78 Kowalewski, D. 32 Kowalski, K. 22 Kraatz, F. 73, 94 Kraft, A. 29 Krähling, V. 22, 91 Krajewski, M. 63 Kranz, C. 26 Krapp, S. 41 Kratzer, R. F. 33 Kraus, M. 72 Krause, E. 41, 72, 92 Krause, E. 41, 72, 92 Kräusslich, H.-G. 15, 20, 25 26, 32, 44, 62 Kraut, A. 92 Krautkrämer, E. 51, 87 Krawczyk, A. 79, 81 Kreijtz, J. H. C. 85 Kreiter, S. 42 Krempl, C. D. 90 Krenz, B. 41, 83 Kreppel, F. 15, 33 Kreuter, A. 48 p 123 Index of Presenting Authors and Chair Persons Krey, T. 90 Krill III, C. 36 Krimmling, T. 89 Krismer, M. 86 Krmpotic, A. 42 Krolla-Sidenstein, P. 61 Kroniger, T. 88 Kropff, B. 22 Krüger, A. 53 Krüger, D. H. 45, 46 Krüger, N. 45, 53 Krumbholz, A. 80, 99 Krumkamp, R. 99 Kubícková, B. 46 Kuecherer, C. 23, 61, 97 Kuehn, J. 53 Kühl, J.-S. 48 Kuhlencord, M. 33 Kühling, L. 52 Kühn, J. 15, 39, 48, 51, 71 73, 77, 80, 98 Kühnl, A. 96 Kuiken, T. 69 Kumar, A. 36 Kummer, M. 91 Kummer, S. 44 Kümmerer, B. 24 Kümmerle, T. 80 Kundi, M. 66 Kunec, D. 82, 85, 86 Kupke, A. 30 Kupke, S. Y. 28 Kurreck, J. 55 Kurts, C. 29 Kurz, M. 75 Kutle, I. 93 Kutschke, D. 43 Kuzmak, J. 62 Kuznetsova, I. 87 Kwiatkowski, M. 24 L Laib Sampaio, K. Laimins, L. p 124 22, 62 47 Lakdawala, S. 28, 62 Laketa, V. 32 Lamp, Be. 64, 89, 90 Lamp, Bo. 31 Landau, N. 57 Landsberg, C. D. 81 Landthaler, M. 88, 93 Lang, K. S. 33 Lang, V. 52 Lange, C. 78, 100 Langenmayer, M. C. 100 Langer, S. 78 Lapp, S. M. 36 Lapuente, D. 32 Larvin, M. 56 Laske, T. 64 Lassen, S. 93 Lassner, D. 89 Lau, S. 93 Le, Grand, R. 54 Le-Trilling, V. T. K. 32, 44, 48 63, 81, 95 Lebbink, R. J. 94 Lecuit, M. 47 Lee, L. N. 32 Leendertz, F. H. 45, 82 Leffler, A. 89 Leger, P. 21 Legewie, L. 94 Lehmann, M. H. 59, 85, 86 Lehmann, U. 94 Lehner, M. 78 Lehr, T. 48 Lei, J. 74, 75 Leibbrandt, A. 91 Leiprecht, N. 37 Leitner, T. 71 Lemke, E. A. 25 Lemmermann, A. W. N. 56 Lemmermann, N. 93 Lempp, F. A. 48 Lenac, T. 87, 96 Lengauer, T. 79 Lenk, M. 46 Lenzi, G. 25 Leroy, E. M. 40 Lesch, M. 91 Li, C. 23 Li, J. 21, 23, 33, 43, 71, 90 Li, N. 6, 7, 8, 13, 14, 54, 70 Li, S. 44, 64, 98, 99 Li, Yan 81 Li, Yanr. 42 Li, Yue. 70 Li, Yun 90 Liao, H.-X. 86 Lichty, B. 33 Ličková, M. 98 Lieber, A. 33 Lieber, D. 22, 52 Liebert, U. G.47, 72, 87, 88, 89 Liedmann, S. 64 Liermann, K. 80 Lim, E. 25 Lim, S. 98 Lin, D. 15, 21, 75, 94 Lin, Y. 23 Lindae, A. 74 Lindel, F. 94 Lindemann, D. 15, 21, 94 Lindemann, M. 58 Link, E. 86 Linnenweber-Held, S. 99 Linster, M. 82 Lischka, P. 28 Liu, F. 55 Liu, H. 23, 75 Liu, Jia 33, 43 Liu, Jin. 33, 71 Liu, Ju. 90 Liu, Q. 41 Liu, W. 90 Liu, Yingl. 55 Liu, Yingx. 90 Liua, Y. 21 Löchelt, M. 62, 84 Locher, S. 21 Lockhauserbäumer, J. 51, 55 Virus Receptors and Entry Löffler, B. 58, 96 Lohmann, V. 24, 58, 63, 77 Lorentzen, E. 53 Lorenzen, S. 70 Lorenzo, L. 47 Loroch, S. 62, 92 Loscher, C. 77 Loutfy, S. 75, 76 Lozach, P.-Y. 15, 21, 30, 52 Lu, F. 43 Lu, G. 21 Lu, K. 45 Lu, M. 23, 43, 56, 70 Lübben, V. 96 Lübke, N. 80 Lucht, A. 60 Ludewig, B. 32 Lüdtke, A. 47 Ludvigsen, M. 70 Ludwig, C. 98 Ludwig, S. 20, 33, 58, 64, 81 91, 96, 97 Luebke, N. 48 Luelf, A. 85, 98 Lugert, R. 97 Lüschow, D. 99 Lutter, T. 89 L’Hernault, A. 88 M Magalhaes, G. V. Ma-Lauer, Y. Maaske, A. Maasoumy, B. Macek, B. Mach, M. Mache, C. Macievich, M. Mackroth, M. Madhugiri, R. Madlung, J. Maganga, G. D. Mahmoudian, S. Maisa, A. 56 73 32 29 37 22 78 48 68 64 37 40 83 45, 87 Maisner, A. 31, 51, 69, 72, 73 Malassa, A. 22, 57 Malberg, S. 42 Maleki, M. 77 Malic, S. 42 Mallagaray, A. 51, 55 Malyshkina, A. 68 Mamerow, S. 84 Mankertz, A. 45, 83 Manns, M. P. 38 Marandu, T. 29 Marcinkeviciute, K. 61 Marcotrigiano, J. 24 Mariggiò, G. 37 Marklewitz, M. 69, 82 Markovic, G. 61 Marr, L. 85, 98 Marschall, M. 92 Marshall, J. 37 Marth, C. 34 Marti, O. 61 Martin, J. 54 Martin, M. 25 Martina, B. 98 Marz, M. 22, 36, 46, 55, 58 64, 95 Maschkowitz, G. 80 Masemann, D. 33 Materniak, M. 62 Matrosovich, M. 51 Matrosovich, T. 51 Matschulla, T. 33 Matthaei, A. 74 Matula, P. 24 Mauch, C. 37 May, J. 99 Mayla, A. 76 Mayr, T. 98 Mayrhofer, P. 73 Maywald, M. 96 Mazelier, M. 30 McFarlane, M. 57 McInerney, G. M. 41 McLellan, J. 38 Medits, I. 52 Medvedev, R. 31, 43, 71, 92 Megger, D. A. 44, 81 Meignin, C. 55 Meineke, D. 26 Meissner, K. 61 Meixenberger, K. 23, 61 Melling, M. 63 Mendonça, R. Z. 79 Menegatti, J. 88, 93 Mentzel, H.-J. 99 Merits, A. 41, 47 Merkel, L. 56 Mertens, T. 20, 26, 29, 73, 74 Messerle, M. 28, 42, 93 Mettenleiter, T. 73 Mettenleiter, T. C. 25, 40, 51 52, 82, 84, 85, 88 Meyer, A. 71 Meyer, B. 70, 95 Meyer, B. 70, 95 Meyer, M. 47 Meyer, T. F. 47 Michler, T. 29 Milbradt, J. 92 Milewska, A. 79 Millen, S. 32 Miller, D. M., 66 Minh, N. N. Q. 82 Mischak-Weissinger, E. M. 42 Mitnacht-Kraus, R. 42 Moens, U. 70 Moesker, F. M. 85 Mohamed, E.-C. 75 Mokdad-Gargouri, R. 76 Mokhtari, Azad, T. 77 Moldenhauer, A.-S. 52 Möller, S. 88 Momburg, F. 32 Moneer, M. 75 Moorthy, M. 82 Moosmann, A. 86 Moreira, E. A. 62 Moreira-Soto, A. 57 p 125 Index of Presenting Authors and Chair Persons Mori, Y. 92 Moritz, F. 43 Morozov, V. A. 98 Moser, O. 100 Mostafa, A. 40 Mostafa, S. 64 Mostajo, Berrospi, N. F. 95 Mounogou, Kouassi, N. 44 Mücksch, F. 32 Mueller, A. 36 Mueller, R. 28 Muether, B. 46 Mühl-Zürbes, P. 91 Mühle, M. 84, 88 Mühlebach, M. D., 42, 58, 85 Muik, A. 34 Müller, A. 15, 46, 51, 65, 70 Müller, A. J. 65 Müller, B. 15, 25, 26, 32, 62 Müller, C. 77 Müller, H. 53 Müller, J. 55 Müller, M. A. 15, 46, 70 Müller, N. 68, 83 Müller, O. 36 Müller, R. 22 Muller, W. A. 87 Muller, Y. 22, 58 Mullick, R. 42 Muluneh, A. 97 Münch, J. 55, 65 Müncheberg, S. 47 Mund, A. 47 Münk, C. 94 Munk, Pedersen, I. 92 Münster, L. 93 Münstermann, D. 60 Münz, C. 15, 39 Murr, M. 88 Murthy, S. 56 Muscolino, E. 92 Musiol, A. 96 Müthing, J. 73 Mutso, M. 41 p 126 N Nagel, C.-H. 74 Nagy, P. 70 Naqvi, A. 76 Nassal, M. 66 Nataly, P. M. 47 Ndembi, N. 45 Neff, C. P. 33 Negri, G. 79 Nehlmeier, I. 59 Nehls, J. 59 Neipel, F. 55 Nemitz, S. 88 Neubauer, K. 48 Neuber, S. 28 Neuenhahn, M. 68 Neumann, F. 95 Neumann, M. 45, 64, 79 Neumann, S. A. 72 Neumann-Fraune, M. 45, 79 Neusser, G. 26 Neuvonen, M. 41 Ng, J. 66 Nguyen, L. 25 Ni, Y. 81, 94 Niedenthal, R. 93 Niedrig, M. 61 Niemann, I. 83 Niemann, S. 96 Nierhoff, D. 79 Niesters, B. 100 Niezold, T. 42 Nikic, I. 25 Nilsson, K. 64 Nitsche, A. 38, 61, 90, 95, 100 Nitschko, H. 75, 78, 98 Nobach, D. 70 Nolden, T. 88 Nordbø, S. A. 70 Norley, S. 83 Nübling, M. C. 78 Nunez, L. 89 Nußbaum, L. 81 O O’Hare, P. 94 Obermeier, M. 31, 79 Obermeier, P. 48 Oevermann, A. 60, 69, 97 Oguzoglu, T. C. 82 Okba, N. 69 Olbert, M. 42 Orth, G. 47 Örvell, C. 53 Osterhaus, A. D. M. 69, 85, 98 Osterman, A. 75, 98 Ostermann, E. 94 Osterrieder, K. 66, 89 Osterrieder, N. 76, 82, 85, 86 Ott, M. 74 Otto, L. 32 Otto, V. 22 O’Farrelly, C. 83 P Pachota, M. Paki, K. Palaiokostas, C. Palmer, B. E. Palmer, C. S. Pan, R. Pan, X. Pang, D. Pang, J. Panning, M. Parodi, A. Paßvogel, L. Patasic, L. Patel, P. Patzina, C. Peibst, B. Peiffer, K.-H. Pejčoch, M. Peng, K. Penin, F. Penninger, J. Peper, J. Pereira, C. F. Pertermann, R. 81 91 40 33 87 38, 44 25 55 23 99 100 73 71 61 22 72 60, 78 98 62 36 91 68 87 58 Index of Presenting Authors and Chair Persons Peteranderl, C. 87 Peterhoff, D. 84, 85 Petermann, P. 53 29 Peters, A. E. Peters, G. 58, 96 Peters, T. 51, 55 64 Petersen, D. Petrachenkova, M. 48 Petraityte-Burneikiene, R. 61 Petrich, A. 46 Pettke, A. 39, 80 39, 80 Pettke, A. 70 Petzold, J. Peuser, I. 79 Pfaender, S. 36, 88 Pfankuche, V. M. 69 Pfeffermann, K. 86 Pfister, H. 48, 97 Pichlmair, A. 15, 21, 22, 24 44, 55, 93 Pietschmann, J. 78 Pietschmann, T. 15, 20, 25, 36 38, 51, 57, 59, 74, 88 Pietzonka, S. 100 Pijlmann, G. 98 Pinho, dos, Reis, V. 69 Pinkert, S. 55, 81 Pinto, M. 80 Pischke, S. 38 Planz, O. 15, 41, 70 Plattet, P. 36, 51 Plegge, T. 70 Pleschka, S. 15, 40, 77, 87 Plettl, A. 61 Ploen, D. 71, 92 Ploss, A. 47 Plotzki, E. 46, 60 Podsiadlowski, L. 82 Poelman, R. 100 Poghossian, A. 60 Pogodalla, A. 80 Pohl, A. 36, 74, 80, 85 Pohlentz, G. 73 Pohlmann, A. 36, 74, 80 Pöhlmann, S. 15, 30, 39, 52 53, 54, 59, 70 Ponnurangam, A. 22, 57, 59 51 Popli, S. Portugal, R. 78 Postel, A. 69, 88 97 Posthaus, H. Poulet, A. 88 Prager, L. 90 Pramudita, A. 72 Prange, R. 95 Prank, U. 74 Price, P. J. R. 59 Proff, J. 78 Proksch, A. 64 Pröll, F. 61 Proll, G. 61 Protzer, U. 29, 68, 77, 92 Prüfer, S. 85 Prüger, P. 61 Przybylski, M. 79 Puchhammer-Stöckl, E. 63, 66 Puff, C. 88 Purcell, A. 66 Pyrć, K. 8 1 Q Qi, J. Qian, J. Qin, R. Qiu, X. Qu, B. Qu, X. Qurishi, N. R Rabenau, H. F. Radonic, A. Radosa, L. Rafati, S. Raftery, M. Raj, V. S. Rajagopal, R. Rajewsky, N. 21, 70, 80 70 29 70 91, 95 90 79 60 38 46, 98 77 86 69 51 93 51 Rana, V. S. Raschbichler, V. 71, 74 Rattay, S. 90 28, 74 Rau, P. Rauch, P. 74 Ravichandran, D. 82 Ray, P. 98 Raynal, B. 90 Raza, M. 91 Real, C. 56 Reber, U. 100 Reddehase, J. M. 56 Reetz, J. 61 Rehwaldt, S. 52 Reibetanz, U. 72 Reichart, B. 98 Reichel, A. 83, 113 28, 64 Reichl, U. Reimann, I. 63, 73, 94 Reimer, E. 56 Reiser, J. 87 Ren, H. 31, 71, 92 Rennert, P. 83 Renz, D. 99 Resa-Infante, P. 44 Rescher, U. 91, 96 Reuter, A. 44, 57 Reuter, A. 44, 57 Reuter, D. 68 Reuter, N. 22, 56, 63 Rey, F. 62 Rheinemann, L. 41 Richardson, J. 88 Richter, M. 63 Rieble, L. 81 Riedel, C. 64 Rieß, M. 92, 94 Riese, P. 42 Rimmelzwaan, G. F. 85 Rimoin, A. W. 45 Ringel, M. 31 Rink, L. 48 Rinker, F. 29 Rippert, A. 22 p 127 Index of Presenting Authors and Chair Persons Ritter, B. 89, 96 Rivière, L. 94 Rodrigez, Urbiola, C. 34 29 Roeder, N. Röger, C. 72 Roggendorf, M. 29, 43, 68, 79 Rohde, C. 22, 91 Rohr, K. 24 Rohrhofer, A. 58 Roman-Sosa, G. 85 Romberg, M.-L. 53 Römer, K. 79 Römer-Oberdörfer, A. 25, 42 88, 96 Romero, Brey, I. 24 Roques, P. 54 Rösch, K. 24 Rosenhahn, B. 36 Ross, S. 58, 88, 100 Rossey, I. 38 Rossmark, S. 88 Roth, J. 33 Rother, F. 21 Rouxel, R. 21, 30 Rubbenstroth, D. 42 Rubin, S. 53 Rubistein-Giuni, M. 40 Rückborn, M. U. 81 Rückert, J. 37, 43, 79 Rüdiger, A.-T. 73 Rudolph, K. 21 Ruemenapf, T. 90 Rümenapf, T. 64, 89 Rupp, S. 85 Rutkowski, A. 88 Ruzsics, Z. 78 Rwego, I. B. 82 S Sadewasser, A. Saelens, X. Sahin, U. Sakhria, S. Sakin, V. p 128 91 38 42 46 25 75 Salem, S. Sallemi-Boudawara, T. 76 Samarina, N. 79 77 Samimi-Rad, K. Samperio, Ventayol, P. 54 Sandbaumhüter, M. 74 Sandig, V. 84 Santag, S. 37 Santander-Parra, S. 89 Santer, F. 34 Saragosti, S. 45 Sass, G. 77 Sattler, C. 43 Sauder, C. 53 Sauerbrei, A. 77, 78, 80, 99 Sauerhering, L. 51, 69 Sauermann, U. 59 Saurav, G. K. 51 Savvatis, K. 81 Sawatsky, B. 53, 72, 86 Schaal, H. 23, 77 Schaar, K. 72 Schade, D. 78 Schaffrath, Rosario, A. 45 Schauflinger, M. 73 Schaumburg, F. 45 Scheffter, R. 84 Schelhaas, M. 15, 20, 21 52, 54 Schelp, C. 85 Schenk, J. A. 61 Schepens, B. 38 Schepsky, P. 31 Scherbaum, N. 56, 58 Scherer, C. 63 Scherer, M. 22, 58, 83 Scheuplein, V. 58 Scheuplein, V. A. 58 Scheurer, S. 84 Schieber, N. 24 Schilling, E.-M. 58 Schilling, M. 22, 58 Schimer, J. 26 Schindler, M. 25, 59, 73, 94 69 Schipper, D. Schippers, T. 76 Schiraldi, C. 80 85 Schirrmeier, H. Schiwon, M. 71 Schlaak, J. 56 Schlenther, I. 90 Schloer, S. 91 Schlottau, K. 46 Schlüter, H. 24 Schmid, V. 84, 99 Schmidt, A. 33, 52, 54 Schmidt, B. 58 Schmidt, C. 95 Schmidt, J. 15, 30, 31, 46, 70 Schmidt, M. A. 54 Schmidt, M. 78, 81, 97 Schmidt, R. 86 Schmidt, S. 28 Schmidt, T. 63 Schmidt, V. 99 Schmidt-Chanasit, J. 15, 30 31, 46, 70 Schmidtke, M. 78, 81 Schmidtko, A. 33 Schmier, S. 40 Schmitt, J. 83 Schmitt, S. 56 Schmitt-Kopplin, P. 43 Schmitz, H. 44, 71, 92 Schneider, I. 71 Schneider, M. A. 53 Schneider, M. 37 Schneider, S. 83, 86 Schneider-Schaulies, J. 68, 94 Schneider-Schaulies, S. 83 Schnellbächer, E. 44, 94 Schnettler, E. 57 Schnierle, B. 54, 69 Schöbel, A. 24 Schoen, A. 95 Scholten, M. 99 Scholten, S. 79 Scholz, B. 25 © International Endotoxin and Innate Immunity Society 14th Biennial Meeting www.mediaserver.hamburg.de 22–24 September 2016 Hamburg/Germany DEaDlInE for abStract SubmISSIon: 30 April 2016! • • • • • • lipopolysaccharide transport Structures of lipopolysaccharide outer membrane Vesicles Plant Innate Immunity Epigenetic control of Innate Immunity antimicrobial Peptides and (Gram-negative) Sepsis • Endotoxin Detection • targeting Innate Immunity www.ieiis2016.de © Wolfgang Meinhardt I wikimedia.com Index of Presenting Authors and Chair Persons Schommartz, T. 41, 62 Schöne, D. 84 Schöning, M. 60 86 Schönrich, G. Schott, K. 44, 94 Schräder, T. 53, 81 64, 81 Schreiber, A. 34 Schreiber, L.-M. Schreiber, M. 34, 90 Schreiner, S. 47, 76 Schrick, L. 61, 90 Schröter, C. 51, 52 Schubert, C. 100 Schubert, T. 84 Schubert, U. 74 Schuck, J. 58 Schudt, G. 87 Schuebel, N. 79 Schuelter, E. 79 Schuetz, J. 37 Schuler-Thurner, B. 58 Schultz, C. 32 Schulz, T. F. 79, 99 Schulze, A. 83 Schulze, M. 97 Schulze, zur, Wiesch, J. 61, 79 Schulzke, J.-D. 46 Schüpbach, G. 97 Schupp, A.-K. 90 Schuster, M. 29 Schuster, P. 58 Schwab, M. 37, 48 Schwab, R. M. 37 Schwab, Y. 24 Schwaiger, J. 68 Schwartz, S. 64, 76 Schwarz, A. 99 Schwarz, S.-M. 25 Schwegler, C. 86 Schwegmann-Weßels, C. 73, 89 Schweiger, B. 77 Schweininger, J. 58 Schweizer, M. 90 p 130 Schwemmle, M. 15, 21, 28, 44 49, 57, 62 Schwudke, D. 63 45, 80 Scoferta, P. Scordel, C. 88 Scott, C. 36 Scrima, A. 87 Scuotto, M. 80 Segalés, J. 69 Seidenstücker, A. 61 Seifried, J. 44, 71 Selbach, M. 91, 97 Selimovic-Hamza, S.60, 69, 97 Sellrie, F. 61 Selvaraj, T. 58 Sendker, F. 55 Senff, T. 56 Serwa, R. 94 Sette, A. 66 Setz, C. 74 Seuberlich, T. 60, 69, 97 Shaalan, M. 75 Shams-Eldin, H. 30 Sharir, B. 40 Shen, T. 43 Shepard, C. 96 Shi, M. D. Y. 87 Shi, X. 57 Shi, Y. 21, 87 Shifflett, K. 91 Shukla, S. 36 Sickmann, A. 62 Sidney, J. 66 Siebels, S. 28, 95 Sierra, S. 79 Silling, S. 48, 97 Simmons, G. 45 Simon, A. 100 Simons, G. 54 Singethan, K. 77 Sinn, L. J. 64 Sinzger, C. 22, 29, 52, 62 Sipo, I. 83 Sitek, B. 44, 81 Siva, Raghavendhar, B. 98 Skelton, J. K. 57 Sláviková, M. 98 69 Sliva, K. Slonska, A. 63, 93 100 Smith, A. A. A. Smith, G. J. D. 82 Smits, S. L. 69 Socher, E. 32, 92 Sodeik, B. 15, 21, 25, 31, 36 74, 79, 80, 96 Soderholm, S. 76 Solanki, M. 33 Sommer, A. 94 Somogyi, S. 23 Song, F. 30 Song, J. 21 Song, X. 70 Sonnabend, J. 95 Sonnewald, U. 41 Sonntag, E. 28 Speckmann, I. 73 Spiegel, M. 70 Spinu, C. 45, 80 Spinu, I. 45, 80 Spoden, G. A. 53 Squire, A. 23 Stab, V. 32, 83 Stäheli, P. 15, 24, 49 Stalmann, G. 62 Stamminger, T. 22, 28, 56, 58 63, 83 Standfuß-Gabisch, C. 56 Stanifer, M. 22 Stanke, N. 94 Stanko, M. 98 Stanslowsky, N. 89 Stech, J. 84 Steer, B. 43 Steffen, I. 45 Steglich, C. 84 Stegmann, C. 22 Stegmann, L. 25 Steiger, J. 37 Index of Presenting Authors and Chair Persons Steingruber, M. 92 Steinkasserer, A. 91 Steinmann, E. 15, 36, 38, 57 59, 88 Steinmetz, N. F. 15, 20, 36 Stellberger, T. 75 Stempel, M. 24 Sterner-Kock, A. 37 Sterz, K. 41 Stevanović, S. 32, 68 Stevenson, N. J. 83 Stewart, F. 33 Stiasny, K. 51, 52, 66, 68, 72 Sticht, H. 22, 32, 58, 83, 92 Stoeger, T. 43 Stoiber, H. 32 Storcksdieck, M. 42, 83 Stram, R. 40 Stram, Y. 40 Straub, E. 37 Strauß, J. 66 Strecker, T. 53, 71, 95 Streeck, H. 42 Striebinger, H. 71 Stroh, E. 69 Stubenrauch, F. 37 Stump, J. 22, 58 Stürmer, M. 60 Su, Y. 82 Subramanian, N. 29 Suffner, S. 73 Sun, B. 15, 39 Suneetha, P. V. 38 Sung, M. W. 36 Superti-Furga, G. 22, 93 Sutter, G. 30, 42, 59, 69, 85 86, 98, 100 Svrlanska, A. 28, 63 Switzer, W. M. 45 Sydow, D. 73 Szabó, R. 98 Szelechowski, M. 88 Szemes, T. 40 T Taheri, T. 77 Tamosiunas, P. L. 61 Tang, B. 55 Tang, J. 94 Tannich, E. 99 Tao, S. 81 Tao, W. 23 Tappe, D. 46, 70 Tatham, M. H. 76 Taube, S. 51, 55 Tauchmann, Y. 89 Tautz, N. 62 Teifke, J. P. 46, 70 Tekes, G. 89 Temchura, V. 68, 83 Tenbusch, M.15, 32, 42, 81, 83 Tenhündfeld, J. 69 tenOever, B. 15 Tetard, M. 21 Thaa, B. 41, 72 Theiß, J. 43 Theiss, S. 23 Thiberge, S. Y. 25 Thiel, H.-J. 89 Thiel, N. 93 Thiel, V. 57 Thiele, S. 44 Thier, K. 53 Thoma-Kreß, A. K. 32, 37 Thomann, S. 58 Thomas, D. 96 Thomas, M. 28 Thomson, E. 40 Thöns, C. 56, 58 Tiegs, G. 77 Timm, J. 56, 58, 60, 66, 80 Timmen-Wego, M. 45 Tippler, B. 72 Tiwarekar, V. 94 Tober, R. 86 Toda, M. 84 Todt, D. 38, 57, 88 Todt, H. 57 Tolosa, E. 61 Tolstrup, M. 100 Tomic, A. 42 Tondera, C. 44, 71, 92 Tortorici, M. A. 62 Townsend, L. B. 79 Trenschel, R. 100 Trilling, M. 15, 43, 44, 48, 63 81, 95 Trimpert, J. 82 Trippler, M. 56 Trojnar, E. 64 Trotard, M. 25 Truchet, L. 60, 69, 97 Truschow, P. 63 Tsouchnikas, G. 66 Tuan, H. M. 82 Tuan, T. A. 82 Tucholska, A. 93 Türeci, Ö. 42 Turki, A. 100 U Überla, K. 42, 68, 83, 94 Uetrecht, C. 15, 36, 51, 55 Uetz, P. 75 Uhrberg, M. 56 Ulbert, S. 85 Ulrich, D. 77, 80 Ulrich, K. 40 Ulrich, R. G. 46, 70 Urban, S. 48, 54, 81, 94, 95 Utt, A. 41 V Vahlenkamp, T. W. 15, 46 Vallbracht, M. 51, 52, 53, 71 van de Poel, S. 37 van de Vijver, D. A. M. 85 van den Brand, J. M. A. 69 van den Dries, L. 85 van Doorn, H. R. 82 Van Ghelue, M. 70 van Gorp, E. C. M. 85 van Krüchten, A. 96 p 131 Index of Presenting Authors and Chair Persons Van Leer-Buter, C. 100 Van Straten, M. 40 Vanwalscappel, B. 57 Varanasi, P. R. 42 Varga, G. 33 Varghese, F. 41 Varjak, M. 47 Veesler, D. 90 Veit, M. 72 Veits, J. 40, 82 Velkovic, V. 40 Verbruggen, P. 95 Vergara-Alert, J. 22 Verheyen, J. 15, 48, 80, 99 Verjans, G. M. G. 89 Vetter, B. 97 Viejo-Borbolla, A. 89, 96 Vieths, S. 84 Vietzen, H. 63, 66 Vieyres, G. 25, 36, 57 Villinger, C. 26, 73, 74, 75 Vizoso-Pinto, M. G. 75 Voigt, Se. 45, 48, 63, 79, 86 Voigt, St. 41 Völker, F. 97 Volkmann, B. 56, 96 Vollandt, D. 61 Volz, A. 30, 69, 85, 98 von, Brunn, A. 73 von, Einem, J. 73, 74, 75 von, Hahn, T. 79 von, Laer, D. 34, 86 von, Messling, V. 53, 72, 86 Vondran, F. 54 Voronkova, N. 48 Voskoboinik, I. 42 Vratskikh, O. 66 W Wacheck, S. 23 Wagner, K. 28 Wagner, R. 72, 84, 85, 86 Wagner, S. 92 Waldmann, K.-H. 30 p 132 Walendy-Gnirß, K. 59 Walker, A. 60, 66 Walland, J. 97 Walotka, L. 23 Walter, H. 79, 80 Walter, S. 36, 88 Walterskirchen, C. 78 Walther, P. 26, 29, 73 Walz, L. 85, 86 Wang, C. 70 Wang, Ha. 21 Wang, Hu. 70 Wang, J. 43 Wang, Li 29 Wang, Lin. 66 Wang, S. 38 Wang, T. 70 Wang, Y. 38 Warnke, C. 100 Watson, M. 57 Watt, A. 91 Way, M. 15, 20 Weber, A. 62 Weber, C. 54, 69 Weber, F.15, 22, 24, 91, 93, 95 Weber, S. 40 Wedemeyer, H. 29, 38, 48, 57 Wege, C. 36, 60, 61 Wegener, H. 51, 55 Wegner, F. 89 Wehner, S. 40 Wei, L. 76 Weidl, D. 41 Weidmann, M. 40 Weidner, T. 54 Weil, S. 58 Weil, T. 33 Weingartl, H. 69 Weis, M. 72, 73 Weisbach, H. 97 Welle, A. 61 Weller, R. 74 Welzel, U. 87 Wendt, L. 71 Wendt, M. 69 Weng, C. 21, 41 Werner, M. 56, 58 Werner, S. 68 Werner, T. 33 Werner-Klein, M. 58 Wernery, U. 70 Wernike, K. 73, 85, 94 Wetzel, C. 85 Whisnant, A. W. 62 Wicht, O. 24 Widera, M. 23, 80, 99 Wiebusch, L. 97 Wiedtke, E. 54 Wiegand, M. 86 Wiegand, T. 21 Wieland, U. 48 Wierich, L. 85 Wiesmann, V. 37 Wijesundara, D. 42 Wild, A.-L. 75 Wilkie, G. S. 99 Willberg, C. 32 Willemsen, J. 24 Wiltzer-Bach, L. 25 Winkler, M. 59 Wisskirchen, K. 92 Witkowski, P. T. 40, 45, 46 Wittenberg, T. 37 Wittmann, S. 56, 96 Wittwer, K. 73 Witzke, O. 99, 100 Wixler, V. 33 Wohlfahrt, J. 94 Wohlsein, P. 69 Wolanski, J. 24 Wolf, G. 56 Wolff, S. 95 Wolff, T. 42, 78, 83, 87, 91, 93 Wollmann, G. 34 Wong, G. 70, 90 Woon, A. 66 Woskobojnik, I. 79 Wrensch, F. 53, 59 Index of Presenting Authors and Chair Persons Wu, J. Wu, K. Wu, S.-Y. Wu, W. Wu, Ya. Wu, Yu. Wu, Ze. Wu, Zh. Wuerth, J. D. Wuestenberg, A. Wulle, U. Wurlitzer, M. Wurzlbauer, A. Wüstenhagen, E. Wüthrich, D. Wyler, E. Wynne, J. Wys, M. Wyss, M. 76 55, 76 37 43 80, 90 33 29 36 22 77 70 24 47 53 60 88, 93 66 36, 51 51 X Xavier, R. C. Xia, X. Xiao, Hai. Xiao, Han Xing Yi, L. Xiong, Y. Xu, J. Xu, K. Xu, S. 47 70 90 94 82 55 98 28 22, 57 Y Y, B. Yan, F. Yan, H. Yan, J. Yan, Q. Yang, D. Yang, H. Yang, Q. Yang, S. Yang, W. Ye, L. Yeonhwa, J. 90 70 55, 76 21, 81 65, 76 43 76 76 70 76 98 95 Youness, B. Yu, W. Yuan, Z. Yumul, R. Z Zaeck, L. Zahorska, R. Ze-Ze, L. Zeichhardt, H. Zeier, M. Zekri, A.-R. Zelikin, A. N. Zelinskyy, G. Zell, R. Zeng, C. Zhang, G. Zhang, L. Zhang, L. Zhang, Q. Zhang, She. Zhang, Shu. Zhang, Wei Zhang, Wen. Zhang, X. Zhang, Y. Zhang, Zhe. Zhang, Zhu. Zhao, X. Zhao, Y. Zhao, Y. Zhe, Z. Zheng, Xi. Zheng, Xu. Zheng, Y. Zhioua, E. Zhong, J. Zhou, J. Zhou, X. Zhu, M. Zhu, S. Zickler, M. Ziebuhr, J. Ziegler, C. 21 42 15, 31 33 96 79 70 81 51, 87 75 100 32, 33 99 38 37 41, 75 41, 75 23, 76 65 90 90 33 38 23 56 76 90 28, 70 28, 70 82 56 70 70 46 23 87 90 44 89 51 40, 64, 77, 89 84 Zielke, B. Zigrino, P. Zillinger, T. Zimmer, B. Zimmer, G. Zimmer, R. Zimmermann, A. Zimmermann, C. Zirkel, F. Zitzmann, N. Zlatkovic, J. Zmora, P. Zou, M. Zou, Y. Zumstein, M. Zurnic, I. Zuwala, K. 28 37 22, 57 84 21, 22, 86 88 90, 96 32, 93 30, 69, 82 36 66 52, 53 65 70 30 94 100 p 133 Upcoming Conferences and Meetings Frontiers of Retrovirology 2016 Complex retroviruses, retroelements and their hosts 12–14 September 2016 • Erlangen (DE) www.frontiers-of-retrovirology.com 109th Annual Meeting of the German Zoological Society (DZG) 14–17 September 2016 • Kiel (DE) www.dzg-meeting.de 14th Biennial Meeting of the International Endotoxin and Innate Immunity Society (IEIIS) 22–24 September 2016 • Hamburg (DE) www.ieiis2016.de 5th International Influenza Meeting 25–27 September 206 • Münster (DE) www.fluresearchnet.de 46th Annual Meeting German Society for Immunology 27–30 September 2016 • Hamburg (DE) Abstract-Deadline 23 May 2016 www.immunology-conference.de National Symposium on Zoonoses Research 13–14 October 2016 • Berlin (DE) 27th Annual Meeting of the Society for Virology (GfV) 22–25 March 2017 • Marburg (DE) www.virology-meeting.de 9th International Symposium on Filoviruses 13–16 September 2017 • Marburg (DE) www.filovirus-meeting.com p 134 Cytotect® CP Biotest Sicher und zuverlässig im gezielten Management der CMV-Infektion nach Transplantationen Cytotect® CP Biotest: Risiken erkennen – professionell handeln Cytotect®CP 100 E/ml Infusionslösung Wirkstoff: Cytomegalie-Immunglobulin vom Menschen Zusammensetzung: 50 mg/ml Plasmaproteine vom Menschen (mind. 96 % Immunglobulin G), Gehalt an Antikörpern gegen CMV von 100 E*/ml (* Einheiten d. Referenzpräp. d. Paul-Ehrlich-Instit.), Höchstgehalt an IgA: 2000 mcg/ml, Glycin, Wasser f. Injektionszwecke. Anwendungsgebiete: Prophyl. klin. Manifestationen einer CMV-Infekt. b. Pat. unter immunsuppr. Ther., insb. Transplantat-Empf.. Gegenanzeigen: Überempfindlichkeit gegen jegl. Bestandteile od. hum. Immunglobuline; insb. b. Pat. mit IgAAntikörpern. Nebenwirkungen: Gelegentlich: Kopfschmerzen, Schwindel, Erbrechen, Übelkeit, Gelenkschmerzen, leichte Rückenschmerzen, niedriger Blutdruck, Schüttelfrost, Fieber, allerg. Reaktionen. Selten: Überempfindlichkeitsreakt. m. plötzl. Blutdruckabfall, Einzelfälle bis z. anaphylakt. Schock, vorrübergeh. Hautreaktionen. Sehr selten: thromboembol. Reakt. wie Myokardinfarkt, Schlaganfall, Lungenembolie, tiefe Venenthrombose. Nicht bekannt: revers. asept. Meningitis, resers. hämolyt. Anämie, Anstieg d. Serumkreatinin-Spiegels u./od. akutes Nierenversagen. Lagerung: Im Kühlschrank lagern (2°C–8°C). In der Originalverpackung aufbewahren, um den Inhalt vor Licht zu schützen. Nicht einfrieren. Biotest Pharma GmbH, Landsteinerstr. 5, 63303 Dreieich Verschreibungspflichtig. Stand der Information August 2015 Biotest Pharma GmbH · Postfach 10 20 40 · 63303 Dreieich · www.biotest.de